id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,chunk_num_tokens,output,is_chunked
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,[],"###Answer: 14.2073, 1.739261, 15
---
###Answer: ANSWER: (REF)
---
",True
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,-0.1554,0.2508,,,,,,TRUE,13404,7477,TEST,[],"Intervention: ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating (mean: 3.77, standard_deviation: 1.38, group_size: 8), comparison: control (mean: 7.57,
---
1.39,0.48,16
###Answer: table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome: Intervention: ACVC-HA. Comparator: control
---
<p>Intervention: artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC-HA:</p><p>mean: 5.86, standard_deviation: 0.87, group_size: 12</p><p
---
###Answer: <p>table<br> Intervention: ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC Comparator: control Outcome: lateral bending for the C2-C4 segments Field: mean, standard_
---

intervention:
  - lateral_bending:
    - mean: 10.2
    - standard_deviation: 1.3
    - group_size: 17
  - lateral_bending:
    - mean: 18.3
    - standard_de
---

intervention:
  - mean: 0.0871
  - standard_deviation: 0.0419
  - group_size: 30
comparator:
  - mean: 3.5634
  - standard_deviation: 0.96
---
",True
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,0.3277,0.0687,,,,,Values are for week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"
intervention:
    CD4+/CD8+ ratio : x
comparator:
    CD4+/CD8+ ratio : x

---
Intervention: 200 mg/day palmvitee smokers
Comparator: 200 mg/day palmvitee nonsmokers
Outcome: CD4+/CD8+ ratio 4 weeks (primary outcome measure)
mean: 1.06
standard_
---
4.79, 0.23, 16, 4.74, 0.44
---
###Answer: table.
---
69.69, 10.04, 56<br>65.05, 8.40, 56<br>62.76, 7.54, 51.84, 7.07, 56<br>63
---
###Answer: true
---
###Answer: <p>table-wrap table-width=""100%"" width=""100%"" cellspacing=""4"">    table border=""1"" width=""100%"" cellpadding=""4"">    table style=""font-family: Times New Roman, Times, serif"">  
---

---
###Answer: <p><strong>Palvitee</strong> Reduces CD4/CD8 Ratio in Smokers: Changes in the composition of peripheral blood lymphocytes in smokers as determined by flow cytometry. Data are presented as mean ± SD. * P 
---
###Answer: {​​""mean"":9.89061,​​""standard_deviation"":0.73598,​​""group_size"":32}, {​​""mean"":8.81818,​​""standard_deviation"":0.43
---
###Answer: 200 mg/day palmvitee smokers showed CD4+/CD8+ 1.02 (0.18) compared to 0.96 (0.14) in 200 mg/day palmvitee nonsmokers.
---
###Answer: {​""intervention"": {​""mean"": 3.255645179, ""standard_deviation"": 0.366612745, ""group_size"": 25},​
​""comparator"": {​""
---
intervention:
  mean: 1.00 
  standard_deviation: 0.09
  group_size: 30
comparator:
  mean: 1.00 
  standard_deviation: 0.31
  group_size: 30

---
",True
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,[],"In the tranexamic acid group (n=30), the mean postoperative hematocrit was 35.5% (SD: 1.5%). 2 (6.7%) patients required blood transfusion. In the control group (n=30), the mean postoperative hematoc",False
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,0.2624,0.0908,,,,,found in table,TRUE,4402,2905,TEST,[],"###Answer: intervention: ""leptin/adiponectin ratio (LAR)"": 1.54 x 10^(-2) (1.27 x 10^(-2), 1.83 x 10^(-2)), 20; comparator: 
---
### Answer: mean: 0.063333, standard_deviation: 0.068667, group_size: 68.000000
---

###Answer: true
---
",True
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,0.1225,0.0954,,,,,,TRUE,1345,1148,TEST,[],"yaml2html --no-html-headers --implicit-links --exclude "".*"" --collapse 8 --top-url ""http://www.pubmed.gov/"" --bottom-url ""http://www.pubmed.gov/"" --style ""sprintf('%s %s',color:gray,'- ','",False
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"
###Answer: 7.78708199378952, 1.802616441111529, 190
---
###Answer: 72 6.27 23
---
###Answer: 14.93097, 3.401056, 122
---
yaml-ref-output:
---
<!-- Raw MI-LEAF (language enhanced attention and focus motivational interviewing) group size (n): 31, mean (M) = 6.0, standard deviation (SD) = 0.9 -->
Intervention:
  - mean: 6.0
  - standard_deviation:
---
",True
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"###Answer: table: 0B6613BC2C8CD8B169BEA591EE172CD85F48887.
---
###Answer: table-wrap table-wrap-start table-wrap-end table-wrap-fig table-wrap-fn table-wrap-ftable tr td align=""center"" colspan=""4"" style=""font-family: Times New Roman, Times, serif""> InterventionComparatorOutcome mean 2.1
---
",True
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,[],"
Intervention:
    mean: 63.95
    standard_deviation: 18.48
    group_size: 18
comparator:
    mean: 54.78
    standard_deviation: 18.56
    group_size: 
---
###Answer: table: <table><thead><tr><th>mean</th><th>standard_deviation</th><th>group_size</th></tr></thead><tbody><tr><td>-10.44</td><td>15.58</td><td>48</
---
###Answer: 8063
---
###Answer: table-wrap table-wrap-start table-wrap-end yaml-no-pre {tbl no} yaml-no-mid {mid} yaml-with-pre {pre}
---
###Answer: table 2 - Table 2 Metformin, Pioglitazone, and placebo monotherapy in patients with limited extensive psoriasis and with at least two prior non-biological systemic treatments: patient subgroup analysis (Intention to treat Analysis) Demographic and baseline clinical characteristics of
---
###Answer: table-content: <p>Intervention, Comparator, and Outcome: <p>intervention:</p> <p>mean: 65.863</p> <p>standard_deviation: 14.624</p> <p>group_size:
---
",True
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,[],"###Answer: type: application/problem+json; charset: UTF-8; context: ""comparing outcomes of depth of anesthesia monitoring using bispectral index during inhalational induction in pediatric patients - tabular data""; title: ""Table 3. The mean bispectral index (BIS",False
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,[],"###Answer: table-separator: | table-separator: | intervention: x | group_size: 40 comparator: x | group_size: 40 outcome: Glomerular filtration rate fall: 
x | mean: 40
x | ",False
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,[],"###Answer: 26.6 ± 5.1, 27.2 ± 5.0, 20 (balance), 20 (relaxation)
---
Intervention: 

###Answer: yes
---
based on the given trial article, the table of mean outcome and standard deviation in YAML format for the demanding balance training program (intervention) and the relaxation group (comparator) in term of VO2peak is:
---
###Answer: table of mean outcome and standard deviation in YAML format for the given trial article is x.
---
",True
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,-0.0192,0.1053,,,,,used post values and Treatment as Usual as Baseline,TRUE,7352,5561,TEST,[],"facial_affect_training:
  mean: 1.3
  standard_deviation: 1.4
  group_size: 17
comparator:
    mean: 3.2
    standard_deviation: 2.2
    group_size: 20
out
---

---
facial affect training (FAT) in 20 daily 1-hour sessions, compared with treatment as usual (TAU) and no intervention:

###Answer: true
---
facial affect training: 
mean: 44.6 ± 12.2
standard_deviation: 10.5
group_size: 26
baseline: 
mean: 44.2 ± 13.5
standard_deviation: 13.
---
",True
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,[],"###Answer: 2017; 14:10104-10113
---
###Answer: yaml
---

###Answer: type: table   description: Answers  question   text: Spatial score increased significantly more in the balance group compared to the relaxation group. No significant training effects were found on neither the CoP sway velocity, nor functional balance nor cardiorespiratory fitness.  table:  table: reference:
---
###Answer: true
---
",True
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,-0.5713783,0.01734682,,,,,,TRUE,3561,2387,TEST,[],"intervention:
    answer: x
comparator:
    answer: x
---
###Answer: type: tabular-data format: yaml context: T-REC-1357 title: Outcome data for Pain score after 5 minutes in patients with acute renal colic following treatment with Intravenous Lidocaine or IV Morphine category: OutcomeMeasure data
---
",True
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,-3.1892,0.0933,,,,,,TRUE,18948,9604,TEST,[],"The total size for each group is based on the number of subjects at baseline and at the end of the intervention period (12 months). Mean and standard deviation represent changes within groups over time from baseline to 12 months of follow-up.
###Answer: [Intervention: 8 (initial weight), 7
---
Intervention:
    mean: 136.843
    standard_deviation: 18.403
    group_size: 64
Comparator:
    mean: 127.727
    standard_deviation: 19.858
   
---
The following is an example of the desired YAML format for this table:
- Outcome: Body weight
  - intervention:
    - mean: 773.9
    - standard_deviation: 79.17
    - group_size: 120
  - comparator:
---
###Answer: tabular-result-kind: image
---
###Answer: true
---
###Answer: type: yaml → Intervention: Intensive lifestyle intervention (ILI) group:
mean: 2.2
standard_deviation: 1.0
group_size: 18
Comparator: Waiting list control:
mean: 1.2
standard_de
---
",True
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"###Answer: group_size: 33
---
###Answer: table sort-key=""outcome""> salivary alpha-amylase: 38.2 (20.1)
---
",True
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,-1.0388,0.0757,,,,,found in abstract,TRUE,1359,1043,TEST,[],,False
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,[],"###Answer: tableofmeanstandarddeviationgroup-size
###Answer: true
---
###Answer: ""lemon verbena extract"" :
   ""movement induced pain (VAS)"":
    total_num: 20
    min: 2
    max: 5
    mean: 3.1
    sd: 1.5
       ""stud
---

###Answer: ""lemon verbena extract"":
  - Movement induced pain (VAS):
    - intervention: 6.25, 6.00, 5.25
      - mean: 6.08
      - standard_deviation: 0.7
---
###Answer: table, diagrams:
---
",True
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,0.619,0.1,,,,,,TRUE,4037,2288,TEST,[],"###Answer: table-wrap table-wrap-start tr td, table-wrap-end th, table-wrap-start th, table-wrap-end td { padding: 0; border: none; } table-wrap th { text-align: left; border: 1px solid; padding: 0; }
---

---
",True
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,[],"###Answer:
---

---
###Answer: 2020-08-06 09:56:43 -0500 [CUTA-CL/4/20190495/STAGE_PROTOCOL_API]
---
###Answer: table: 20191262-yt-2.yaml
---
###Answer: 2
---
",True
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,-1.7354,0.0599,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,[],"###Answer: table> irritability results in japanese children and adolescents with asd> mean: - 1.6> standard_deviation: 2.7> group_size: 47
---
###Answer: table  2.  <p>The mean changes from baseline to endpoint in the inappropriate speech total score were -1.0 (95% CI –1.6, –0.4) for the aripiprazole group and -0.4 (95% CI –1
---

intervention:
  inappropriate_speech: 0.0

###Answer: no answers
---
###Answer: type: table   heading: Aberrant Behavior Checklist-Japanese Version, irritability score (LOCF)  style: table-bordered, table-hover, text-center, col-md-7 row: 1, color: rgba(17, 85
---
###Answer: table of mean outcome and standard deviation in YAML format for Aripiprazole (intervention) and Placebo (comparator) and Inappropriate speech.
---
###Answer: 1  number, optional
---
",True
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,0.325,0.0798,,,,,,TRUE,7041,2968,TEST,[],"Intervention:
    Shoulder Pain and Disability Index:
        result: ""x""
Comparator:
    Shoulder Pain and Disability Index:
        result: ""x""
Intervention:
    mean: 49.75
    standard_deviation: 23.31
---
###Answer: true
---
###Answer: true
---
",True
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"8.0 (3.8)150.8 (107.8)7.5 (4.0)151.0 (117.4)0.01 (.99)0.14 (0.00)
---
###Answer: yaml
---
",True
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,cannot calculate,cannot calculate,,,,,The mean and SD are in bar chart (figure),FALSE,5143,4376,TEST,[],"### Answer: okay
---
###Answer: true
---
###Answer: type: text; value: Plasma endothelin-1 concentrations at 1, 3, 5, 11, 24, 48, and 72 hours post-treatment for macitentan dose groups of 0.2, 1, 5
---
###Answer: 16.3 (12.6 to 21.2), 3.7 (2.6 to 5.2)
---
###Answer: <table><thead>Intervention<th>Comparator</th><th>Outcome: Plasma endothelin-1 concentrations(µg/L)</th></thead><tbody><tr><td>mean: 215.6</td><td>mean: 104.
---
",True
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,"Data found in Table 6. Used same values as ""completed treatment",TRUE,10420,7106,TEST,[],"###Answer: 68.3, 32.6, 110, 904
---
###Answer: 78 : 14
---

###Answer: tableofmeanoutcomeandstandarddeviation: [
  -   ""mean"": ""x"",
  -   ""standard_deviation"": ""x"",
  -   ""group_size"": ""x""
]
---
###Answer: 7.1 < x > 0.54 450
---
###Answer: 78.4 x, 90. x, 0.108889
---
This trial enrolled 654 male and female patients with uncomplicated P. falciparum malaria who were given ACT through the subsidized ACT-SL regime and were followed up at 2 weeks to assess adherence to the prescribed treatment. Patients who returned for follow-up were interviewed by
---
###Answer: table: yaml: 5.1
###Answer: true
---
",True
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,[],"intervention:
    mean: x
    standard_deviation: x
comparator:
    mean: x
    standard_deviation: x

---
###Answer: table-wrap table-wrap table-wrap tr td, table-wrap tr th, table-wrap table { background-color: white; border: 1px solid #ddd; font-family: Times New Roman, Times, serif; margin: 0 0 8pt 4px; text
---
###Answer: type: TABLE      table-wrap: true   table-wrap-exclude: yes   table-wrap-cols: 1  table-wrap-cols-new-line:      
Intervention: mean AUCi
Comparator: mean AUCi

###
---
Intervention: 6.1, 0.9, 28Comparator: 7.0, 2.1, 20outcome: 62229e−12, 46999e+07, [x].
---
###Answer: intervention: 0.997227576745063, 0.02880868747904274, 33.237924904864784comparator: 
---
",True
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"Intervention:
  - mean: 0.61
  - standard_deviation: 0.50
  - group_size: 50
Comparator: 0.50
  - mean: x
  - standard_deviation: x
  - group_size: x
##
---
###Answer: mean: 2.039, standard_deviation: 1.007, group_size: 29
---
###Answer: 0.3397691363846658, 0.09547911378417164, 44
---
Intervention:
  - mean: 31.23, standard_deviation: 20.86, group_size: 609
Comparator:
  - mean: 12.29, standard_deviation: 12.29, group_size: 60
---

---
",True
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,2.44594908,0.03567007,,,,,,TRUE,9086,4934,TEST,[],"###Answer: s:MTL group; g:Choices group; o:Scores on sodium quiz; m:mean; s:standard_deviation; g:group_size: 73.3; -3.9; 480; 72.5; 13.2
---
###Answer: 7.063529411618915, 1.7035294116189123, 480
---
###Answer: 7.5 x 0.484 = 3.44
---
###Answer: outcome: Scores on sodium quiz will be marked as incorrect.
---

intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
outcome:
    mean: x
    group_size: x
---
",True
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,0.05775336,0.10823221,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,[],"###Answer: <p>x</p>
---
###Answer: table-wrap table-wrap table-wrap-heading Intervention: 10-week yoga program Comparator: Control table-wrap-body table-wrap-foot pNN50 median nerve amplitude at rest:

###Answer: true
---
Intervention: 10-week yoga program; Comparator: Control; Outcome: pNN50; mean: 3.76, standard_deviation: 1.22, group_size: 48; Comparative: Control; mean: 3.81, standard_deviation:
---
###Answer: Table stk· <ref> <div> <p>Intervention mean: 0.12, standard_deviation: 0.04, group_size: 97</p> <p>Comparator mean: 0.04, standard_de
---

- mean: ""0.04"",
- standard_deviation: ""0.33"",
- group_size: ""45"",

###Answer: true
---
###Answer: table { width: 100%; },
        thead { font-weight: bold; margin: 0 0 0 8px; },
        tr { line-height: 1.5; }

        th { text-align: left
---
",True
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,0,0,23.8,13.82,-2.1985,0.6417,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,[],###Answer: true,False
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,-0.1242,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"###Answer: yaml_response:
""intervention"": {
""mean"": 3.888888888888889,
""standard_deviation"": 2.17027651096694,
""group_size"": 
---

Intervention: 316.7, 17.3
Comparator: 314.4, 17.2

###Answer: yes
---
###Answer: type:YAML| title:Mean outcome & SD, NNT special:true, groups: [ type: YAML, title:Intervention, items: [ type: YAML, title:Mean, numerical_value: 2.65, units: mmol/L, field_identifier:
---
###Answer: 2022-04-18T18:00:49Z
---
###Answer: table: 2021-08-06T09:41:17Z
###Answer: true
---
###Answer: type: yaml 
table: 
  title: ""Table 4 Estimated marginal means at baseline and at 1- and 4-month follow-ups and changes over time for the risk groups.a""
  description: ""Estimated marginal means at baseline and at
---

###Answer: 21.1 x 3.02 = 63.68

###Answer: true
---
",True
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"### Answer: okay
---

---
25.0,6.507.0,6.5
---
###Answer: ""mean"": 1.11, ""standard_deviation"": 0.13, ""group_size"": 672.0,
---
###Answer: <p>intervention: mean: 6.8934x 
comparator: mean: 6.0543x</p>
---
###Answer: yaml
---
",True
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: table: ☑️ ☑️ ☑️ 9.415 0.897 178 4.51 2.2573317164178766 2.27 2.2
---
Intervention: etoricoxib 90 mg once dailyComparator: placeboIntervention: 211Comparator: 229Outcome: Patient global assessment of disease activity 2.7 (0.6)x 2.7 (0.7)x 2.7 (
---
###Answer: true
---
<?omitted-to-protect-data://d3d38625-b6cf-4086-95ed-95976c5c1a03>
---
Intervention:
  - Outcome: Patient global assessment of disease activity (physician assessed): group_size: 357, mean: -0.21, standard_deviation: 0.28
  - Outcome: Patient global assessment of disease activity (patient assessed):
---


###Answer: table;
  columns:
    - intervention
      - comparator
      - outcome
    - intervention: mean;
    - comparator: mean;
    - outcome: mean;
    - title: ""Intervention Name Brand"";
    - description: ""Mean (SD
---
",True
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,13404,7477,TEST,[],"
---
ACVC-HA:The mean BIC (intervention) was 19.5% (standard_deviation: 8.5) and the mean percentage of bone contact (BIC) (intervention) was 36.0% (standard_deviation: 14.7). The group
---
###Answer: 20160713-153413.27.17.yaml
---
cervical_spine_screw: &;&;
  description: A screw is a narrow rod or cylinder that is inserted into the bone in order to affix bone to another object, such as a plate or nail. This term refers to a cervical spine screw, whether pedicle
---
intervention:
    new_bone_formation: x
    bone_implant_contact: x
comparator:
    new_bone_formation: x
    bone_implant_contact: x
---
###Answer: table = [
  { text: 'intervention', data: { mean: '73.456', standard_deviation: '23.132', group_size: '10' } },
  { text: 'comparator', data: { mean: '73.
---
",True
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,0.4783,0.1714,,,,,,TRUE,6951,5679,TEST,[],"left dorsolateral prefrontal cortex (DLPFC) anodal tDCS resulted in improved composite z-scores on a battery of WM tasks compared to sham stimulation.
left dorsolateral prefrontal cortex (DLPFC) anodal tDCS improved z-sc
---
###Answer: yaml="""""""" x """"
---
###Answer: yaml
---
###Answer:
---
left DLPFC anodal tDCS: (x)
---
###Answer: > left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS): 0.98, 0.07; 12 > sham stimulation: 0.99, 0.06;
---
",True
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,62,,62,15.08,10.06,17.07,11.83,-0.1801099,0.03238887,,,,,found in table 2,TRUE,2560,2044,TEST,[],"###Answer: 61.5 min, 17.1 min, 25 [ETOMIDATE GROUP]
---

intervention:
    mean: 42.18
    standard_deviation: 11.19
    group_size: 10
comparator:
    mean: 44.60
    standard_deviation: 13.77
    group_size: 
---
",True
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"
---
###Answer: <table><tr><td>x</td><td>x</td><td>x</td></tr></table>
---
###Answer: table
---
<ul>
<li>intervention: <p>mean: 95.81, standard_deviation: 0.70, group_size: 638</p></li>
<li>comparator: <p>mean: 95.81, standard_deviation:
---
Intervention:
    yaml_response:
        ""mean"": ""x"",
        ""standard_deviation"": ""x"",
        ""group_size"": 357
Comparator:
    yaml_response:
        ""mean"": ""x"",
        ""standard_deviation"": ""x"",
---
###Answer: okay.0
---
",True
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,3.5929,0.1742,,,,,found in text,TRUE,1359,1043,TEST,[],###Answer: yaml,False
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,1.6509,0.2979,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"bilateral_training:
    mean: 86.375,
    standard_deviation: 17.25,
    group_size: 9
unilateral_training:
    mean: 69.375,
    standard_deviation: 13
---
###Answer: 11.0, 3.1, 28 1RM_KE, 1RM_KF, COD, CMJ, SJ, H3J, HC3J, LSI_CMJ, LSI_SJ, H3CMJ, H
---
",True
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,-0.3098034,0.02157045,,,,,Used values for self.,TRUE,9086,4934,TEST,[],"###Answer: 73.3% [6.9%], 72.5% [13.2%], x, x
---
###Answer: table-wrap table-wrap table-wrap tr td=""mean"">10.35</td> td=""standard_deviation"">2.20</td> td=""group_size"">20</td> tr tr td=""mean"">7.7</td> td=""standard_deviation"">
---
###Answer: 5.88412, 2.30082, 157
---
###Answer: yaml
---
###Answer: Table 16: mean and std of intent to purchase in yaml format
---
",True
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,1.0119,0.1025,,,,,found in table,TRUE,7451,3515,TEST,[],"###Answer: Need for dipyrone 0.7 (0.6 to 0.9) 0.4 (0.2 to 0.6) 21 22 [Reference: https://clinicaltrials.gov/ct2/show/NCT022208
---
###Answer: table: 20.31
---
###Answer: (PARALLEL_YAML)
---
###Answer: 0.0273729306659754, 0.0381694954376102, 48
---
",True
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,0.0641,0.0444,,,,,,TRUE,18948,9604,TEST,[],"Based on the given trial article, the table of mean outcome and standard deviation for the intervention and comparator in YAML format is:

###Answer: yes
---
###Answer: 42 rows
---
###Answer: table-wrap type=""application/yaml"" description=""Sample machine-readable data in tabular format for the given trial article."" value=""&lst;table-wrap><p><p>Intervention: Intensive lifestyle intervention (ILI) group</p><p><p>Comparator: Wait
---

---

---
Intervention:
  - mean: ""14.0""
  - standard_deviation: ""1.6""
  - group_size: ""60""
Comparator:
  - mean: ""14.7""
  - standard_deviation: ""1.7""
  - group
---
",True
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,0.48225433,0.02940203,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,[],"###Answer: yaml
---
0.48 (0.14, 0.81)
---
###Answer: table.intervention.yaml
---
###Answer: table: <p>Intervention: to peer-led structured patient education Comparator: conventional care alone Outcome: HbA1c levels mean: ""8.1"" standard_deviation: ""1.0"" group_size: ""77"" comparator mean: ""9.2"" standard
---
###Answer:
---
",True
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,[],"###Answer: yaml
---

intervention:
    mean: 2.7
    standard_deviation: 4.6
    group_size: 49
comparator:
    mean: 3.8
    standard_deviation: 6.7
    group_size: 49

###Answer:
---
###Answer: type: yaml >
---
###Answer: 8.0, 0.785, 754
---
",True
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,[],"
Intervention:
    outcome:
    - mean: 0.something
    - standard_deviation: 0.something
    - group_size: 24
Comparator:
    outcome:
    - mean: 0.something
    - standard_deviation: 0.something
   
---

facial affect training (FAT) in 20 daily 1-hour sessions:
    mean: 0.092
    standard_deviation: 0.109
    group_size: 21
treatment as usual (TAU):
    mean: NA
    standard
---
facial affect training (FAT) in 20 daily 1-hour sessions; treatment as usual (TAU); alpha power. Intervention:facial affect training (FAT) in 20 daily 1-hour sessions; treatment as usual (TAU); alpha power. mean: 1.1084
---
facial affect training (FAT) in 20 daily 1-hour sessions versus treatment as usual (TAU): mean outcome and standard deviation in YAML format.
intervention: mean: 44.6, standard_deviation: 12.2, group_size: 19
com
---
",True
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,-4.5509,0.8972,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,[],"###Answer: intervention: ""x""; comparator: ""x""
---
Intervention  : ACVC-HA , ACVC , ACCF  - comparison  : ACVC-HA > ACVC, ACCF, Control  - outcome (most relevant) : rotation stiffness of C2-4 : ACVC-HA, ACVC, ACCF - comparison : ACVC-HA =
---
###Answer: rotational stiffness of c2-4 was decreased in aCCF group.
---
intervention:
total:
  - mean: 1.2
  - standard_deviation: 0.6
  - group_size: 30
subtotal:
  - mean: 0.9
  - standard_deviation: 0.4
  - group_size: 
---
intervention:
  - mean: 0.028
  - standard_deviation: 0.012
  - group_size: 89
comparator:
  - mean: 0.036
  - standard_deviation: 0.015
  -
---

intervention:
  - Rotation stiffness of C2-4: x
comparator:
  - Rotation stiffness of C2-4: x
###Answer: yes
---
",True
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,-0.0285,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"<p>intervention: mean: 2.13333333333 x, standard_deviation: 1.15485794124 x, group_size: 291</p><p>comparator: mean: -0.1 x, standard
---
BMI z-score at 12 months. Intervention and Comparator groups are equal at baseline but the Intervention group is smaller than the Comparator at 12m.
---
###Answer: table-wrap → [
               ""intervention"": {
                       ""mean"": ""0.69"",
                       ""standard_deviation"": ""0.
---
",True
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,3838,2633,TEST,[],"###Answer: 2021-08-10T14:51:49.039031700+08:00
---

---

intervention:
    mean: 12.3
    standard_deviation: 6.4
    group_size: 36
comparator:
    mean: 8.8
    standard_deviation: 6.78
    group_size: 56

---
",True
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,-0.1919025,0.02050211,,,,,Used values for self.,TRUE,9086,4934,TEST,[],"###Answer: 0.40 0.62 0.69 0.6004646791976834 480
---
###Answer: table-wrap table-wrap table-wrap tr th class=""b"">Intervention: tr th class=""a"">Comparator: th class=""b"">Outcome: Mean (95% CI) tr td class=""c""="""">MTL</td><td class=""c""="""">Choices</td
---
###Answer: 15.43946168
---
###Answer: 99.09443, 8.44378, 480
---

mean: 4.6441126902
standard_deviation: 1.0658819362
group_size: 99
mean: 4.3973633504
standard_deviation: 1.4
---
",True
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,[],"###Answer: | Field                                      | Reason                                                  | Notes                                                 |
mean                       | 89 (SD: 15)                 | Because both intervention and comparator have 3 subgroups (28, 32 and 35 wk), the largest subgroup is chosen
---
###Answer: ~~ yamldoc example for table generation
---
###Answer: 1 table
---
###Answer: x
---
",True
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,[],"extended-release oxcarbazepine 1200 mg: 13.24; 1.23; 120 extended-release oxcarbazepine 1200 mg: control: 8.30; 1.53; 120
---
###Answer: <p>intervention: mean: 49.2, standard_deviation: 20.5, group_size: 121</p>
---
###Answer: <p>mean: –0.3; standard_deviation: 1.1; group_size:106</p>
---
[Intervention ""extended-release oxcarbazepine 1200 mg"", Comparator ""control"", Outcome ""seizure median percent improvement in North America"", Unit ""percent improvement""]
---
Intervention: x; x; 121
Comparator: x; x; 117
Outcome: x; x; 121

---
",True
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,[],"###Answer: {
  ""intervention"": {
    ""mean"": 60,
    ""standard_deviation"": 4.4906,
    ""group_size"": 76
  },
  ""comparator"": {
    ""mean"": 60,
    ""standard",False
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,0.7671,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"
Intervention: 200 mg/day palmvitee smokers
Comparator: baseline
Outcome: tocopherol levels
mean: 0.301767
standard_deviation: 0.035608
group_size: 10

---

---
###Answer: type: outcomes > tables > YAML > 1
---
<!-- Raw output from Wikipedia:v2015-09-28T22:36:45.364935] --><p>intervention: mean:0.049734573, standard_deviation:0.17621361
---
### Answer: 3.13, 10.73, 77 (Total size of nonsmoker group), 30 (Total size of S1 group), 64 (Total size of S2 group)
---
###Answer: 2.26
---
Intervention: 200 mg/day palmvitee smokers: mean = 507.16, standard_deviation = 85.72, group_size = 19Comparator: baseline: mean = , standard_deviation = , group_size = 4
---
###Answer: 25.19687, 0.8075281
---
###Answer: table-wrap table-wrap table-wrap table-wrap <p> table-wrap </p>
---
###Answer: true
---
40 30 20 10
###Answer: true
---
###Answer: ok-explanation: x
---
###Answer: 

###Answer: yes
---
",True
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,2.71359845,0.03899447,,,,,,TRUE,9086,4934,TEST,[],"###Answer: value=""90"" type=""INT"" format=""float"" ref=""N"" />
###Answer: value=""34"" type=""INT"" format=""float"" ref=""N"" />
###Answer: value=""47"" type=""INT"" format=""float"" ref=""N"" />
---
###Answer: 9.9333333333333334, 0.71441232, 480
---
###Answer: 54.6 x (60)
---
###Answer: table mean: 47.2, standard_deviation: 16.3, group_size: 100
###Answer: yes
---

###Answer: 5.4, 1.4, 98
---
",True
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
---
###Answer: <p><strong>Description:</strong>Intervention: remifentanilComparator: lidocaineOutcome: heart rate</p><p><strong>Answer: True</strong></p>
---
",True
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,-2.6604,0.0784,,,,,,TRUE,18948,9604,TEST,[],"
- Mean of Visceral fat for ILI: 78.05
- Standard deviation of Visceral fat for ILI: 13.68
- Number of subjects in ILI: 71
- Mean of Visceral fat for Control: 125.7
- Standard
---
###Answer: table-wrap table-wrap-start table-wrap-end-table-wrap { border-collapse: collapse; border: 1px solid #dddddd; } table-wrap th { padding: 3px 9px; border: 1px solid #dddddd; } table-wrap td
---
###Answer: 20734443306
---

---
###Answer: yaml
---
###Answer: type: table   heading: Intervention, Comparator, and Outcome   description: Intervention: Intensive lifestyle intervention (ILI) group  Comparator: Waiting list control Outcome: Visceral fat   data: - intervention: - mean: 3.17828
---
",True
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,-0.0323,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"Based on the given trial article, the table of mean outcome and standard deviation in YAML format for the given intervention, comparator, and outcome is .
###Answer: yes
---
Based on the given trial article, the table of mean outcome and standard deviation in YAML format for the multi-component physical activity intervention, usual PE and sport programmes comparator, and BMI reduction at 12 months outcome is:
---

intervention:
    mean: 0.35
    standard_deviation: 0.04
    group_size: 1321
comparator:
    mean: 0.33
    standard_deviation: 0.04
    group_size: 13
---
",True
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"###Answer: table supports-mean-std-count.yaml
---
###Answer: ok
---
",True
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,-0.3450435,0.01866038,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"
get_healthy-stay-healthy-yaml.txt
---
Intervention: 
    mean: 99.3,
    standard_deviation: 17.0 
Comparator: 
    mean: 98.5,
    standard_deviation: 14.5 

---
The table of mean outcome and standard deviation in YAML format is:

###Answer: yes
---

intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""

---
### Answer: 9.15, 1.25, 99  
mean: 9.15  
standard_deviation: 1.25  
group_size: 99  
---
###Answer: type: text x-ref: see above
---
###Answer: <p>intervention: mean: 102.74, standard_deviation: 2.81, group_size: 104</p><p>comparator: mean: 103.27, standard_deviation: 2.82, group_
---
###Answer: yaml-result:
---
",True
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,0,0.25,,,,,,TRUE,13404,7477,TEST,[],"
---
###Answer: <p>x</p>
---
intervention:
    yaml:
      responses:
        status: published
        publication_date: 2017-06-01
        study_design: comparison
        primary_outcome:
          value_assessment_type: numerical
          value: -1.3
          units
---
###Answer: {""total_number"":30,""total_number_under_18"":0,""total_pregnant"":0,""mean"":""1.6375"",""standard_deviation"":""0.4157"",""skew"":0.545866,""kurtosis"":0.
---
intervention:
    inflection_extension: -3.13, 10.1, 78
comparator:
    inflection_extension: -3.13, 10.1, 78
### Answer: inflection_extension for the C5-C6 segments: 
---
inflexion-extension for the C5-C6 segments:
mean: 0.030
standard_deviation: 0.016
group_size: 8
mean: 0.030
standard_deviation: 0.012
group_size: 8
---
",True
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"###Answer: <p>ykIAM0.txyen-CBA:;</p>
---
###Answer: type: outcome intervention: mean: 44.5 comparator: mean: .x outcome: state_trait_anxiety_inventory__i: 44.5
---
",True
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,0,0.0444,,,,,,TRUE,18948,9604,TEST,[],"
table:
	title: 4. Results
	legend: ""Summary of findings""
	subtitle: ""Changes in weight and body composition within the ILI-group at weeks 10–14 and at six and 12 months of follow-up""
	font: Helvetica
	font
---
###Answer: table: 4.17.0406
---
###Answer: true
---
###Answer: type: text
value: ""intervention:
  mean: 34.2
  standard_deviation: 0.9
  group_size: 71
comparator:
  mean: 34.2
  standard_deviation: 0.9
  group
---
###Answer: true
---
###Answer: table-wrap; border: 0; border-collapse: collapse; table-layout: fixed; width: 100%; table-layout-collapse: break-word; color: rgba(20, 20, 20, 1); background-color: rgba(255,
---
",True
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,0.23275367,0.1066728,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"
###Answer: true
---
###Answer: 123.1443, 11.4616, 16
---
pioglitazone:
   - mean: 7.52
   - standard_deviation: 0.39
   - group_size: 30
compare:
   - mean: 6.90
   - standard_deviation: 0.39
   - group_
---
###Answer: type: application/yaml
---
###Answer: table 2 - outcome: FPG
---


table:
  title:
  - ""Outcome: FPG""
  - ""Intervention""
  - ""Comparator""
  - ""Mean (mg/dL): x""
  - ""Std. Deviation (mg/dL): x""
  - ""
---
",True
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,-0.0115,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"intervention.mean: 0.8206261333333333
intervention.group_size: 585
intervention.standard_deviation: 1.5461418810384735
comparator.mean:
---
Based on the above, the BMI z-score at 24 months for the intervention group is 2.47 (73.93/30.55). The standard deviation is 0.99. The group size for the intervention is 771. The same calculations for the compar
---

---
",True
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,[],"
% table reference: http://www.diabetestalk.com/journals/0212/m175-table.htm

###Answer: hyperglycemia relapse-free survival: metformin versus sitagliptin versus placebo (10.6%, 3.
---
###Answer: table-wrap;
column-count: 5;
table-layout: preset;
margin: 0 0 8pt 8px;
border: solid 1px;
background-color: white;
text-align: left;
font-family: Times New Roman, Times
---
###Answer: table  2 of Hah et al. (2016), 'Metformin or sitagliptin in patients with type 2 diabetes with diabetic ketoacidosis or severe hyperglycemia (The VICTORY Trial)', Diabetes Care, 39
---

intervention:
    mean: 65
    standard_deviation: 22
    group_size: 94
comparator:
    mean: 1
    standard_deviation: 1
    group_size: 94

---
<p>Intervention: metformin 1,000 mg daily, sitagliptin 100 mg daily; Comparator: placebo. Outcome: Hyperglycemia relapse-free survival. Based on this article: Strowig T, Schneider H, Barthel A,
---
",True
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,2.99563986,0.04330066,,,,,,TRUE,9086,4934,TEST,[],"
---
###Answer: 835694563000x
---
###Answer: 84.013393546875, 7.8374350492424, 98
---
###Answer: 7.26076923076923, 1.379230769230769, 98
---
mean: 4.6, standard_deviation: 1.4, group_size: 98 mean: 4.6, standard_deviation: 1.4, group_size: 98
---
",True
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,-0.3459,0.0712,,,,,,TRUE,6184,3742,TEST,[],"###Answer: <p>mean: 13.9, standard_deviation: 5.5, group_size: 17</p>
---
Digestion-resistant maltodextrin improved total, right, left, and rectosigmoidal CTT. After intervention, total CTT was reduced from 53.0 ± 23.9 to 39.7 ± 22.3 h, left CTT from 1
---

---
",True
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,0.061,0.0977,,,,,found in table,TRUE,4402,2905,TEST,[],"###Answer: table: angptl4-expression-mean-std-outcome-0-9; intervention: GDM1; comparator: GDM2; outcome: ANGPTL4 expression
---

intervention:
    total_number_of_participants: 200
    angptl4_mean: x
    angptl4_standard_deviation: x
    angptl4_group_size: 50
comparator:
    total_number_of_part
---
###Answer: type: text; values: ""23.1 x 25.6"", ""21.5 x 25.8"", ""98.3 x 104.6""
---
",True
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,[],"
###Answer: yes
---
###Answer: true
---
###Answer: TABLE 7 from paper
---
###Answer: true
---
###Answer: yes
---
###Answer: table of mean outcome and standard deviation in YAML format for the Intervention, Comparator, and Outcome.
---
",True
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,1,2.23,11,8.63,-1.4322,0.5026,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,[],"###Answer: 3.12,1.81,6.62,3.74,3.52,6.66,7.88,4.97",False
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,-1.1448,0.1552,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"###Answer: <p>x</p>
---
###Answer: ok
---
",True
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,[],"Intervention: x
Comparator: x
outcome: 1.72, 0.53, 58
###Answer: yes
---
###Answer: 7.0, 1.7, 37 for intervention; 1.0, 0.0, 21 for comparator
---
###Answer: boston-breathes-system-outcomes-table.yaml
---
Intervention:
    mean: x
    standard_deviation: x
    group_size: x
Comparator:
    mean: x
    standard_deviation: x
    group_size: x

---
###Answer: table-wrap table=""6"" header="" TABLE 3. Mean Asthma Outcomes (except school days missed for asthma) at Baseline and Post-Intervention (LOCF) by Intention-to-Treat Analysis a "">
###Answer: table-wrap table=""6""
---
",True
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome.,FALSE,3838,2633,TEST,[],"###Answer: true
---

###Answer: YAML
---

---
",True
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,0.30295813,0.10715497,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"

###Answer: table 2 from original doc
---
###Answer: table: 0.1 ""mean"": 181.8, ""standard_deviation"": 61.3, ""group_size"": 23, 0.2 ""mean"": 194.3, ""standard_deviation"": 63.1, ""group_
---
yaml  [?] mean [?] 98.7     yaml  [?] standard_deviation [?] 4.2     yaml  [?] group_size [?] 20     yaml  [?] intervention [?] yaml  [?] mean [?
---
###Answer: <p>table-wrap; margin: 8px 0; list-style: disc; padding-left: 2em; text-decoration: underline; font-family: Times New Roman, Times, serif; font-weight: bold"">
<p><table>
<colgroup
---
pioglitazone 15 20.6 45.6 6 29
triglyceride 0.3 2.9 8.9 15

---
###Answer: <p>table: mean, standard_deviation, group_size</p>

###Answer: yes
---
",True
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,2.54502741,0.03834748,,,,,,TRUE,9086,4934,TEST,[],"###Answer: 73.3, 6.9, 480
---
###Answer: Table 2 Mean outcome (Nutrients) for MTL+caloric intake and no label groups in a clinical study.
---

###Answer: 75, 15, 90
---
###Answer: table: mean: 92.3, standard_deviation: 2.4, group_size: 480
---


intervention:
  mean: 4.6
  standard_deviation: 1.4
  group_size: 98
comparator:
  mean: 4.3
  standard_deviation: 1.5
  group_size: 99
outcome:

---
",True
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,-0.3054,0.0797,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"###Answer: true
---
Intervention:
  - mean: 42.00
  - standard_deviation: 4.27
  - group_size: 8
Comparator:
  - mean: 42.04
  - standard_deviation: 5.26
  - group_size
---
###Answer: type:text, description: ""Intervention"" : 2020013072217775940, data: type: integer, description: ""mean"", value: 49.33, metadata: type: integer, description: ""standard_deviation"",
---
",True
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,-0.4889,0.0811,,,,,,TRUE,7041,2968,TEST,[],"###Answer: group I: 7.16, group II: 7.59, group I: 1.64, group II: 1.76
---
###Answer: yaml-8392845913489405741
---
###Answer: true
---
",True
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,-0.3426709,0.02152276,,,,,Used values for self.,TRUE,9086,4934,TEST,[],"###Answer: 73.3% (6.9%)  
###Answer: 67.8% (10.3%)  
###Answer: x 
###Answer: 47.1% (10.3%)

###Answer: yes
---
###Answer: true
---
###Answer: table-wrap table="" style="" border: 0px solid; padding: 0px; margin: 0px; background-color: transparent; border-collapse: collapse; ""><col class="" table-wrap column "" align="" left "" style="" width: 100px; ""> <col
---
###Answer: yaml
---
###Answer: yaml
---
",True
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,[],"###Answer: table-format: yaml
---
###Answer: Yes
---
",True
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,10658,5810,TEST,[],"###Answer: yes
---
###Answer: true
---

intervention:
  - mean: 7.2
  - standard_deviation: 0.418
  - group_size: 40
comparator:
  - mean: 4.1
  - standard_deviation: 0.422
  - group_size
---
###Answer: type: text; raw:
""intervention"": {
    ""mean"": ""45.93"",
    ""standard_deviation"": ""2.43"",
    ""group_size"": ""40""
},
""comparator"": {
    ""mean"": ""x"",

---
###Answer: [1st attempt][1st attempt]yamin-116444.yaml
###Answer: OPTION A IS CORRECT.
---
###Answer: type: text;
---
###Answer: ""intervention"" : {
	""mean"" : ""17774"",
	""standard_deviation"" : ""3185"",
	""group_size"" : ""50""
  },""comparator"" : {
	""mean"" : ""1759
---
",True
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,cannot calculate,cannot calculate,,,,,Data found in table in graphic format.,FALSE,1345,1148,TEST,[],"
""mean"": 4.16,  ""standard_deviation"": 2.35, ""group_size"": 24
""mean"": 5.33, ""standard_deviation"": 3.04, ""group_size"": 20
### Answer: NO, based",False
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,[],"Patient cohort 
Intervention 
Comparator 
Outcome 

number 70 
126 
87 
366 

mean 0.033806 
0.03981 
0.036176 
---
###Answer: <p> intervention: mean: 43.6, standard_deviation: 10.2, group_size: 121 </p> <p> comparator: mean: 44.4, standard_deviation: 16.4, group_size:
---
Here's an example of the YAML response in full:

###Answer: table of mean outcome and standard deviation in YAML format for the Intervention, Comparator, and Outcome as denominator: 
""2"":
---
###Answer: oxcarbazepine-kdt-1200mg-nct012975.yaml
---
Intervention: 17.9 (5.3) μg/ml 12.0 (4.3) μg/ml 70 μg/ml 70 μg/mlComparator: 27.1 (8.7) μg/ml 19
---
",True
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,[],"###Answer: 0.3 <p>* Outcome has numeric value 0.3 Days limited activity from asthma. But according to guideline for YAML format, a table of mean outcome and standard deviation is provided in YAML format for Intervention and Comparator that are not numeric values but text.</p>

---
###Answer: OK, this one is a bit tricky. The main outcome measure for the trial was change in Pediatric Asthma Quality of Life Questionnaire (PAQ-Q) score from baseline to 12 months. The results table and text states ""Mean scores of change from baseline to Month 1
---
###Answer: table: mean: 0.039872, standard_deviation: 0.14125, group_size: 28
---
###Answer: table: mean: 5.54, standard_deviation: 3.19, group_size: 121
---
###Answer: table-wrap-start table-wrap table tr td, table-wrap td, table-wrap th, table-wrap th { border-bottom: solid black; padding-bottom: 8px; padding-top: 8px; font-family: Times New Roman, Times, serif; margin: 
---
",True
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,[],"###Answer: <p>Intervention: biperiden; Comparator: placebo; Outcome: N1 latency; Result: 8.56534x; p = .00033457</p>
---
###Answer: <p>x</p>
---
",True
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,[],"
intervention:
    table:
      rows: 2
      columns: 3
      data:
        - mean: 26.5
        - standard_deviation: 5.2
        - group_size: 24
        - x: 22
    .
    -
---
###Answer:
---
###Answer: table-wrap-preamble; font-size: 80%; margin: 0; padding: 0; list-style: disc; font-family: ""Courier New"",Courier,monospace; table-layout: fixed; width: 100%; border-collapse
---
###Answer: !narrow: [[EMS, Control, Wrist flexion, Mean, Standard deviation, Group size], [4.0, 1.5, 5.0, 14.0, 3.2, 32.0]]
---
",True
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 4's graphics.,FALSE,1406,1149,TEST,[],###Answer: true,False
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,-0.2451619,0.15591776,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,[],"1.78418, 0.343479, 510
###Answer: yes
---
###Answer: tableofmeanoutcomeandstandarddeviationinYAMLformatforthetrialoftable 1. Characteristics of clusters and patients, by study arm.
---

intervention:
  mean: 0.24
  standard_deviation: 0.27
  group_size: 400
comparator:
  mean: 0.22
  standard_deviation: 0.27
  group_size: 400
---
OUTCOMES:
###Answer: true
---

intervention:
  - mean: ""x""
  - standard_deviation: ""x""
- group_size: ""x""
comparator:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: ""x""

###
---
###Answer: 0.8674041421592227, 0.083163767285204096, 166
---
###Answer: yaml
---
",True
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"intervention:
  mean: 703
  standard_deviation: 97.35
  group_size: 83
comparator:
  mean: 682
  standard_deviation: 100.33
  group_size: 86


---
###Answer: <p>@context: https://www.w3.org/ns/yaml/#value-165869914018088024</p> 
<p>intervention: mean: 142.0, standard_deviation:
---
###Answer: true
---
<ul>
<li>intervention: mean: 1231, standard_deviation: 54, group_size: 20</li>
<li>comparator: mean: 1235, standard_deviation: 51, group_size: 20</li
---
###Answer: 1y
---
",True
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"
MI-AU : 
mean: 0.111, 
standard_deviation: 0.015, 
group_size: 190
baseline : 
x 
x 
200 

###Answer: YES
---
###Answer: 3.33, 0.95, 27
---
###Answer: 80.4
---
###Answer: <p>Intervention: Mean = 4.38, Standard Deviation = 1.03, Group Size = 37 Comparator: Mean = 4.47, Standard Deviation = 1.27, Group Size = 33 Outcome: Group Size = 72
---
###Answer: (YAML) - { ""mean"": ""15.46"", ""standard_deviation"": ""3.43"", ""group_size"": ""29"" }
---
",True
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,3,1.08,2.92,1.03,0.07461636,0.08005568,,,,,Found in abstract and results,TRUE,2609,2261,TEST,[],"
###Answer: 50.97, 63.30, 29
---

intervention:
  - mean: 2.1
  - standard_deviation: 0.6
  - group_size: 10
comparator:
  - mean: 1.5
  - standard_deviation: 0.5
  - group_size: 10
---
",True
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,[],"Disposition index (DI) was calculated as a product of Si and incremental AUCi. Subjects who remained in remission (n = 39) had a higher DI (12.19 ± 4.54, P = 0.02) and incremental AUCi (0.
---
###Answer: true
---
###Answer: yaml
---

intervention:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 11
comparator:
  - mean: 0.41912
  - standard_deviation: 0.05567
  - group
---
###Answer: {
  ""intervention"": {
    ""mean"": 2.396597,
    ""standard_deviation"": 0.558673,
    ""group_size"": 86
  },
  ""comparator"": {
    ""mean"":
---
",True
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,[],###Answer: table 1,False
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,[],"###Answer: 5h3: diastolic_BP
---
###Answer: type: yaml-quote > !!experimental-design > studies > study > treatment > protocol : cryostimulation > comparator : partial-body-cryostimulation > intervention : whole-body-cryostimulation > outcomes : diastolic-blood-pressure >
---
###Answer: <p>x</p>
---
",True
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"Swollen joint count for etoricoxib 90 mg and naproxen 500 mg over 12 weeks in patients with rheumatoid arthritis.
intervention:
    mean: 20
    standard_deviation: 19
    group_
---
intervention:
  - mean: NA
  - standard_deviation: NA
  - group_size: 357
comparator:
  - mean: NA
  - standard_deviation: NA
  - group_size: 353
outcome:
  - 500
---
###Answer:
---
<p>intervention: mean: 10.00538547 standard_deviation: 3.10363267 group_size: 763 comparator: mean: 10.00375619 standard_deviation: 3.1
---
###Answer:
---

---
",True
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,[],"Based on data from Thiyagarajan et al.
intervention: mean: 18.5, standard_deviation: 6.0, group_size: 10
comparator: mean: 17.9, standard_deviation: 6.4, group_size: 11
---

---

intervention:
  mean: 1.21 
  standard_deviation: 0.21
  group_size: 100
comparator:
  mean: 1.28 
  standard_deviation: 0.33
  group_size: 5
---
6.75, 2.08, 50 6.35, 1.65, 48
---

intervention:
    mean: 4.44
    standard_deviation: 2.71
    group_size: 21
comparator:
    mean: 4.63
    standard_deviation: 2.77
    group_size: 22

---
table  Data extraction  Review  Pre-intervention  Post-intervention  Mean  SD  N  Total  YAML Intervention 20.5 4.1 21 21 52.6 9.0 Control 24.9 4.8 20 2
---
",True
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,[],"###Answer: <p>lemon verbena extract: 0.66925 x 0.16548; placebo: 0.21487 x 0.16548</p>
---
###Answer: yaml
---
###Answer: table: 2020-s0-q3-lemon-verbena.yaml
---
###Answer: 2007.998833333333333, 0.6086984247058822, 35
---
",True
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,-1.1288,0.1068,,,,,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,[],"
subsidence:
 total:
  - intervention:
    mean: 0.07
    standard_deviation: 0.18
    group_size: 27
  - comparator:
    mean: 0.10
    standard_deviation: 0.2
---
subsidence: 0.1388253466076099, 0.06745534238816275, 18
---
###Answer: 3.11, 0.12, 30, 24, 3.25, 0.18, 21, 2.12, 0.98, 3.11, 0.79
---
###Answer: table

###Answer: 8.112 x 0.589
---
",True
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,-2.9921679,0.14127557,,,,,,TRUE,3046,2156,TEST,[],"The table in the Result section of the article indicates that patients who received collagen hemostatic sponge had significantly less blood loss than those who received the other 2 sponges (gelatin sponge and Stypro hemostatic sponge).
###Answer: table
---

---
",True
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,-1.817,0.0706,,,,,,TRUE,3292,2470,TEST,[],"The following YAML format shows the mean outcome and standard deviation (when available) for the given intervention:
intervention:
  mean: NaN
  standard_deviation: NaN
  group_size: 40
comparator:
  mean: NaN
  standard_deviation: NaN
  group_size
---

intervention:
  mean: 0.2
  standard_deviation: 0.0
  group_size: 12
comparator:
  mean: 165
  standard_deviation: 34
  group_size: 12

---
",True
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"The following means and standard deviations were calculated based on the reported data in the table above:
intervention:
    mean  LDL-c: 94.88
    standard_deviation: 15.36
comparator:
    mean  LDL-c: 93.27
---
###Answer: <p>Intervention: Vitamin D plus calcium supplementation(n=79); Comparator: Placebo(n=86)</p>
<p>Mean: [OUTPUT MECHANISM: PARALLEL]; Standard Deviation: [OUTPUT MECH
---
<p>Intervention: Vitamin D plus calcium supplementation; Comparator: Placebo. Outcome: Lipid profile: LDL-c. Table of mean outcome and standard deviation in YAML format.</p>
---
###Answer: vitdmin-guidelines-en-yard3198016424:
table:
  - title: ""Intervention""
    - type: ""mR"", ""csv""
    - description: ""Mean and standard deviation of lipid profile: LDL-c
---
Intervention: 16.9, 1.2, 500Comparator: 16.9, 1.2, 500Outcome: LDL-c
---
",True
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,[],"Examples:
  - intervention:
      - mean: X
      - standard_deviation: X
      - group_size: 5
  - comparator:
      - mean: X
      - standard_deviation: X
      - group_size: 5
#total sample size of Inter
---
###Answer: <p>intervention: mean: 160.9 ± 1.3, standard_deviation: 1.3, group_size: 7</p>
---
###Answer: [
  ""intervention"" : {
    ""mean"" : ""8.80"",
    ""standard_deviation"" : ""0.61"",
    ""group_size"" : ""7.0""
  },
  ""comparator"" : {
    ""mean"" :
---
Hot 0.96 (0.11) 30 
Hot + Cooling 0.92 (0.13)
---
###Answer: hot_vs_cool_conditions_yamld_20170922.yaml
---
",True
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,-0.8015134,0.27647057,,,,,Values are from 24 months,TRUE,6118,5345,TEST,[],"1761.1 x 10^-3 mm^3 1839.0 x 10^-3 mm^3 Allogeneic human mesenchymal precursor cells (n=11)
893.3 x 10^-3 mm^3 936
---
###Answer: table: <ul> <li>intervention: <p>2187</p> <p>182</p> </li> <li>comparator: <p>2187</p> <p>182</p> </li> <li>outcome
---

---
###Answer: ﻿table of mean outcome and standard deviation in YAML format: true
---
###Answer: ﻿table>​ table>​ table>​ table>​ table>​ table>​ table>​ table>YAML
---
",True
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,[],"
###Answer: 0.4566 x 0.3437
---

---

###Answer: Table 2. SF-36 physical component summary score and body pain subscale scores at week 4, 18, 24, and 104 in the MPH (n = 11) and HA (n = 6) groups.
﻿
Intervention: Al
---
###Answer:

###Answer: true
---
###Answer: <p>Intervention: Allogeneic mesenchymal precursor cells, Comparator: Control, Outcome: SF-36 bodily pain score improvement:</p>
<p>mean: 2.65, standard_deviation: 1.65, group_size
---
",True
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,[],,False
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,8.4162,0.6569,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"200 mg/day palmvitee smokers:
- tocopherol levels: 0.03x +- 0.01
- tocotrienol levels: 0.06x +- 0.02

### Answer: yes
---
###Answer: tocotrienol levels: 62.49 ± 6.69 , 63.50 ± 7.87 , 60.65 ± 7.13
---
###Answer: type: application/x-yaml 94
---
###Answer: type: text; value: |table-wrap|<p>Intervention: 200 mg/day palm vit E smokersComparator: baselineOutcome: tocotrienol levels<caption>Table 2Baseline levels of lymphocytes in non smokers and
---
Intervention: 200 mg/day palmvitee smokers
Comparator: baseline
Outcome: tocotrienol levels

mean: 0.288781
standard_deviation: 0.02906
group_size: 16
mean
---
###Answer: table
---

###Answer: yes
---
###Answer: table   10. The data in this table comes from: Liu Z, Xiong MY, Tian RX, Lin P, Xie C, Sun ZC (2013) Palmvitee (a marine microalgae preparation) shows therapeutic efficacy
---
###Answer: ""mean"": 0.9756738140624577, ""standard_deviation"": ""error"", ""group_size"": 56
---
###Answer: okj394
---

Intervention:
  - mean: ""8.06 ± 2.10""
  - standard_deviation: ""2.13 ± 0.69""
  - group_size: ""30""
Comparator:
  - mean: ""8.43 ±
---
###Answer: table[type=""TABLE""] tr:nth-child(3) > td:nth-child(1) {
  font-family: ""Cambria"", ""Tahoma"", ""Helvetica"", ""Verdana"", ""Arial"", ""sans-serif"";
  font-size
---
###Answer: true
---
",True
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,-0.9238,0.0995,,,,,found in table,TRUE,4402,2905,TEST,[],"###Answer: table of mean outcome and standard deviation in yaml format for the given trial article ""tight"" glycaemic targets were associated with normalisation of the increased leptin/adiponectin ratio in cord blood.
---
ANGPTL4 expression: 23.11 ± 5.71, 21.47 ± 5.64, 98.33 ± 0.92 for GDM1, GDM2, and control groups, respectively.
---
ANGPTL4 in cord serum, ng/mL: 19.9 ± 15.0
---
",True
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,[],"###Answer: <p>The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period: x</p>
---
###Answer: <p>intervention: mean: 5.6, standard_deviation: 3.0, group_size: 49</p>
---
###Answer: H0: {""mean"": 426.75, ""standard_deviation"": 19.64, ""group_size"": 50}, H1: {""mean"": 430.67, ""standard_deviation"": 21.92, ""group_
---
",True
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,-0.207,0.0706,,,,,Had to do some simple math to get accurate group size.,TRUE,6184,3742,TEST,[],"
intervention:
  - mean: 13.3
  - standard_deviation: 4.7
  - group_size: 29
comparator:
  - mean: 11.5
  - standard_deviation: 4.6
  - group_size: 
---

---

---
",True
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,187.9,82,230.8,75,-0.538859,0.06908641,,,,,,TRUE,3046,2156,TEST,[],"###Answer: true
---

intervention:
    mean:675.4
    standard_deviation: 38.7
    group_size: 42
comparator:
    mean:648.6
    standard_deviation: 25.6
    group_size: 40
out
---
",True
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,0.9498,0.1855,,,,,,TRUE,6951,5679,TEST,[],"left DLPFC anodal tDCS significantly improved overall WM performance in adults with high-functioning autism compared to sham stimulation.
###Answer: yes
---
Intervention:
  mean: ""x""
comparator:
  mean: 4.8086106
Outcome:
  mean: 0.09
group_size: 26
Intervention:
  standard_deviation: 0.74
comparator:

---
Intervention:
  - mean: 72.3, standard_deviation: 29.8, group_size: 12
  - mean: 78.5, standard_deviation: 22.5, group_size: 12
  - mean: 76.
---
###Answer:
---
###Answer: 3.37, 0.44
---
###Answer: table: mean, standard_deviation: Number, group_size: Number
---
",True
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,[],"
intervention:
    activities_of_daily_living: ""x""
comparator:
    activities_of_daily_living: ""x""
### Answer: 16.0 (6.2)
###Answer: nobelow the cut-off scores for individuals with
---
###Answer: ---

###Answer: yes
---
Allogeneic mesenchymal precursor cells:
""mean"": 44.44,
""standard_deviation"": 15.45,
""group_size"": 6
""mean"": 44.44,
""standard_deviation"": 15.45
---
###Answer: 124476457845815804626
---
###Answer: 2015; 9.62; 423
---
",True
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,[],,False
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,[],"
electrical muscle stimulation (EMS):
    mean: 30
    standard_deviation: 3
    group_size: 24
control:
    mean: 26
    standard_deviation: 3
    group_size: 28

---
###Answer: 1. x
---
###Answer: 7.5, 18.423680702, 24
---
###Answer: 2020-08-31T18:34:45.951Z
---
",True
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,-0.3005,0.1065,,,,,used post values and Treatment as Usual as Baseline,FALSE,7350,5561,TEST,[],"facial affect recognition training (FAT) in 20 daily 1-hour sessions improved performance on several measures of facial affect recognition (FAR) in schizophrenia. FAT improved performance in four out of four FAR tasks: same/different discrimination (mean difference HC24 vs. S
---
facial affect training (FAT) in daily 1-hour sessions for 20 days improved general MCCB performance, but did not remediate poorer performance in Social Cognition compared to baseline. facial affect training (FAT) in daily 1-hour sessions for 20 days improved general
---
facial affect training (FAT) in 20 daily 1-hour sessions versus baseline (CE and TAU): Mean outcome and standard deviation in YAML format
mean: 3.0222
standard_deviation: 1.6506
group_size: 9
mean: x
---
facial affect training (FAT) in 20 daily 1-hour sessions vs baseline; mean T-scores and SD, n=19 per group, FAT vs baseline, MCCB/social cognition, pre-post.
intervention: mean: 39.5 ± 1
---
",True
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,7041,2968,TEST,[],"###Answer: true
---
###Answer: true
---
###Answer: true
---
",True
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,-0.2845666,0.02142635,,,,,,TRUE,9086,4934,TEST,[],"###Answer: 89.87 13.34 480
---
###Answer: yaml
---
###Answer: 9.631, 1.556, 98
---
###Answer: yaml
---

---
",True
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,-0.1610069,0.12958478,,,,,found in table 2,TRUE,9410,4699,TEST,[],"###Answer: yaml
---
###Answer: true
---
###Answer: true
---
###Answer: 0.2466 x 4.3506e-03
---
antibiotic:
  mean: x
  standard_deviation: x
  group_size: 16
attachment gain:
  mean: -1.8808
  standard_deviation: 2.2536
  group_size: 72 (total size)
---
###Answer: antibiotic: 0.64, 0.23, 401
placebo: 0.42, 0.39, 400
attachment gain: 0.43, 0.23, 400
---
",True
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,0.74878609,0.1157639,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,[],"###Answer: intervention: 0.04, 0.04, 18; comparator: 0.04, 0.04, 19; outcome: LF:HF component of HRV [Measure], x, x
---
###Answer: table
---
###Answer: yaml
---
10.0, 8.638929314868999, 70 14.0, 13.097561169809105, 76
---

Intervention: 10-week yoga program
Comparator: Control
Outcome: LF:HF component of HRV:
###Answer: yes
---
###Answer:

###Answer: 72.00 x

###Answer: 13.53 x
---
",True
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,1.2873,0.2012,,,,,,TRUE,6951,5679,TEST,[],"

Intervention: right dorsolateral prefrontal cortex (DLPFC) anodal tDCS improved WM performance in autism
---
###Answer:

###Answer: ok: true
---
right_DLPFC__anodal_tDCS:
  mean: 71.0
  standard_deviation: 29.8
  group_size: 16
sham:
  mean: 78.5
  standard_deviation: 24.3

---
right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS)
mean: 0.09
standard_deviation: 0.81
group_size: 10
comparator
mean: 0.00
---
right_DLPFC_anodal_tDCS_vs_sham_stimulation_on_WM_performance_in_ASD.yaml
---
###Answer: yaml
---
",True
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,1.35893992,0.05594726,,,,,Numerical values based on intention-to-treat,TRUE,9725,6231,TEST,[],"0.03; 6.15; 1
###Answer: no
---
<p><strong>Description:</strong>The table of mean outcome and standard deviation of Vaginal Maturation Index for the intervention and comparator as specified by Randomized Controlled Trial: Vaginal Estriol Plus Viable Lactobacillus acidophilus KS40.</p><pre><
---
###Answer:
---
### Answer: ↓
---
###Answer: indented output shown below
---
###Answer: table of mean outcome and standard deviation in yaml format
---
",True
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,1.3883,0.054,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,[],"###Answer: table:
  - name: results
    children:
      - name: double-headline-study-design
        children:
          - name: intervention
            children:
              - ref: https://clinicaltrials.gov/ct2/study/NCT00
---
###Answer: true
---
###Answer: group_size: 47
---
###Answer: valid YAML data
---
###Answer: table of mean outcome and standard deviation in YAML format for Intervention, Comparator, and Outcome: 4.00 x 0.84, 4.00 x 0.84, 4.00 x 1.43; 12, 1
---
###Answer: 4.1 x, 6.4 x, 7.9 x
---
",True
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,[],"###Answer: table of mean outcome and standard deviation in YAML format for the intervention, comparator, and outcome NCT01639599.
---
###Answer: ""intervention"": {
    ""mean"": ""5.80143564"",
    ""standard_deviation"": ""1.88606867"",
    ""group_size"": ""49""
},
""comparator"": {
    ""mean"":
---
###Answer: type: table 
title: Comparing sedation levels following anesthesia: A double-blind, randomized controlled trial of haloperidol 
overdose in a dosage-dependent manner .
date_published: 2017
published_in: Drugs Context
---
",True
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,[],"###Answer: table-wrap table-wrap-caption Intervention, Comparator, and Outcome; Mean outcome with standard deviation: Table-wrap for intervention, comparator, and outcome. <p>time_unit: seconds</p> <table> <thead> <tr> <th>intervention</th> <",False
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,-0.1060797,0.1083392,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,[],"###Answer: table [ yAML ]
---
10.1371/journal.pone.0212359.t001Table 2. Quality of life - MCS (SF36).  Total cohort  Yoga group Control group Mean (95% CI) Mean (95% CI) Mean (95
---
0.17641
---
###Answer: 18.35, 6.12, 58
---
10-week yoga program versus control (no intervention):
yaml:
- mean: 45.3; standard_deviation: 8.9; group_size: 32
- mean: 47.5; standard_deviation: 10.6; group_size:
---
###Answer: table  3 Mean SF-36 component scale scores at baseline, post-test and 6-month follow-up. PCS: Physical Component Summary; MCS: Mental Component Summary. Results based on intention-to-treat analysis.
                        Intervention (n =
---
",True
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,12997,7944,TEST,[],"###Answer: Yes
---
###Answer: <p>intervention: mean: 10.08, standard_deviation: 2.35, group_size: 326</p>
---
###Answer: type: application/yaml, value: <p>x</p>
---
###Answer: 2.37, 0.91, 326
---
###Answer: table 2 of Lim et al 2014: Mean (SE) length of inpatient hospital stay (days) 7 (0.26) 8 (0.23) 9 (0.23) 9 (0.24) 0.99 0
---
intervention: &;mean&;: 5.0958x; &;standard_deviation&;: 2.6173x; &;group_size&;: 619
comparator: &;mean&;: 4.6715x; &;standard
---

---
",True
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,-0.058139,0.07553046,,,,,found in table 2,TRUE,6682,5735,TEST,[],"###Answer: yaml
---
<p>intervention: mean: 78.1, standard_deviation: 12.0, group_size: 29<p>comparator: mean: 74.5, standard_deviation: 18.1, group_size: 30</p>
---
Intervention:
    mean: 97.2 
    standard_deviation: 12.2 
    group_size: 27
Comparator:
    mean: 91.7 
    standard_deviation: 12.8 
    group_size: 2
---

---
###Answer: table
---
###Answer: table:
  - title: ""Mean (standard deviation) language score on the Bayley-III in infants whose mothers were given tablet daily containing 150 μg iodine during pregnancy""
  - entries:
    - text: ""intervention"":
        -
---
",True
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,[],"###Answer: <p>intervention: mean: 56.42042891152342, standard_deviation: 29.741577137082316, group_size: 37</p>
---
###Answer: ""intervention"" : {
                               ""mean"" : 13.363,
                               ""standard_deviation"" : 11.097,
                               ""group_size"" : 20
                             },
""comparator"" : {
                        ""
---


intervention:
    mean: 38989.4
    standard_deviation: 865.92
    group_size: 18
comparator:
    mean: 37239.2
    standard_deviation: 737.5
---
###Answer: [
  {
    ""mean"": ""76"",
    ""standard_deviation"": ""15"",
    ""group_size"": ""20""
  },
  {
    ""mean"": ""73"",
    ""standard_deviation"": ""15"",
    ""
---
",True
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,[],###Answer: 4,False
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,-0.6287208,0.06996075,,,,,,TRUE,3046,2156,TEST,[],"<p><p>intervention: mean: 146.392409675922, standard_deviation: 20.953769427028, group_size: 30 </p>intervention: mean: 118.
---
outcome:
intervention: 231.5 ± 18.1
comparator: 213.0 ± 10.1

###Answer: yes
---
",True
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,-2.8604,0.088,,,,,"all means and std found in table 2, given as mean change from baseline",TRUE,7551,5383,TEST,[],"###Answer: 20130.0000, 3.266666666666667, 47
---
###Answer: <p>aripiprazole: 7.5 (1.0)                placbeo: 9.2 (1.3)</p>
---

intervention:
  - Parent-rated Aberrant Behavior Checklist irritability subscale score: x
  - Treatment difference (least square mean (95% CI)): -3.94 (-5.78 -- -2.10)
comparator:
  - Parent-
---
###Answer: OK
---
###Answer: yaml
---
###Answer: table: mean: 11.91391, standard_deviation: 3.32179, group_size: 39
---
",True
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,1.05077696,0.02462157,,,,,Available in abstract and table,TRUE,9086,4934,TEST,[],"
MTL+caloric intake group:
    mean: 73.3
    standard_deviation: 6.9
    group_size: 100
comparator:
    mean: 0 [x]
    standard_deviation: 0 [x]
    group_
---
###Answer: yaml
---
Intervention: x
Comparator: x
###Answer: yes
---
MTL+caloric intake group: 73.3 (6.9)e,i
TL+SNL group: 74.7 (3.3)g,j,k
###Answer: yes
---
###Answer: <p>mean: 4.6861, standard_deviation: 1.3886, group_size: 98,</p>
---
",True
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 5's graphics.,FALSE,1406,1149,TEST,[],###Answer: yaml,False
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"
intervention:
    result:
        - enjoyment: 4.0
comparator:
    result:
        - enjoyment: 6.2
---
###Answer: 6.4 0.87 456 x
---
",True
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,[],"
intervention:
  mean: 29.8
  standard_deviation: 1.7
  group_size: 10
comparator:
  mean: 26.9
  standard_deviation: 0.867116
  group_size: 2",False
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,,,,,,,standard deviations not given and means are mean change,FALSE,7450,5464,TEST,[],"Intervention: 4.4 , 1.6 , 27 Comparator: 3.4 , 1.3 , 21 Outcome: 5 , 2 , 28
---
###Answer: <p>Outcome: Days of wheeze mean: 1.67 standard deviation: 2.04 group_size: 10</p>
---
###Answer: table: 2020-07-15T09:39:52Z
---
# The table of mean outcome and standard deviation in YAML format for the given trial article:
---
###Answer: yaml
---
",True
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,-1.2099846,0.12194464,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,[],"###Answer: 1.true1.656.39x
---
###Answer: x
---
###Answer: <p>table-wrap-start: <table-wrap class=""table-wrap center"">table-wrap-table border=""1"" style=""font-family: Times New Roman, Times, serif"">table-wrap-heading>Descriptiontable-wrap-table-row><p>table-wrap-
---
###Answer: <p><table>x</table></p>
---

intervention:
    table:
      groups:
        - intervention:
          - mean: 1.92
          - standard_deviation: 0.74
          - group_size: 10
        - comparator:
          - mean: 3.16
          -
---
###Answer: type: application/x-yaml-smile; value: --- \nintervention: mean: 1.8, standard_deviation: 1.1, group_size: 18\ncomparator: mean: 3, standard_deviation: 1, group_size: 
---
###Answer: type: numerical
value: 2.1 [SD, 0.7]
---
# Table of Mean and Standard Deviation in YAML for quantitative contour sharpness of the Cervicothoracic Spine:
intervention:
    mean: 0.0153
    standard_deviation: 0.0029
    group_size: 8
comparator
---
Intervention: Short-bore MR imaging, Comparator: Open MR imaging, Outcome: quantitative contour sharpness of the cervical-thoracic spine. (Note: ""n"" is not provided for group sizes since those are described in the previous fields.)
type: response
title: Quant
---
###Answer: table-wrap-ans: <p>Intervention:</p> <table-wrap> <tbody> <tr> <td data-type-code=""code"" data-value-date=""2017-01-10""> <p>mean: 0.82578
---
",True
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,0,0.02919864,,,,,Mean change,TRUE,3178,2587,TEST,[],"
intervention:
    mean: x
    standard_deviation: x
    group_size: 69
comparator:
    mean: x
    standard_deviation: x
    group_size: 68

---
Real-Time Continuous Glucose Monitoring Reduced Mean HbA1c at 26 Weeks in Children with Type 1 Diabetes TYPE: Clinical Trial (Diabetes Technology) OUTCOME: HbA1c reduction GROUP SIZE: 69 INTERV
---
",True
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,[],"###Answer: 2.5 mg: 744.45, 25.61; 5 mg: 793.96, 23.39; placebo: 847.78, 20.44
---
###Answer: table-wrap-start   Intervention: 2.5 mg   Comparator: placebo   Outcome: LDL cholesterol   Total size of each group for Intervention and Comparator.
table   Intervention:
mean: 4.61
standard_
---
0.3907730616901175, 11.582654511004061, 177
---
2.5 mg: x; placebo: 240

---
",True
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,[],"mild-cooling: {mean: 3.383333333, standard_deviation: 1.083333333, group_size: 12} , no cooling: {mean: 1.214285714,
---

intervention:
    outcome: Glasgow outcome score at 6 months post-trauma
    yaml:
        - type: numeric
          value: Numeric to rate outcomes as favorable or unfavorable (scale unknown)
        - type: numerical_change
          value: Numeric to rate outcomes as
---
",True
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,0.0911,0.0444,,,,,,TRUE,18948,9604,TEST,[],"
Intervention: Intensive lifestyle intervention (ILI) group
Comparator: Waiting list control
Outcome: baseline fat-free mass
mean: 42.6
standard_deviation: 5.2
group_size: 71
### Answer: 42.6
---
###Answer: table-wrap table-wrap-start table-wrap-end table-wrap-meta title=""table-wrap"" class=""table-wrap"" style=""-webkit-font-smoothing: antialiased; -webkit-box-sizing: content-box; box-sizing: content-box;
---
###Answer: true
---
###Answer: type: text; response: ""intervention: mean: 87.5, standard_deviation: 10.0, group_size: 71\ncomparator: mean: 80.3, standard_deviation: 6.8, group_size: 71
---

Intervention:
    table: 
        title: Intervention
        col_names:
            col_name: mean
            col_name: standard_deviation
            col_name: group_size
        val:
            val: 42.0
            val: 11.4

---
###Answer: table-wrap; font-family: Consolas, ""Courier New"", monospace; font-size: 1.04761904761905em; color: rgba(0, 0, 0, 1); white-space: pre-wrap
---
",True
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,0.1297,0.2505,,,,,,TRUE,13404,7477,TEST,[],"
intervention: x
comparator: x
outcome: x
---
###Answer: ""intervention"" : {
      ""mean"" : ""78±11"",
      ""standard_deviation"" : ""10"",
      ""group_size"" : ""10""
    },
    ""comparator"" : {
      ""mean"" : ""68±1
---
intervention:
    yaml: {
        ""mean"": ""246"",
        ""standard_deviation"": ""56"",
        ""group_size"": ""10""
    }
comparator:
    yaml: {
        ""mean"": ""190"",
        ""standard_
---

intervention:
  - mean: 238.8 
  - standard_deviation: 25.48
  - group_size: 13
comparator:
  - mean: 338.5
  - standard_deviation: 45.34

---

intervention:
    response: x
comparator:
    response: x

###Answer: TRUE
---

intervention: x
comparator: x

###Answer: OPTION B IS CORRECT.
---
",True
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,-0.4117458,0.35605481,,,,,found in abstract,TRUE,4542,3636,TEST,[],"
---

intervention:
    x: 0.35
    x: 0.38
comparator:
    x: 0.37
    x: 0.23
outcome:
    MMP-9: 100 mg - 88.5 (16
---

intervention:
  - mean: ""819""
  - standard_deviation: ""167""
  - group_size: ""7""
comparator:
  - mean: ""790""
  - standard_deviation: ""160""
  - group_size
---
###Answer:
---
",True
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,[],"group 1: mean: 65, standard_deviation: 2, group_size: 25
group 2: mean: 61, standard_deviation: 3, group_size: 20
group 3: mean: 41, standard_deviation: 4,",False
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,0.06854473,0.02132769,,,,,,TRUE,9086,4934,TEST,[],"###Answer: 73.3% (6.9%)
---
###Answer: table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap:
""mean"": 6.2,
""std"": 0.9962768
---
###Answer: yaml-response: 
mean: 84.0
standard_deviation: 9.0
group_size: 98

---
###Answer: table : mean, standard_deviation, group_size : ""intervention"" 107, 6, 27, ""comparator"" 100, 13, 27, Taste perception x x
---

###Answer: table-wrap table="" width=""100%"" style=""width: 100%; font-family: Times New Roman, Times, serif"" align=""center"" cellspacing=""4"">
mean: 4
standard_deviation: 1
group_size: 50

---
",True
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,[],"
1500 mg calcium:
    mean: 3.0
    standard_deviation: 0.5
    group_size: 15
500 mg calcium:
    mean: 3.0
    standard_deviation: 0.5
    group_
---

# mean: 3.0
# standard_deviation: 2.3
# group_size: 88
comparator:
  # mean: -1.9
  # standard_deviation: 2.0
  # group_size: 66

###Answer: yes
---
###Answer: true
---
###Answer: [ { ""type"": ""number"", ""value"": 8465, ""unit"": ""g"" }, { ""type"": ""number"", ""value"": 356.838, ""unit"": ""g"" }, { ""type"": ""number"", ""value"": 17, ""unit
---

intervention:
  mean: 10.2
  standard_deviation: 1.5
  group_size: 18
comparator:
  mean: 5.8
  standard_deviation: 1.0
  group_size: 16

---
###Answer: true
---
###Answer: true
---
",True
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,-1.5744,0.262,,,,,,TRUE,1507,1019,TEST,[],"Intervention: 0.83, 0.92, 0.74, 0.82
Comparator: 0.97, 0.99, 0.97, 0.93
###Answer: yes",False
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,0.035327,0.1547859,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,[],"
---
intervention:
  mean: 0.82
  standard_deviation: 0.21
  group_size: 2211
comparator:
  mean: 0.82
  standard_deviation: 0.21
  group_size: 221
---

intervention:
    mean: 19.81
    standard_deviation: 5.37
    group_size: 115
comparator:
    mean: 17.95
    standard_deviation: 5.29
    group_size: 1
---
###Answer: <p>intervention:mean: 50.0, standard_deviation: 32.0, group_size: 67</p>
---
intervention:
  - mean: 0.53
  - standard_deviation: 0.23
  - group_size: 24
comparator:
  - mean: 0.17
  - standard_deviation: 0.19
  - group_size:
---
###Answer: outcome: ""treatment-according-to-guidelines"" → NUMBER; standard_deviation: NUMBER; group_size: NUMBER
intervention: ""provider-school"" → x; standard_deviation: x; group_size: x
comparator: ""control"" →
---
Intervention:
  - mean: 0.93276923
  - standard_deviation: 0.20084385
  - group_size: 420
Comparator:
  - mean: 0.02388082

---
",True
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,[],"###Answer:
---
###Answer: true
---
###Answer: {""type"":""intervention"",""mean"":0.16339651626234397,""standard_deviation"":1.0438543372801677,""group_size"":22}
---
###Answer: table, example:
---
",True
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,91.2,6.62,92.04,7.15,-0.1203,0.0668,,,,,found in table,TRUE,1359,1043,TEST,[],,False
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,-0.1361,0.2005,,,,,,TRUE,13148,4660,TEST,[],"###Answer: <p>outcome: In-stent late lumen loss at 9 months data:</p><p>intervention: mean:0.11; standard_deviation:0.25; group_size:12</p><p>comparator: mean:0.16;
---
###Answer: 0.11±0.25 mm for Genoss DES™ and 0.16±0.43 mm for Promus Element™
---
###Answer: yaml1
---
table-wrap table class=""pubmed"">
  <caption>In-stent late lumen loss at 9 months results from the Genoss Element versus Promus Element paclitaxel-eluting stent trial. A serial intravascular ultrasound study.</caption>
  <colgroup>
    <col
---
###Answer: table: mean,standard_deviation,group_size, type: intervention, comparator, outcome: In-stent late lumen loss at 9 months - YAML format
---
",True
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,0.9238,0.0083,,,,,Used values for weeks 52 (final timepoint).,TRUE,12247,10091,TEST,[],"
---
###Answer:
###Answer: true
---

###Answer: 12.2 x 2.4
---
### Answer: yaml
---
###Answer: yaml
---
###Answer: 91.4, 12.6, 567
---
",True
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,[],"The table of mean outcome and standard deviation in YAML format for the given intervention, comparator, and outcome is <p>intervention: Mean: 611.9868 standard_deviation: 284.4287 group_size: 26 comparator: Mean: 67
---
###Answer: table 1 A in Bakhai et al., Drugs R D (2019) 19:325-335
---
###Answer: <p>Intervention {mean: 7.4, standard_deviation: 18.5, group_size: 12}, Comparator {mean: , standard_deviation: , group_size: }</p>
---
5 mg elobixibat: mean LDL cholesterol: 0.52; standard deviation: 0.33; group size: 40 40
---
",True
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,cannot calculate,cannot calculate,,,,,Values are in figure.,FALSE,12247,10091,TEST,[],"
intervention:
  - mean: 0.686
  - standard_deviation: 0.170
  - group_size: 408
comparator:
  - mean: 0.159
  - standard_deviation: 0.199

---
Intervention:
mean: 73.1, standard_deviation: 20.3, group_size: 393
Comparator:
mean: 67.1, standard_deviation: 21.2, group_size: 199
###Answer: yes
---

intervention:
    fatigue_assessment_scale_improvement: x
comparator:
    fatigue_assessment_scale_improvement: x
###Answer: NO CHANGE
---

intervention:x
comparator:x
outcome: mean, standard_deviation, group_size

###Answer: OPTION C IS CORRECT.
---
###Answer: 8.78924975686326, 1.82401974242731, 44.4
---
###Answer: table:
  - name: Intervention
    - type: array
      - elementType: string
      - items:
        - intervention

  - name: Comparator
    - type: array
      - elementType: string
      - items:
        - comparator

 
---
",True
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,0.5979,0.2612,,,,,,TRUE,13404,7477,TEST,[],"
---

intervention:
  - lateral bending for C4-C5 segments: 5.08451685254388, 0.891786914548478, 9
  - lateral bending for C2-C
---

---
intervention:
    lateral_bending: 0.83, 0.48
comparator: 0.83, 0.45
###Answer: yes
---
###Answer: Table 6 and 7 below
---
6.37, 0.70, 5
---
",True
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,0.0084,0.0444,,,,,,TRUE,18948,9604,TEST,[],"(Refer to example.csv)
intervention:
  mean: 79.867
  standard_deviation: 7.967
  group_size: 139
comparator:
  mean: 85
  standard_deviation: 8.5
 
---
###Answer: table-wrap table-wrap-start table-wrap-end table-wrap-foot style=""display: table-row; margin: 0; text-align: center; font-family: Times New Roman, Times, serif"" > <p style=""margin: 0; text-align: center"">
---
###Answer:table <p>Intervention: Intensive lifestyle intervention (ILI) groupComparator: Waiting list controlOutcome: baseline fat mass</p>mean: -1.7,standard_deviation: 2.5,group_size: 71mean: -0.5
---
###Answer: type: application/problem+json; charset: UTF-8; status: 200; info: ""intervention_mean"": 77.8, ""intervention_sd"": 13.7, ""comparator_mean"": 87.3, ""comparator_sd"": 
---

Intervention: INT ,[?] COM ,[?] Fat_mass 
Comparator: COM ,[?] Fat_mass 
Outcome: FATMASS 4.4E01 1.1E+01 68 4.4E+01 4.
---
Intervention:
    mean: 31.78896
    standard_deviation: 11.842545
    group_size: 14
Comparator:
    mean: 32.97651
    standard_deviation: 18.
---
",True
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,-0.2663137,0.25221634,,,,,Added the last timepoint to the outcome name. Since there are 10 different time points.,TRUE,7288,4607,TEST,[],"Hot and Hot+Cooling condition: 0.80 (0.09), 0.90 (0.11), 0.81 (0.10), 0.88 (0.07), 0.84 (0.13), 0.92 (
---
###Answer: [
  ""mean"": 160.99999999999999,
  ""standard_deviation"": 0.935908333333333,
  ""group_size"": 7
}
]
---
The table of mean outcome and standard deviation in YAML format for this example is below:
###Answer: yes
---

hot + cooling conditions :
    decrease in exercise intensity as time elapsed (at time 10): 1.234 (0.345)
14 subjects
hot conditions :
    decrease in exercise intensity as time elapsed (at time 10): 0.123 (0
---
###Answer: [x]
---
",True
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,0.59900785,0.0951747,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"###Answer: table of mean outcome and standard deviation in YAML format as requested.

###Answer: yes
---
###Answer: true
---
###Answer: 8.85, 1.80, 46
---
###Answer: type: application/x-yaml
---
###Answer: true
---
###Answer: table: {
  ""intervention"": {
    ""mean"": 163.8,
    ""standard_deviation"": 33.6,
    ""group_size"": 23
  },
  ""comparator"": {
    ""mean"": 210.
---
",True
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,0.01562115,0.04545593,,,,,,TRUE,9725,6231,TEST,[],"###Answer: table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome: 
Intervention: Vaginal estriol plus viable Lactobacillus acidophilus
---
###Answer: true
---
###Answer: <p>intervention: mean: 3.6, standard_deviation: 1.6, group_size: 24</p>
---
###Answer: yaml
---
###Answer: intervention: mean: xxxx, standard_deviation: xxxxx, group_size: xxxxx; comparator: mean: xxxxx, standard_deviation: xxxxx, group_size: xxxxx
---
###Answer: value=""x"" group_size=""89"" standard_deviation=""x"" mean=""x""
---
",True
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,[],"
###Answer: 1. x
---
###Answer: 36.24,1.79,""28""

###Answer: yes
---

Hot:
  - mean: 13.375
  - standard_deviation: 1.806
  - group_size: 8
Hot + Cooling:
  - mean: 12.15
  - standard_deviation: 1.554
---

---
###Answer: yaml
---
",True
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,[],"Intervention: <p>0.098199, 0.062786</p>Comparator: <p>0.098438, 0.062786</p>Outcome: <p>0.098199</p",False
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,3.55292234,0.22416584,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,[],"InterventionComparatorOutcomemean1009697standard_deviation32.89.49.4group_size239310
###Answer: yes
---
Intervention:
    mean: 2.16
    standard_deviation: 0.20
    group_size: 244249
Comparator:
    mean: 2.16
    standard_deviation: 0.20
    group_size: 2
---
Phlebotomy questionnaire score: CHC A -- Numerator:249 -- Denominator:290 -- Missing data:82 -- Mean: 5.49 -- Standard deviation:1.84 -- Group size: 91
---
The following example shows how the YAML format for the fields ""mean"", ""standard_deviation"" and ""group_size"" might look like for the given trial article:
intervention: mean: 4.0, standard_deviation: 1.0, group_size: 598
comparator: mean
---
### Answer: <p><em>Incomplete data. Please verify and update answer.</em></p>
---
",True
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,[],"
intervention:
  mean: x
  standard_deviation: x
  group_size: 9
comparator:
  mean: x
  standard_deviation: x
  group_size: 12

###Answer: yes
---

###Answer: yes
---
###Answer: true
---
###Answer: table ::= nds-r-output : ' 2000' , groups: ' 15' , ' 15' , ' 0' , ' 1500' , ' 500' , ' , ' 0' , ' , ' 54
---
###Answer: ""x""
---
###Answer: <table><tr><td>mean: 41.2,</td><td>standard_deviation: 13.1,</td><td>group_size: 18</td></tr></table>
---
###Answer: 5.25
---
",True
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"
---
###Answer: <p>intervention: mean: 34.10, standard_deviation: 3.14, group_size: 89</p>
---
###Answer: table-cell-aligned-xs-stretch-1-col .table-cell-aligned-xs-stretch-1-col; font-family: "" Times New Roman"", Times, serif; margin: 0 0 0 8px; text-indent: 0"">9.9
---
###Answer: yaml
---
###Answer: table <dl>
  <dt>intervention</dt>
  <dd>mean: 2.556</dd>
  <dd>standard_deviation: 0.395</dd>
  <dd>group_size: 100</dd>

---
",True
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,[],"###Answer: 1. table: 1 2 3 4 5 6 7 8. ""intervention"" : {
	""mean"" : 5.366666666666666,
	""standard_deviation"" : 6.2
---
Intervention: mean: 10.7, standard_deviation: 1.8, group_size: 76; comparator: mean: 10.9, standard_deviation: 1.8, group_size: 75.
---
###Answer: 1.06, 1.06, 0.61
---
###Answer: true
---
###Answer: 2016-05-23 15:45:01 UTC+8
---
",True
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,[],"###Answer:
---
50.0, 9.1, 667
---
###Answer: 4.1 < 4.3
---
###Answer: 4.6 (3.3)   14 (11)
---
",True
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: |

###Answer: yes
---
###Answer: <p>intervention: mean: 1.84, standard_deviation: 1.70, group_size: 200<p>comparator: mean: 1.70, standard_deviation: 1.62, group_size: 180
---
###Answer: 5.16, 11.73, 79 [ naproxen 500 mg twice daily, placebo, tender joint count ]
---
<ul><li><p>mean: 8.89</p><p>standard_deviation: 1.99</p><p>group_size: 494</p></li><li><p>mean: 10.06</p><p>standard_deviation: 
---

intervention:
    tenderness-joint-count: x
comparator:
    tenderness-joint-count: x

---
intervention:
  mean: 172 
  standard_deviation: 13 
  group_size: 81
comparator: 
  mean: 417 
  standard_deviation: 71 
  group_size: 150

---
",True
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,0.1626,0.079,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"Intervention:
  external_rotation_range: x
Group I: 63.9848579579695, 7.59690556511857
Group II: 59.6090909090
---
Intervention: 3.76, 1.45, 60Comparator: 4.63, 2.10, 60Outcome: x, x, x
---
Intervention:
    motion_range_shoulder_external_rotation:
        yaml:
            - mean: x 
            - standard_deviation: x
            - group_size: 20
Comparator:
    motion_range_shoulder_external_rotation:
        yaml
---
",True
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
###Answer: <p><strong>Intervention:</strong> remifentanil<br /><strong>Comparator:</strong> normal saline<br /><strong>Outcome:</strong> mean blood pressure</p>
---
###Answer: <p>x</p>
---
",True
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 3's graphics.,FALSE,1406,1149,TEST,[],###Answer: yaml,False
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,,,,2.4,0.1,3.4,0.1,-9.9164,0.5779,,,,,raw values foun din text,TRUE,7551,5383,TEST,[],"###Answer: table_data: 
title: Results
description: Based on the given trial article, what is the table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome?
---
###Answer: table  2 Demographics and clinical characteristics of patients with intellectual disability, by treatment group.
###Answer: false
---
### Answer:
---
###Answer: true
---
###Answer: tableofmeanoutcomeandstandarddeviationinyamlformatforaripiprazole-1577340936
---
###Answer: <p>intervention: mean: 1.75; standard_deviation: 0.60; group_size: 22</p>
---
",True
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,1.029,0.0781,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"
intervention:
	mean: 98.823983
	standard_deviation: 1.57089694
	group_size: 10
comparator:
	mean: 84.314780
	standard_deviation:
---
type: text
---
###Answer: ANSWER: (GITHUB DOCUMENTATION)
---
###Answer: intervention: 37.71, 6.31, 48; comparator: 35.34, 4.49, 56
---
Intervention: 200 mg/day palmvitee non-smokers:
    mean: 1.92
    standard_deviation: 0.59
    group_size: 56
Comparator: baseline:
    mean: 2.36
    standard
---
###Answer: 200 mg/day palmvitee nonsmokers: 8.85, 1.43, 44
---
###Answer: <table-wrap><table><colgroup><col align=""left"" /><col align=""center"" /><col align=""right"" /><col align=""right"" /><col align=""right"" /><col align=""right"":=""roman"" /><col align=""right"" /><col align
---
###Answer: table-wrap table=""25757520-144731143"" header="" table=""25757520-144731143"" header=""tr"" > <td>Intervention: 200 mg/day
---
###Answer: type: text; value: ""intervention"":
    mean: ""2.05"",
    standard_deviation: ""0.55"",
    group_size: ""56""
    },
  ""comparator"":
    { mean: ""2.31"",
      standard
---
###Answer: true
---
###Answer: table  14.
---
###Answer: Type: text/javascript;charset: utf-8;base64,PD94bGFlZCB0aGUgc3RhdGUuaWVmIGxlbmx5IHRoaXMuaWVmIGxlbmx5IHRoaXMua
---
<table> 
<thead><tr><th col=""intervention"" class=""header"">Mean</th><th col=""comparator"" class=""header"">Mean</th><th col=""intervention"" class=""header"">SD</th><th col=""comparator"" class=""header"">SD</th></tr></
---
",True
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,-0.6451,0.0701,,,,,found in abstract,TRUE,1359,1043,TEST,[],"outcomes:
  - onset_of_sensory_block:
    intervention: 6.26 ± 0.81
    comparator: 5.10 ± 0.65
    x
  - duration_of_sensory_block:
    intervention:",False
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,[],"facial affect training (FAT) in 20 daily 1-hour sessions increased alpha power during dynamic facial affect recognition  Intervention: facial affect training (FAT) in 20 daily 1-hour sessions; Comparator: pre-intervention state  Comparison: FAT improved FAR performance, though
---

facial_affect_training:
    mean: 0.5
    standard_deviation: 0.7
    group_size: 10
baseline:
    mean: 0.4
    standard_deviation: 0.6
    group_size: 10

---
###Answer: yaml
---
100% match.
---
",True
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"### Answer: 0.9950000000000003, 0.200632722324163, 946
---
###Answer: <p><strong>Description:</strong>Serum C-reactive protein 0.36 (0.03) µg/mL</p>
---
###Answer: table: !""#$%&'()*+,-.0123456789:;<=>?@ABCDEFGHIJKLMNO<P<RSTUVWXYZ[\\]^_`abceFghIklmnoPQrST
---

###Answer: true
---
###Answer: |
Intervention: etoricoxib 90 mg once daily
Comparator: placebo
Outcome: Serum C-reactive protein
Intervention:
  → mean: 1.56
  → standard_deviation: 0.32
  → group_
---
###Answer: <p>table: [                                                                                                                     
---
",True
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,given as median and range,FALSE,7451,3515,TEST,[],"###Answer: 2.10</p><p>Mean values and SD. Outcomes - Pain scores (0-10) (0=no pain; 10=maximal pain): Resveratrol (n=22) Placebo (n=22). P=0.7</
---
###Answer: 2.28, 0.56, 20
---
###Answer: <p>intervention: mean: 3.2, standard_deviation: 2.4, group_size: 22</p>
---
###Answer: table, plain: 0.9937228119139946, table, diagonal: [ [ 0.08411366779058776, 0.104613806686
---
",True
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,-0.2105282,0.016759,,,,,,TRUE,3561,2387,TEST,[],"Intervention:
  - mean: 38.63
  - standard_deviation: 4.11
  - group_size: 36
Comparator:
  - mean: 35.23
  - standard_deviation: 12.37
  - group
---
intervention:
  mean: 10,
  standard_deviation: 1,
  group_size: 25
comparator:
  mean: 9,
  standard_deviation: 2,
  group_size: 25

---
",True
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: 2.2.1.1
---
###Answer: 11 (SD .36831702, n = 181)
---
###Answer: 2.75, 0.81, 120
---
naproxen:
    mean: 0.43
    standard_deviation: 0.55
    group_size: 3434
placebo:
    mean: -0.43
    standard_deviation: 0.55
    group_size: 3
---
###Answer: naproxen 500 mg twice daily
---

intervention:
    meaning: ""Patient global assessment of pain""
    method: HHS
    display_label: 500 mg Naproxen Sodium Extended-release Tablets in the Treatment of Osteoarthritis pain
    num_sd: 1.
---
",True
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,[],"###Answer: <ul>
  <li>haloperidol: <p>1 mg</p>
  <li>haloperidol: <p>2 mg</p>
  <li>saline: <p>x</p>
</ul>
---
For Intervention:
– Mean: 146, Standard deviation: 2.226, Group size: 50
For Comparator:
– Mean: 148.5, Standard deviation: 1.79, Group size: 50
For Outcome: 
– YAML
---
###Answer: yaml
---
",True
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,cannot calculate,cannot calculate,,,,,SD is not given.,FALSE,12690,6902,TEST,[],"metformin:
    mean: x
    standard_deviation: x
    group_size: 17
sitagliptin:
    mean: x
    standard_deviation: x
    group_size: 16
placebo:
    mean: x
    standard_deviation
---
###Answer: true
---

---
metformin 1,000 mg daily, sitagliptin 100 mg daily 
restricted_mean_time_to_hyperglycemic_relapse 805.67 203.90 661.06 138 1
---


intervention:
mean: 8.162
standard_deviation: 1.983
group_size: 27
comparator:
mean: 8.602
standard_deviation: 1.684
group_size: 29

##
---
",True
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,-1.5691765,0.26155787,,,,,Values on mean change are based on what is reported in abstract.,TRUE,3146,2589,TEST,[],"###Answer: > NUMBER -0.14 ± 0.05°C:
---

###Answer: yaml
---

intervention:
  - mean: -0.28
  - standard_deviation: 0.11
  - group_size: 30
comparator:
  - mean: NA
  - standard_deviation: NA
  - group_size: NA
---
",True
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,[],"
intervention:
    hyperglycemia_relapse_free_survival: 0.808176127019826
    standard_deviation: 0.205960822040644
    group_size: 
---
###Answer: table-wrap;
---
###Answer: intervention:  x; x; 27  comparator:  x; x; 17  outcome:  x; x; 44
---

Intervention:
    hyperglycemia relapse-free survival: 0.6835, 0.1767
Comparator:
    hyperglycemia relapse-free survival: 0.3097, 0.1614

---
hyperglycemia_relapse_free_survival:
intervention:
    mean: 91.3%
    standard_deviation: 0.14934
    group_size: 211
comparator:
    mean: 90.8%
    standard
---
",True
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: 12.63, 14.58, 395
---
The following table shows the mean and standard deviation for each group: 

###Answer: yes
---
###Answer: 0.9578398162175496, 0.24182856078587464, 110
---
outcome: swollen-joint-count:
  - intervention: 1:
    - mean: 2.43
    - standard_deviation: 2.43
    - group_size: 786
  - comparator: 1:
    - mean: 2
---

intervention:
  - mean: [x]
  - standard_deviation: [x]
  - group_size: [x]
comparator:
  - mean: [x]
  - standard_deviation: [x]
  - group_size: [x]

---

---
",True
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,3.71430281,0.0577096,,,,,,TRUE,9086,4934,TEST,[],"###Answer: 74.72666666666667, 6.979416666666667, 480
---
#####Answer: table-wrap table-wrap table-wrap tr td=""mean"": ""3.69813860386443"", td=""standard_deviation"": ""4.39064693567917"", td=""group_size"": ""90
---
###Answer: 67.36271346, 12.79368424, 98
---
###Answer: true
---
Intervention:
    mean: 59
    standard_deviation: 3
    group_size: 480
comparator:
    mean: 4.4
    standard_deviation: 1.3
    group_size: 99
Outcome:
    mean: x
---
",True
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,[],"
intervention:
    response:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
comparator:
    response:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
###Answer: 1 table
---
###Answer: true
---
###Answer: yaml
---
",True
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"###Answer: table-yaml-2016-hoeven-pmc4576123-1.10001-intervention-comparator-outcome-0-12-151_150-117-4-107-8-1-
---
###Answer: ~~~~
---
",True
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,-0.0248738,0.25001933,,,,,The numerical values are from Exercise state.,TRUE,7288,4607,TEST,[],"
###Answer: true
---
###Answer: type: object
    table:
      collapse: true
      cells:
        value:
          value_format: ""double""
- intervention:
  mean: 4.2139478
  standard_deviation: 1.2089373

---

intervention:
    mean: 69
    standard_deviation: 7
    group_size: 8
comparator:
    mean: 69
    standard_deviation: 7
    group_size: 8

---

###Answer: hot_01 = 7.69; hot_02 = 8.78; cool_01 = 6.96, cool_02 = 8.05; hot_01_sd = 2.5; hot_02_sd = 0
---
###Answer: hot_plus_cooling_conditions:
  mean: 9.30446116418728
  standard_deviation: 2.34553220192016
  group_size: 20

---
",True
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,cannot calculate,cannot calculate,,,,,Median was only given.,FALSE,9517,6474,TEST,[],"###Answer: table <p><table><thead><tr><th>Intervention</th><th>Comparator</th><th>Outcome</th></tr></thead><tbody><tr><td>10.3</td><td>5.8</td><td>PFS - 95% CI
---
###Answer: <p>table:<br/> <table><tr><th>mean</th><th>std</th><th>group_size</th></tr><tr><td>-0.34282</td><td>0.249599</td><td>5
---
###Answer: <p>table: <p> Progression-free survival. <p>Reference: 1RGHJDSYKF2D2B3FGH456\"">article: trial.html"">
---

###Answer: 5.2 x 1.09 [group_size: 92]
---

###Answer: {
  ""mean"": 1.74,
  ""standard_deviation"": 1.03,
  ""group_size"": 59
}, {
  ""mean"": 1.05,
  ""standard_deviation"": 0.52,

---
###Answer: 44.66666666666664, 1.875, 46</p></textarea></p><h2>Description:</h2><p>This intervention has a mean PFS of 44.666666
---
",True
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,[],"###Answer: 15.266666666666667, 4.114826482648263
---

---
###Answer: table-wrap table-wrap-key-value table-wrap-value=""yan-tl-2016-00505-sn"" table-wrap=""intervention, comparator, outcome"" x=""mean, standard_deviation, group_size"" mean=""57"", standard_de
---
###Answer: table-wrap; font-size: 1.04761904761905em; color: rgba(0, 0, 0, 1); font-family: Times New Roman, Times, serif; margin: 0 0 8pt 4
---
",True
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,[],"
###Answer: [Outcome 1, Intervention 1, Comparator 1, Outcome 2]",False
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,0.28575833,0.0185746,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"###Answer: <p><strong>Description:</strong>The table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome.</p><p><strong>Answer: yes</strong></p>
---
###Answer: yaml
---

intervention:
  mean: 32.7 ± 7.3
  standard_deviation: 6.3
  group_size: 13
comparator:
  mean: 29.1 ± 5.8
  standard_deviation: 7.9

---
GetHealthyStayHealthy' (GHSH) is an automated, tailored chronic disease prevention intervention targeting individuals at risk of cardiovascular disease (CVD). GHSH delivers text messages and tailored email or postal communications to support changes in physical activity, healthy e
---
###Answer: yaml
---
### Answer: yaml-output > 67.44 KB
---
###Answer: tablebox: 2018-october-08-get-healthy-stay-healthy-trial-mean-outcomes-and-standard-deviations-yaml
---
###Answer: 

###Answer: true
---
",True
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: <p>x</p>
---
<table><thead><tr><th>Intervention</th><th>Comparator</th><th>Outcome</th></tr></thead><tbody><tr><td>naproxen 500 mg twice daily</td><td>placebo</td><td>Serum C-reactive protein
---
###Answer: table: yaml_output
---
###Answer: <table-wrap> <label>Table 3</label> <caption><p>Mean (95% confidence interval) serum C-reactive protein ratios between treatments over 12 weeks</p></caption><table><thead><tr><td></td><td>N
---

---
###Answer: ACTUAL OUTPUT IS TO BE INSERTED IN THIS FORM FIELD
---
",True
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,-3.7647135,0.18477557,,,,,,TRUE,3046,2156,TEST,[],"###Answer: 230 x 0.066 ""x""
---

intervention:
  mean: 188.0
  standard_deviation: 9.7
  group_size: 20
comparator:
  mean: 185.1
  standard_deviation: 5.9
  group_size: 18
out
---
",True
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"###Answer: 150.8, 107.8, number missing
---
###Answer: (In bold)
---
",True
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,2318,1990,TEST,[],"###Answer: intervention: x; comparator: x
---
###Answer: true
---
",True
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,17.9,3.2,31.9,6.7,-2.6318902,0.12439038,,,,,found in fig3,TRUE,6401,5359,TEST,[],"###Answer: 2020-01-13 13:55:08Z:17299947694532 \
    intervention: mean: 33 mg, standard_deviation: 76.1457, group
---
###Answer: 7.30 x 30, 7.30 x 15, 7.30 x 12, 7.30 x 12, 7.30 x 14
---
###Answer: group D has the lowest pain score when compared with other groups.
---
###Answer: type: application/x-yaml
---
###Answer: table-cell wrapped-value=""x"" table-wrap=""true"" data-source-reference=""article_9763085_0"">
---
###Answer: type: application/x-yaml 129 KB
---
",True
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,1.4252,0.2786,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"###Answer: 4.77, 7.78, 9
---
intervention:
    mean: 8069436.3
    standard_deviation: 0
    group_size: 16
comparator:
    mean: 7353923.0
    standard_deviation: 640652.6

---
",True
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,24.6,4.5,31.9,6.7,-1.2625038,0.0799493,,,,,found in fig3,TRUE,6401,5359,TEST,[],"###Answer: [Reference: Intervention: E group Comparator: P group Outcome: morphine requirements]
---
###Answer: table-wrap table-wrap-start table-wrap-end <p>intervention: mean: 1.066191588938144, standard_deviation: 1.136903076715571, group_
---
intervention:
    mean: 84.2
    standard_deviation: 10.1
    group_size: 8
comparator:
    mean: 130.3
    standard_deviation: 7.8
    group_size: 10
###Answer
---
###Answer: 0.446881465629575 x
---
###Answer: <p> intervention: mean: 5.1333333333333, standard_deviation: 0.0, group_size: 30 comparator: mean: 5.1333333333333, standard_
---

---
",True
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,[],"###Answer: 8.12 x 14.37
---

Intervention: 7.983, 1.134166666666666, 38
Comparator: 6.9, 1.05, 37
###Answer: acceptable
---
",True
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,0.3811,0.0077,,,,,Used values for MCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,[],"
---

---

intervention:
  - mean: ""7.35""
  - standard_deviation: ""13.88""
  - group_size: ""39""
comparator:
  - mean: ""0.10""
  - standard_deviation: ""10.44
---

intervention:
  - mean: 2.18
  - standard_deviation: 12.2
  - group_size: 43
comparator:
  - mean: 2.00
  - standard_deviation: 12.2
  - group_size
---
###Answer: 4.0000000000000005, 0.857358941603258, 556
---
###Answer: 90.6
---
",True
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,0.4722,0.0447,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,[],"###Answer: table_data: | mean: 10.31 x | standard_deviation: 4.30 x | group_size: 34 x | table_data: | mean: 11.95 x | standard_deviation: 5.95 x | group_size
---
###Answer: table  2.
---
###Answer: 5.37973702, 5.37973702, 45
---
# ARTICLE: SY N 0 0 2; 72(6):652-7 # ABSTRACT: Background Although aripiprazole has been associated with a lower incidence of treatment-emergent extrapyramidal symptoms compared with other dopamine-receptor antagonists
---
###Answer: table of mean outcome and standard deviation in YAML format for aripiprazole and placebo for Aberrant Behavior Checklist Japanese Version Irritability subscale score
---
###Answer: table  4; 5.
###Answer: yes
---
",True
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,-0.2216,0.0503,,,,,,TRUE,10658,5810,TEST,[],"###Answer: yaml
---
###Answer: table-wrap x column-wrap.
---
###Answer: <p>Interferon gamma-induced protein 10: mean: 986.69, standard_deviation: 488.20, group_size: 40</p>
---
###Answer: type: yaml > <p>21.22</p>, <p>45.93</p>, <p>20</p>, <p>40</p>, ""intervention: mean: NUMBER, standard_deviation: NUMBER, group_size: NUMBER
---
###Answer: yaml
---
###Answer: table<p>Intervention: Vitamin D supplementationComparator: ControlOutcome: Interferon gamma-induced protein 10</p>mean: -16.119standard_deviation: 23.407group_size: 182.1
---
###Answer: table = [ { ""number"": ""+1"", ""text"": "">=0.302"", ""group_size"": ""50"" }, { ""number"": ""-1"", ""text"": ""<0.302"", ""group_size"": ""50"" } ]
---
",True
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,cannot calculate,cannot calculate,,,,,Only difference in response rates as percent is given.,FALSE,9517,6474,TEST,[],"###Answer: [x] NUMBER; STD DEV: NUMBER; n: NUMBER
---

Intervention:
  - mean: 1.16
  - standard_deviation: 1.27
  - group_size: 53
Comparator:
  - mean: 0.27
  - standard_deviation: 1.21
  - group_size
---
###Answer: A table in YAML format is included at the end of the example.
---

###Answer: 8.1 (x)
---
24 6.5 79
---
yaml: 																																																																		
---
",True
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"<yaml>
    intervention:
        mean: NA
        standard_deviation: NA
        group_size: 353
    comparator:
        mean: NA
        standard_deviation: NA
        group_size: 242
</yaml>
---
naproxen 500 mg twice a day (this format is for presenting continuous data).<table-wrap><table><thead><tr><th>Mean</th><th>Standard Deviation</th><th>Group Size</th></tr></thead><tbody><tr><td>7.8</
---
###Answer: table_result:
  table_title: Health Assessment Questionnaire disability; see Appendix A: Health Assessment Questionnaire disability score description
  description: value: 0.858
mean: 0.858
standard_deviation: 0.21
---
naproxen 500 mg twice daily: 1.12 (0.99, 1.27)
placebo: 1.00 (0.87, 1.13)
---
naproxen 500 mg twice daily:
  - mean: 0.52
  - standard_deviation: 0.18
  - group_size: 67
placebo:
  - mean: 0.51
  - standard_deviation: 0
---
###Answer: disability intervention: mean: 0.9311260557806201, standard_deviation: 0.1434750640194267, group_size: 806  Comparisons Comparisons included
---
",True
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,0.2478,0.0071,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,[],"
intervention:
  - mean: 6.3
  - standard_deviation: 12.6
  - group_size: 287
comparator:
  - mean: 3.1
  - standard_deviation: 13.2
  - group_size:
---

###Answer: YAML
---
",True
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,[],"
###Answer: 9.65, 3.04, 11
---
###Answer: true
---

intervention:
  - Mean: ""8.00""
  - Standard deviation: ""1.23""
  - Group size: 10
comparator:
  - Mean: ""6.45""
  - Standard deviation: ""2.05""
  - Group size: 
---
###Answer: <p>TABLE  4</p>
---
###Answer: {
  ""intervention"": {
    ""mean"": 4.33333333333333,
    ""standard_deviation"": 0.633333333333333,
    ""group_size"": 
---
",True
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,[],"duloxetine 60 and etoricoxib 120mg (group D/E): x
---
###Answer: <p>table-wrap-start: <p> </p><table><th>Intervention</th><th>Comparator</th><th>Outcome</th><th>mean</th><th>standard_deviation</th><th>group_size</th></tr><tr><
---
###Answer: s: 4.2499999650274145, s: 4.937574332679019, g: 146, s: 5.05285745202
---
###Answer: {
    ""mean"": 3,
    ""standard_deviation"": 1,
    ""group_size"": 30
  }
---
###Answer: okay
---
###Answer: syntax error
---
",True
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,[],"###Answer: okay
---

fibromyalgia:
    intervention:
        mean: 54.8
        standard_deviation: 29.4
        group_size: 28
    comparator:
        mean: 51.6
        standard_deviation: 25.4
       
---
###Answer: yes
---
###Answer: tableyaml-05042003141022.yaml
---
###Answer: <p>Table 1. Summary of data analysis with a separation test a . Outcome: Fibromyalgia Impact Questionnaire scores. Per-protocol analysis. F1-11d, F12d, F13d, F14-20d = Fibromyal
---
",True
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"
intervention:
    table:
        rows: 2
            row:
                col: 1
                    value: 147
                col: 2
                    value: 7
        row:
            col: 1
                value: 145
            col: 2
---
###Answer: <p>intervention: mean: 10.35, standard_deviation: 3.10, group_size: 326</p>
---
###Answer: 1 tab. 1 text
---
###Answer: 4.2, 0.9, 66
---
###Answer: table of mean outcome and standard deviation in yaml format for Intervention, Comparator, and Outcome:
---
",True
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,[],"###Answer: 30.517, 1.8695140436945978, 30
---
2016-10-10-AML-cp-00004.yaml
---
intervention:
  mean: 0.36
  standard_deviation: 0.15
  group_size: 45
comparator:
  mean: x
 
---
",True
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,[],"###Answer: table
---
zidovudine prophylaxis initiation:; leucocyte count:
mean: 8333
standard_deviation:
group_size: 667
comparator:
mean: 8421
standard_deviation:
group_size: 776

---
###Answer: intervention: 4.11, standard_deviation: 0.57, group_size: 104 comparator: 4.30, standard_deviation: 0.64, group_size: 103 outcome: 4.11, standard_
---
###Answer: 7.150 x
---
",True
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,[],"EMS patients: 48.0 (12.9), 52.0 (14.2)
 
control patients: 26.1 (15.1), 27.6 (13.2)

###Answer: yes
---
###Answer: .example-image.yarl-file
---
###Answer: hip flexion:
  “intervention”:
    “mean”: 0.12791064
    “standard_deviation”: 0.03806292
    “group_size”: 24
  “comparator”:
---
###Answer: hip flexion:
  mean: 4.09
  standard_deviation: 3.23
  group_size: 9

###Answer: yes
---
",True
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"intervention:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 33
comparator:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 33

---
###Answer: true
---
",True
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Info in figure graphics.,FALSE,3292,2470,TEST,[],"
clonidine:
    mean: 74.4
    standard_deviation: 7.6
    group_size: 40
midazolam:
    mean: 79.9
    standard_deviation: 10.6
    group_size: 4
---

intervention:
    mean: 0.311837
    standard_deviation: 0.088094
    group_size: 15
comparator:
    mean: 0.311640
    standard_deviation: 0.0
---
",True
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,[],"###Answer: 26 A 26 B
---
###Answer: 7.54 (2.57), 9.44 (5.48)
---

---
###Answer: <p>Intervention: demanding balance training program Comparator: relaxation group Outcome: memory score Mean: 90.55 Std: 16.36 Group size: 30 Mean: 87.50 Std: 15.52 Group size: 
---
",True
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,0.6598,0.0811,,,,,,TRUE,29049,17627,TEST,[],"###Answer: .example-table-1.yaml

###Answer: OPTION A IS CORRECT.
---
###Answer: <p>table: <p>yahoo: <p>intervention:0.39;0.22;39<p>control:0.33;0.21;30</p></p></p></table>
---
###Answer: table general_mental_health__15_mean and general_mental_health__15_sd (Intervention: Intuitive Eating and Acceptance and Commitment Therapy, Comparator: Control).
---

intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: 100
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: 100

---

intervention:
    mean: 5.0
    standard_deviation: 1.5
    group_size: 50
comparator:
    mean: 1.0
    standard_deviation: 0.5
    group_size: 50

###Answer:
---
<p>Intervention: x</p>
---
###Answer: 5.17, 2.08, 40
---
###Answer:
---

intervention:
  mental_health:
    mean: 4.033
    standard_deviation: 1.499
    group_size: 13
comparator:
  mental_health:
    x: -
### Answer: intervention,comparator,
---
###Answer: 5.07, 6.31, 40
---
###Answer: type: application/x-yaml 2021-01-01T00:00:00Z
---
###Answer: alic> and B) without a difference in mean PCS score (C).
---
###Answer: x
---
",True
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,[],"<table>
<thead>
<tr>
<th>Intervention</th>
<th>Comparator</th>
<th>Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>mean</td>
<td>mean</td>
---
###Answer: table-wrap table-break;
---
###Answer: type: tabular > ouput language: yaml > language: markdown > Examples: <p>intervention: mean: 0.2, standard_deviation: 1.0, group_size: 3 </p> <p>comparator: mean: 0.0, standard
---
###Answer: true
---
###Answer: a table of mean outcome and standard deviation in YAML format for the given intervention, comparator, and outcome
---
###Answer: antibiotic : x
---
",True
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,cannot calculate,cannot calculate,,,,,No SD information provided,FALSE,15527,8380,TEST,[],"###Answer: 45.8, 10.6, 55
---

intervention:
  mean: 5.51
  standard_deviation: 1.45
  group_size: 64
comparator:
  mean: 5.23
  standard_deviation: 1.99
  group_size: 17

---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome [Intervention, Comparator, Outcome]
---

intervention:
    mean: 18.64
    standard_deviation: 6.45
    group_size: 270
comparator:
    mean: 54.69
    standard_deviation: 17.36
    group_size: 
---
###Answer: ok_9d365c12c3228b8a4f39e42dd7df723f
---
###Answer: yaml
---
###Answer: 1. yaml
---
###Answer: intervention.yaml
###Answer: 40.567.1, group_size: 562
---
",True
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,0.20018961,0.01847923,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"###Answer: <p>x</p>
---
###Answer: yaml
---
###Answer: 3.4, 1.6, 27
---

###Answer: healthcare/mindbody/gi healthy stay healthy:intervention_total_mean_sd.yaml
---
###Answer: value=""x""
---
###Answer: table: 57a4a759e883d2584d7c5c9ca79960f6
---
###Answer: yaml-p6
---
###Answer: true
---
",True
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,[],"intervention: mean: 0.0024, standard_deviation: , group_size: 1
comparator: mean: 0.0008, standard_deviation: , group_size: 1",False
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,[],"

intervention:
    duration_objective_response: x
    duration_objective_response_sd: x
    group_size: 59
comparator:
    duration_objective_response: x
    duration_objective_response_sd: x
    group_size: 
---

---
###Answer: 18.36, 9.09, 36 [x]
---
###Answer: table: yaml: [
  ‘intervention’: { ‘mean’: ‘8.69’, ‘standard_deviation’: ‘5.21’, ‘group_size’: ‘29’ },
  ‘comparator’: { ‘mean’: ‘7.0
---
###Answer: true
---
###Answer: yaml
---
###Answer: 13.84258, 1.83474, 27
---
###Answer: true
---
###Answer: table of mean outcome and standard deviation in yaml format for BTH1677 arm and Control arm for duration of objective response
---

Intervention: x
Comparator: 17.5 ± 2.1

###Answer: true
---
",True
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,[],"
intervention:
    table: 6
    table_heading: Community knowledge
        - Comparison to Group A
        - Comparison to Group B
    x: x
    x: x
intervention:
    mean: 0.04
    standard_deviation: x
    group_
---
###Answer: table-wrap table-content tr th:nth-child(1) {text-align: left; font-family: helvetica; font-size: 1.1em; padding: 0.5em 9px; border-top: 1px solid; border-right: 1
---

intervention:
  mean: ""x""
  standard_deviation: x
  group_size: 1764
comparator:
  mean: ""x""
  standard_deviation: x
  group_size: 1764
outcome: x

---
###Answer: type: table-card       heading: Outcome: Community knowledge       value: table-data                                - intervention: ""Provider-school""                                - comparator: ""Control""                                - outcome: ""Febrile patients testing positive for malaria received ACT""                                - rows:                                  
---

intervention:
    table: Mean: 0.683, Standard Deviation: 0.206, Group Size: 373.0
comparator:
    table: Mean: 0.649, Standard Deviation: 0.285, Group Size: 2
---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome community knowledge from trial article ↵( UID: 0000231 )
---
Intervention:
  - mean: 2.75
  - standard_deviation: 1.08
  - group_size: 114
Comparator:
  - mean: 1.03
  - standard_deviation: 0.00
  - group_size
---
",True
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: table yaml_value:""- - mean: 14.4 , standard_deviation: 11. - - mean: 15.7 , standard_deviation: 11. - - mean: 16.7 , standard_deviation: 11.""
---
Efficacy results on swollen joint counts are expressed as mean (SD). The mean change from baseline in swollen joint count for each patient group and its corresponding (SD) was as follows:
---
###Answer: table_data.yaml
###Answer: yes
---
Comparator: 211, 211, 211Intervention: 206, 206, 206Outcome: swollen-joint-count: 13.23, 13.23, 13.23
---
###Answer: <p>intervention: mean: 3.21, standard_deviation: 1.16, group_size: 65</p>
---
###Answer: table-wrap table; font-family:""Cambria"",serif; margin: 0 0 8pt 4px; text-indent: 0; text-align: left; background-color: white; border: 2px solid black; padding: 4px 6px 4
---
",True
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,1.0576,0.2533,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"bilateral training:
  mean: 68,
  standard_deviation: 11,
  group_size: 8
unilateral training:
  mean: 48,
  standard_deviation: 9,
  group_size: 9
---
###Answer: 33.336 x 0.108 x 273.80 / 2 = 8.03788 -- n.a.
---
",True
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"naproxen 500 mg twice daily:
  mean: 1.35
  standard_deviation: 14.92
  group_size: 194
placebo:
  mean: 1.86
  standard_deviation: 16.
---
naproxen:
  - mean: 19.4
  - standard_deviation: 12.5
  - group_size: 138
  - intervention
  - comparator
patient global assessment of disease activity:
  - x: x
---
###Answer: table <p>Intervention: naproxen 500 mg twice daily\nComparator: placebo\nOutcome: Patient global assessment of disease activity</p><p>mean: 1.2436881243688124e
---
<ul>
<li>intervention: mean: 9.93; standard_deviation: 2.69; group_size: 20</li>
<li>comparator: mean: 9.93; standard_deviation: 2.69; group_size: 
---
###Answer: <p>Intervention: mean: 0.70609, standard_deviation: 0.20242, group_size: 356 Comparator: mean: 0.61529, standard_deviation: 0.19217
---
###Answer:
""intervention"": {
""mean"": 1.0,
""standard_deviation"": 0.25,
""group_size"": 19
},
""comparator"": {
""mean"": 1.0,
""standard_deviation"": 0.25
---
",True
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,0.0422,0.0769,,,,,,TRUE,29049,17627,TEST,[],"Intervention: 1.6 (0.7), 1.6 (0.7), 1.6 (0.7), 1.6 (0.5)Comparator: 1.5 (0.8), 1.5 (0.7), 1.5 (0.7), 
---
###Answer: table: yaml,
---
###Answer: yes
---
intervention:
    mean: 3.0
    standard_deviation: 4.0
    group_size: 100
comparator:
    mean: 1.0
    standard_deviation: 2.0
    group_size: 100
### Answer:
---

intervention: x
comparator:
    mean: 33.2
    standard_deviation: 6.8
    group_size: 16
###Answer: yes
---
Intervention: mind body food study.
general_physical_health: x.
---
###Answer: type: application/x-yaml
---
###Answer: type: text
###Answer: x
---

yaml:
  - type: intervention
    title: Intuitive Eating and Acceptance and Commitment Therapy
    description: The outcome represents the results for the intervention.
    studies:
      - citation: 25828436
      - id: intervention/
---
###Answer: 1. 6. 4. 4. 5. 8. [YAML-FULL TABLE]
---
###Answer: yaml
---
###Answer: alliction> and B) without a difference in Si (C).</p>
---
###Answer: yaml
---
",True
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,-0.3445812,0.01865965,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"intervention, comparator, outcome: mean, standard_deviation, group_size; x.
###Answer: true
---
###Answer: ok
---

intervention:
  mean: 8.7
  standard_deviation: 2.0
  group_size: 13
comparator:
  mean: 9.3
  standard_deviation: 2.5
  group_size: 7

###Answer: yes
---
###Answer: 200 OK
---
###Answer: <p><table><thead><tr><th>Intervention</th><th>Comparator</th><th>Outcome</th></tr><tbody><tr><td>mean</td><td>9.488698</td><td>x</td></tr><tr><td
---
###Answer: table: 0.1.1-g-0.2.1    <p>intervention: mean: 0.1, standard_deviation: 0.2, group_size: 100  comparator: mean: 0.1, standard_deviation: 0
---
###Answer: true
---
###Answer: yaml
---
",True
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,-0.0582,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"###Answer: table  ➡ yamldomain.com/10.1186/s12889-022-10801-z
---
###Answer: intervention: mean: 0.91
    standard_deviation: 0.05
    group_size: 13533
comparator:
    mean: 0.49
    standard_deviation: 0.06
    group_size: 
---
###Answer: <p><table> <tbody> <tr> <td>mean: 48.41</td> <td>standard_deviation: 1.91</td> <td>group_size: 104</td> </tr> <tr> <td>mean:
---
",True
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,-0.2172012,0.07594364,,,,,found in table 2,TRUE,6682,5735,TEST,[],"###Answer: yml
---
###Answer: bayley-iii: mean and standard deviation
---
###Answer: table:: 2.19.02; yaml:: 158115449191280
---
Intervention, Comparator, and Outcome:
###Answer: table 4 in original source
---
###Answer: table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap
---
intervention:
    mean: ""x""
    standard_deviation: ""x""
    group_size: ""x""
comparator:
    mean: ""x""
    standard_deviation: ""x""
    group_size: ""x""
###Answer: true
---
",True
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,cannot calculate,cannot calculate,,,,,Not enough measures given for calculation,FALSE,1047,859,TEST,[],"Intervention: 3.4, 0.6; 30
Comparator: 1.1, 0.1; 30",False
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,-1.2060514,0.07410885,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,[],"outcome:
""intervention"" : [
  {
    ""mean"" : 0.3911921896710166,
    ""standard_deviation"" : 0.0926288888807586
---
###Answer: type: application/yaml
---
###Answer: ANSWER: (Comparator) OPTION B IS CORRECT.
---
###Answer: yaml-result html-result
---
###Answer: table: 12.14537.29709; value: 0.086674886; units: arbitrary
---
###Answer: table-wrap table-wrap-key-value=""&as;f"" table-wrap-key=""kind"": Literal ""quantity"" table-wrap-key-value=""&as;f"" table-wrap-key=""title"": Literal ""Contour Sharpness Score"" table-wrap-key
---
###Answer: 2.7 (0.6) x 49, sd = 6.58
---
###Answer:
---
###Answer: true
---
<p>Table 4. Contour sharpnessc</p>
---
",True
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,-0.9305774,0.07388312,,,,,,TRUE,3046,2156,TEST,[],"###Answer: yes
---

---
",True
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,854,745,TEST,[],,False
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,-0.0232,0.0769,,,,,,TRUE,29049,17627,TEST,[],"
intervention:
    mean: 999999
    standard_deviation: 999999
    group_size: 30
comparator:
    mean: 999999
    standard_deviation: 999999
    group
---
###Answer: 3.72 x 1.38; 3.75 x 1.54; 17
---
###Answer: type: application/x-yaml
---
###Answer: type: text,
      value: ""intervention: mean: 1.234 x10^2, standard_deviation: 5.234 x 10^1, group_size: 1234\ncomparator: mean: 7.89 x
---

intervention:
    mean: 0.25
    standard_deviation: 0.25
    group_size: 40
comparator:
    mean: x
    standard_deviation: x
    group_size: x

---

intervention:
  - mean: 1
  - standard_deviation: 1
  - group_size: 22
comparator:
  - mean: x
  - standard_deviation: x
  - group_size: 20
outcome:
  - BMI:
---
###Answer: table-wrap summary=""Based on the given trial article, the table of mean outcome and standard deviation in YAML format for the intervention, comparator, and outcome is as follows:""; result=""85.8±13.4 x 46""; type=""nz"">
  <table-
---
###Answer: type: application/problem+yaml; application/x-yaml; application/vnd.yaml;
        text/yaml;charset=utf-8;
title: Mean (BMI) Outcome with Standard Deviation for Intervention and Comparator;
content:
- intervention:
    mean
---

intervention:
  mean: 33.4685306122805
  standard_deviation: 9.176501977821644
  group_size: 14
comparator:
  mean: x
 
---
###Answer: 5.07, 6.31 85, 75
---
###Answer: okay

###Answer: yes
---
###Answer: valid YAML syntax
---
###Answer: x
---
",True
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,1.25,2.5,0,0,0.6784,0.4756,,,,,found in table,TRUE,1146,884,TEST,[],"Intervention: Buprenophine 64 mg
Comparator: Buprenophine 96 mg
Outcome: Anxiety

mean: 7.28
standard_deviation: 1.46
group_size: 3
mean: 6.71
",False
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,[],"###Answer: table-wrap table-margins=""guides"" id=""t1"" yaml-no-trailing-comma=""true"" xref=""###question"">
###Answer: true
---
###Answer: type: application/x-yaml
---
",True
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"
Intervention: x
Comparator: x
Outcome: x
---
### Answer: 5.49, 1.58, 210
---
###Answer: yaml
---
###Answer: service.gov.uk/table/Table01
---
Intervention:
    mean: x
    standard_deviation: x
    group_size: 7
Comparator:
    mean: x
    standard_deviation: x
    group_size: 6
###Answer: true
---
",True
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,0.1005,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"###Answer: 1349 159.12 45.66 1.85 616.12 49.05 ""x"" ""x""
---

Intervention:
  - Mean (2009): 8.56
  - Standard deviation (2009): 2.00
  - Group size (2009):846
Comparator:
  - Mean (2009): 8.30
 
---
###Answer: type: application/x-yaml
---
###Answer: service: post.department: research.tdiscipline: stats.text: [Intervention + targeting environmental-level factors]:fruit intake {TABLE: 2}
---
###Answer: true
---
###Answer: table: 0.1 ""intervention"": 
   data:  0.1 ""intervention"" ""mean"" 1.67 
   data:  0.1 ""intervention"" ""standard_deviation"" 0.08 
   data:  0.
---

###Answer: intervention: mean: ""x"",standard_deviation: ""x"",group_size: 251comparator: mean: ""x"",standard_deviation: ""x"",group_size: 198fruit intake: mean: 5.3440751
---
",True
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,-0.2276,0.0503,,,,,,TRUE,10658,5810,TEST,[],"###Answer: intervention: mean: 62.22, standard_deviation: 18.96, group_size: 40 comparator: mean: 69.35, standard_deviation: 16.05, group_size: 40
---
###Answer: table, intervention: { mean: 10.0, standard_deviation: 5.2, group_size: 40 }, comparator: { mean: 10.0, standard_deviation: 5.2, group_size: 40 }
---
intervention:
  - mean: 7.67
  - standard_deviation: 0.447887
  - group_size: 6
comparator:
  - mean: 7.533333
  - standard_deviation: 0.47
---
###Answer: type: text; value: ""Intervention: vitamin D supplementation\nComparator: control\nOutcome: interleukin 2\nIntervention: mean: x\nIntervention: standard_deviation: x\nIntervention: group_size: x\nComparator
---
###Answer: Table 2
---
###Answer: intervention.yaml

---
###Answer: type: intangible
---
",True
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,-1.7238,0.2743,,,,,,TRUE,1507,1019,TEST,[],"intervention:
    table:
      - name: mean
        value: ""0.83""
      - name: standard_deviation
        value: ""0.05""
      - name: group_size
        value: ""10""
      - name: time_point
        value:",False
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,-1.5322,0.2587,,,,,,TRUE,1507,1019,TEST,[],"<table>
<thead>
<tr>
<th>intervention</th>
<th>mean</th>
<th>standard_deviation</th>
<th>group_size</th>
</tr>
</thead>
<tbody>
<tr>
<td> Sal",False
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,0.0956,0.0029,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,[],"
intervention:
    yaml: !float(6.3), !float(12.4), 919
comparator:
    yaml: !float(2.9), !float(12.7), 922
---
###Answer: 60.0 x AND 48.4 x
---
",True
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,-0.201397,0.045685,,,,,,TRUE,9725,6231,TEST,[],"###Answer: 70000000000000000000, 206.49622671165024, 34
---
2.2

###Answer: 2.2.1. table of mean outcome and standard deviation in yaml format for vaginal estriol plus viable lactobacillus acidophilus KS40 as intervention and placebo as comparator among healthy pre- and postmenopausal
---
###Answer: table; align-items: center; display: flex; flex-direction: column; height: 100%; justify-content: center; width: 100%;>
  <tbody>
    <tr>
      <td>Intervention</td>
      <td>Comparator
---
###Answer: true
---
###Answer: true
---
###Answer: table, data-hash -> [ ""mean"": 8, ""standard_deviation"": 2, ""group_size"": 20 ]
---
",True
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,cannot calculate,cannot calculate,,,,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,12685,6812,TEST,[],"Note: this format is experimental, but has the advantage of being much more human and machinereadable than the current, rather vague format.
---

---
###Answer: ocular itching for visit 3B at 7 min: 1.5% (N=70) mean 1.2699999999999997, standard_deviation: 1.08105326948
---
Intervention:
  mean: 2.1
  standard_deviation: 0.5
  group_size: 70
Comparator:
  mean: 1.2
  standard_deviation: 0.8
  group_size: 68

---
###Answer: type: yaml-structure-result > !important YAML: |- 7 min : 0.6 > x 1.7 (67) > x 1.6 (64) 15 min: 0.3 > x 1.8 (67) > x 
---
###Answer: yaml
---
###Answer: ocular itching for visit 3B at 7 min: yaml
---
",True
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,[],"###Answer: yaml
---
###Answer: 8.0 × 3 = 24, 9.0 × 3 = 27, 8.0 × 5 = 40, 9.0 × 5 = 45
---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome ""fibromyalgia impact questionnaire scores"" of the article ""Soy isoflavones for the treatment of fibromyalgia: A proof-of-concept randomized controlled trial"" (Gard
---
###Answer: 400 characters
---
###Answer: test: summary: ✖️ Table 1 intervention:
mean: 0.89
standard_deviation: 4.19
group_size: 51
comparator:
mean: …
standard_deviation: …
group_size: …

---
",True
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,[],"###Answer: 7.40 x 1.30

###Answer: OPTION A IS CORRECT.
---
###Answer: 1476.9588140625, 15.96577668589373, 50
---
###Answer: true
---
Intervention: 1500 mg calcium, Comparator: 500 mg calcium, Outcome: systolic or diastolic blood pressure
---
###Answer: true
---
###Answer: 6.66 x
---
###Answer: <table><thead><tr><th>Intervention (n=18)</th><th>Comparator (n=16)</th></tr><tbody><tr><td>mean: 129.7</td><td>mean: 124.6</td></tr
---
",True
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,[],"36573535 NUM;42424233 NUM;68325255 NUM;28345355 NUM;2343
###Answer: 36573535; 424242",False
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,-0.1881,0.2511,,,,,,TRUE,13404,7477,TEST,[],"inflexion-extension for the C2-C6 segments: mean = 4.35, standard_deviation = 2.32, group_size = 16 inflexion-extension for the C2-C6 segments: mean = x, standard_deviation = x, group_size = x
---
inflexion-extension for the C2-C6 segments: ""mean"": 5.82800236831968, ""standard_deviation"": 0.490268477178909, ""group_size"": 4
###
---
intervention:""mean"": 4.0, ""standard_deviation"": 0.6, ""group_size"": 10intervention:""mean"": 3.9, ""standard_deviation"": 0.6, ""group_size"": 10comparator:""mean"": 4.0, ""standard
---
###Answer: table: <p> intervention: mean: 2.97, standard_deviation: 1.56, group_size: 8 <p> comparator: mean: 6.55, standard_deviation: 2.26, group_size: 8 </p
---
intervention:
  - mean: 7.33
  - standard_deviation: 1.12
  - group_size: 90
comparator:
  - mean: 0.50
  - standard_deviation: 0.47
  - group_size:
---

""intervention"": {
    ""mean"": ""6.395083658450164""
    ""standard_deviation"": ""3.6825275225036304""
    ""group_size"": ""10""

---
",True
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,-0.2877,0.1064,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,[],"
###Answer: MCCB performance : Processing Speed mean: .4343 x 10^3 , standard_deviation: .0777 x 10^3 , group_size: 14.5 .
###Answer: yes
---

facial_affect_training_1:
    mean: 55.1
    standard_deviation: 12.1
    group_size: 18
facial_affect_training_2:
    mean: 56.2
    standard_deviation: 8
---
Intervention: facial affect training (FAT) in 20 daily 1-hour sessions; Comparator: baseline; Outcome: MCCB performance: Processing Speed:
# table-wrap-before { margin: 0; padding: 0; }
# table-wrap-after {  border:
---
Intervention : facial affect training (FAT) in 20 daily 1-hour sessions  There is no comparator.  - Processing speed was improved following FAT treatment.  - Processing speed mean: 44.6 (12.2)  standard deviation: 12.2  - Total
---
",True
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,-1.1693949,0.29779588,,,,,"Values are from ""total tibial plateau"" for 24 months",TRUE,6118,5345,TEST,[],"Table 3 Tibial Bone Expansion (mm) Outcomes Over 24 Months of Follow-up (ITT-LOCF Analysis) Parameter HA (n = 6) MPC+ HA (n = 11) Difference, LOCF-adjusted p value Tibial bone expansion (
---
###Answer: type: application/x-yaml
---
﻿
###Answer: ""x""
---

Intervention:
total tibial bone expansion: 0.5 (2.4)
comparator: 
total tibial bone expansion: 4.0 (2.3)

###Answer: yes
---
###Answer:
---
",True
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,0.1101,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"###Answer: table: yaml-basic.yaml
---

intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""

---
###Answer: intervention: group_size: 982.014963922481 1769.75736515594 0.0000609587496303992 0.
---
###Answer: type: yaml >
---
###Answer: yaml
---
###Answer: Table 4 from the ""Supplemental material"" section of the article ""The Amsterdam Nutrition Campaign: design of a clusterrandomised controlled trial of community-based nutrition interventions"" by R.J. Kok et al. (2013), published by BMJ
---

intervention:
  mean: 10.5
  standard_deviation: 2.5
  group_size: 20
comparator:
  mean: 10.0
  standard_deviation: 2.0
  group_size: 10

---
",True
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,0.5347,0.2589,,,,,,TRUE,13404,7477,TEST,[],"The table below is generated using the information provided in the article.

###Answer: yes
---
Intervention: 64.96339, 53.53934, 21Comparator: 77.69598, 64.18553, 195Outcome: x, x, 21
---
ACVC and ACVC-HA groups: 13.9±1.9 degrees, 13.8±1.1 degrees, 11.0±1.7 degrees, 12.9±1.9 degrees ACCF group: 9.2±1.1 degrees, 12
---

intervention:
  - lateral_bending:
      - 10.1±1.2 (29)
  - standard_deviation:
      - 1.1 (29)
  - group_size:
      - 10 (29)
comparator:

---
###Answer: <p>intervention: mean: 7.47, standard_deviation: 1.45, group_size: 60; comparator: mean: x, standard_deviation: x, group_size: 30.</p>
---

---
",True
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,This outcome is measured by Short-Form 36-Items (SF-36).,FALSE,12247,10091,TEST,[],"
---
<p>pty ga improvement: 4.2 x 10.2, sdd: 3.8, grp_size: 807</p>
---
certolizumab_pegol:
    intervention:
    - mean: 9.939
    - standard_deviation: 15.151
    - group_size: 1088.5
    - total_size: 1088.5

---

intervention:
    - mean: x
    - standard_deviation: x
    - group_size: x
comparator:
    - mean: x
    - standard_deviation: x
    - group_size: x
outcome:
    - health_related_quality_of_life
---
###Answer: table: 2020-01-29T09:14:47.077863Z
    text: |
      intervention:
          mean: 44.1
          standard_deviation: 4.9
          group_size:
---
###Answer: .intervention.mean: 71.4
  .intervention.standard_deviation: 20.448540199178186
  .comparator.mean: 74.3
  .comparator.standard_deviation: 
---
",True
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,2.11539588,0.03166271,,,,,,TRUE,9086,4934,TEST,[],"Outcome 1: 73.3 (6.9); Comparator 1: 67.8 (10.3); Intervention 1: 47.5 (6.7); Group Size: 480

###Answer: yes
---
###Answer: 97
---
###Answer: 3.75, 1.36, 89
---
###Answer: table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap <p>mean : ""47.29375"" , standard_deviation: ""19.643826137"" , group_size: ""101""
---
mean: 4.6, standard_deviation: 1.4, group_size: 98 intervention mean: 4.6, standard_deviation: 1.4, group_size: 98 comparator mean: 4.1, standard_deviation: 1.5, group
---
",True
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,0.7142,0.2364,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"###Answer:
---
###Answer: group_size: 67.59
mean: 0.346
standard_deviation: 0.653
---
",True
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,[],"Learned irrelevance index: 0.1959218536811996; standard deviation: 0.1267808795072425

###Answer: false
---
###Answer: <p>yarn: 0.414</p>
---
",True
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,-0.404,0.0704,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"intervention:
  mean: 60.21
  standard_deviation: 5.35
  group_size: 13
comparator:
  mean: 62.28
  standard_deviation: 5.09
  group_size: 13

---
###Answer: type: table
---
[intervention:
    mean: ""0.97"",
    standard_deviation: ""0.397454"",
    group_size: ""20""
comparator:
    mean: ""0.91"",
    standard_deviation: ""0.21972
---
###Answer: true
---
###Answer: <p>intervention: mean: 61.36, standard_deviation: 8.46, group_size: 30.14<p>comparator: mean: 54.26, standard_deviation: 5.70, group_size:
---
###Answer: (yama)
---
Based on the given trial article, the table of mean outcome and standard deviation in YAML format for the intervention, comparator, and outcome The percentage of B cells is:
- Nonsmokers (Intervention): mean: 84.67, standard_deviation: 9.59, group_
---
###Answer: table  6
---
###Answer: type: application/yaml
---
###Answer: 3.33, 0.74, 29
---
###Answer: [200, 200, 200, 200, 200, 62, 30, 40, 20, 100]
---
###Answer: okay
---
Intervention:
total white blood cells count:
total B cells count: 11.0 x 109 ± 2.4 x 109
complement components C3: 
pre-citrate-treated plasma: 
log10 C3: 2.66 x
---
",True
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,0.20597307,0.02051639,,,,,,TRUE,9086,4934,TEST,[],"
###Answer: 73.3, 6.9, 480
---
###Answer: Tabulated data in YAML format for MTL group and Choices group for the outcome Taste Perception.
###Answer: true
---
###Answer: 20.21343, 3.45979, 90
---
###Answer: table 3
---
###Answer: table 3
---
",True
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,cannot calculate,cannot calculate,,,,,Does not have group size information in article.,FALSE,6725,3999,TEST,[],"
###Answer: handgrip strength: 16.2 ± 11.1 kg
---
###Answer: handgrip strength: 43.6467 x,
---
###Answer: type: application/x-yaml ﻿header: table ﻿table: ﻿row: 1 ﻿cell: 0 ﻿value: 0.70 ﻿row: 2 ﻿cell: 0 ﻿value: 0.96 ﻿row: 3 ﻿
---
Intervention:
  - mean: 0.77
  - standard_deviation: 0.88
  - group_size: 15
Comparator:
  - mean: 0.56
  - standard_deviation: 0.60
  - group_size:
---
",True
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,[],"
###Answer: 4.38803 x
---

---
###Answer: table: <p>The table below presents the mean anxiety symptom scores before and after ABM for the treatment group and the placebo group. Scores can range from 0 to 25, with higher numbers indicating greater anxiety. There were no significant pre-post differences for the placebo group in either
---
",True
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,32.2,15.5,33.68,18.91,-0.0842565,0.08007099,,,,,Graphic format table,TRUE,2609,2261,TEST,[],"Here is the table of mean outcome and standard deviation for the given article:
###Answer: yes
---

intervention:
  mean: 331.0
  standard_deviation: 0.0
  group_size: 40
comparator:
  mean: 324.0
  standard_deviation: 0.0
  group_size: 40

---
",True
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,0.64440958,0.1402544,,,,,,TRUE,4260,2410,TEST,[],"###Answer: {""mean"": 10.00, ""standard_deviation"": 0.54, ""group_size"": 25},

###Answer: true
---
###Answer: ok
---
###Answer: true
---
",True
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,[],"###Answer: ""x""
---
###Answer: true
---
",True
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,-0.0781,0.0788,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"Intervention:
    table:
        - kind: result
            values:
                - type: numerical
                  data: 71.16
            - type: numerical
                  data: 9.614
            - type: numerical
                  data: 32
Comparator:

---
Intervention:
  - mean: 166.66
  - standard_deviation: 21.38
  - group_size: 10
Comparator:
  - mean: 160.68
  - standard_deviation: 30.71

---
###Answer: true
---
",True
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,0.2491,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,[],"
intervention:
  ""mean"": 7.45976431,
  ""standard_deviation"": 1.85225281,
  ""group_size"": 17.0
comparator:
  ""mean"": 7.45976
---

facial_affect_training_outcome:
    outcome: mccb-visual_learning
    interpretation: ""FAT improved visual learning in the SZ patient sample relative to the TAU and CE groups""
facial_affect_training_intervention:
    intervention:
        mean: 
---
###Answer: yaml
---
facial affect training (FAT) in 20 daily 1-hour sessions intervention: mean=""44.6 ± 12.2"" standard_deviation=""46.2 ± 9.9"" group_size=""20"" comparator: mean=""39.3 ± 
---
",True
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,7.89939403,0.76522202,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,[],"intervention: 96 14.94 21
comparator: 63 14.18 26

###Answer: yes
---
Phlebotomy training programme; Before the phlebotomy training May 2014, CHC A; Phlebotomy questionnaire score: CDC C; 60 of 7557 blood samples (0.79%) were rejected; 7 of 589 blood samples (1.3
---
###Answer: type: application/x-yaml-smell-like-coffee
---
Phlebotomy training programme:
    mean: 144.35
    standard_deviation: 14.72
    group_size: 94
Comparison: No intervention or comparison group, only an outcome was assessed:
    mean: 70
    standard_de
---
###Answer: yaml
---
",True
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,[],"###Answer: 2.64, 1.45, 38; 2.67, 1.35, 37
---

- POI: In the Gum group, 8 patients developed mild POI, 19 patients developed moderate POI, and 11 patients developed severe POI. In the No gum group, 1 patient developed mild POI, 5 patients developed moderate POI, and 2 patients developed
---
",True
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,-0.3847888,0.00858754,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,[],"###Answer: | ContentsTable 1. Baseline demographic and clinical characteristics (safety population) (n[total] = 819; n[ITT population] = 298, 307, 214)CharacteristicQuetiapine 300
---
###Answer: true
---

intervention:
  - mean: 7.5
  - standard_deviation: 2.3
  - group_size: 11
comparator:
  - mean: 4.0
  - standard_deviation: 2.0
  - group_size: 10
---
###Answer: ok1: 1.0 (0.19); ok2: 1.1 (0.23); ok3: 0.0 (0.17)
---
",True
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,-0.0685,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"###Answer: yaml
---

Intervention: 0.30, 0.10, 1001
Comparator: 0.20, 0.05, 1000

###Answer: true
---
Intervention:
    mean: x
    standard_deviation: x
    group_size: 470
Comparator:
    mean: x
    standard_deviation: x
    group_size: 368
---

---
###Answer: type: tabular_data format: yaml id: 6087 format: general text: <p>Intervention: Individual cognition and self-regulation processes interventionComparator: Individual cognition and self-regulation processes interventionOutcome: Vegetable intake</p>
---
###Answer: <p>intervention: mean: 5.833333333333333, standard_deviation: 0.628205128205128, group_size: 1068.36068
---

Intervention:
mean: 1.33, standard_deviation: 2.31, group_size: 497
Comparator:
mean: 0.59, standard_deviation: 2.56, group_size: 369
---
",True
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,[],"###Answer: 20.60545560.35504258123007559686, 0.4593385346033117, 54
---

intervention:
    mean: 55, standard_deviation: 21, group_size: 81
comparator:
    mean: 54, standard_deviation: 17, group_size: 89

###Answer: yes
---
###Answer: table [type: intervention, comparator, outcome, guideline, list: false, label: ""mean + standard_deviation"", unit: , order: chronological, order_by: mean, sort_order: desc, exclude: [mean, standard_deviation], data_format: yaml,
---
###Answer: yaml
---
",True
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,-0.2059408,0.02041274,,,,,Used values for self.,TRUE,9086,4934,TEST,[],"mlc-2019-0034_yaml.zip
---
###Answer: table_data.yaml
---
###Answer: 0.00
---
###Answer: table, diagram, or flow chart (TEXT)
---
1 mean, 0.35 standard deviation, 480 individuals
---
",True
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,[],"
intervention:
    chemokines: ~
        yaml: <p>4.00 (2.33, 4.00)</p>
    groups: (4 groups)
    group_id: ~
        yaml: <p>control (0)</p>
       
---
###Answer: OK, this is correct.
---
13.63, 3.8, 31 15.46, 2.6, 15
---
02
---

intervention:
  mean: 4.83
  standard_deviation: 0.58
  group_size: 14
comparator:
  mean: 4.65
  standard_deviation: 0.65
  group_size: 13

---

Intervention: [14.3, 19.547659237659243, 21].
Comparator: [17.4, 19.238662402386623, 20].
---
",True
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,0.0492187,0.12920574,,,,,found in table 2,TRUE,9410,4699,TEST,[],"###Answer: 23.7648, 6.1253, 10
---
###Answer: yaml
---
###Answer: table 2 summary <p>Intervention: probiotic; Comparator: placebo; Outcome: reduction of plaque; Language: English</p>
---
###Answer: table
---
###Answer: true
---
###Answer: yes
---
",True
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,-2.0343126,0.20230713,,,,,,TRUE,4260,2410,TEST,[],"###Answer: 6.034 x 1.648, 5.805 x 0.886, 19
---
intervention:
    mean: 81.06
    standard_deviation: 6.29
    group_size: 10
comparator:
    mean: 82.42
    standard_deviation: 6.27
    group_size: 11

---
###Answer: table-wrap table-wrap table-wrap table-wrap { border-collapse: collapse; border-width: 0; margin: 0; padding: 0; } table { border-collapse: collapse; border-width: 0; margin: 0; padding: 0; } caption {
---
",True
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,0.0971,0.0444,,,,,,TRUE,18948,9604,TEST,[],"
intervention:
  mean: 170
  standard_deviation: 7
  group_size: 71
comparator:
  mean: 150
  standard_deviation: 8
  group_size: 33

###Answer: true
---

---
###Answer: table-wrap table-wrap-start table-wrap-end<table><thead><tr><th>Group</th><th>Type</th><th>n</th><th>Mean</th><th>SD</th></tr><tbody><tr><td>ILI</td><td>
---
###Answer: table-wrap table-wrap-start table-wrap-end <p>intervention: <p>mean: 141.3</p> <p>standard_deviation: 8.3</p> <p>group_size: 71</p> <p>comparator
---
###Answer: true
---
**Explanation: The given trial article reports numerical data in the text of the article but does not provide a table with those data. 
The closest thing to the requested data is in Table 8, but that table doesn't have some important information such as group size and standard deviation. 
Luckily, the authors do
---
",True
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,-0.4954,0.0793,,,,,Actually psychological inflexibility in the article,TRUE,29049,17627,TEST,[],"
---
###Answer: table; align-content: space-between; margin: 0 0 8pt; width: 100%; flex-direction: row; background-color: white; height: 40px; border-style: solid; border-width: 1px; border-color: #e
---
###Answer: <p>intervention: mean: 4.2 x 10^5, standard_deviation: 1.3 × 10^5, group_size: 502 comparator: mean: 2.1 x 10^5, standard_deviation: 7
---

intervention:
    mean: x
    standard_deviation: x
comparator:
    mean: x
    standard_deviation: x
---


Intervention: x
Comparator: x

###Answer: YES
---

intervention:
    mean: 10.26
    standard_deviation: 2.24
    group_size: 26
comparator:
    mean: 15.00
    standard_deviation: 5.95
    group_size: 10
---
###Answer: yaml
---
###Answer: yaml
---

Intervention:
  mean: 10.833333333
  standard_deviation: 4.25
  group_size: 14
Comparator:
  mean: 10.5
  standard_deviation: 1.5
  group_
---
###Answer: 2 columns
---
###Answer: <p>intervention: mean: 15.91, standard_deviation: 4.82, group_size: 26; comparator: mean: 14.94, standard_deviation: 4.65, group_size: 26; outcome
---
###Answer: table <p>yrus-intervention-mean: 4.13 
yrus-intervention-sd: 0.61 
yrus-intervention-n: 26 
yrus-comparator-mean: 4.31 
yrus-comparator-sd: 
---
###Answer: table: 4.0, type: integer, units: -, primary: true, description: , status: publishable
---
",True
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: table: <table><tbody><tr><td style=""border: 1px solid #dddddd; padding: 3px; height: 100px; background-color: rgba(20, 20, 20, 0.5);"" align=""center"">63
---
Intervention: [
  {
  ""mean"": 83.66666666666666,
  ""standard_deviation"": 20.603636363636365,
  ""group_size"": 81

---
###Answer: true
---
<ul>
<li>Intervention: 17.83* (10.55, 25.12)</li>
<li>Comparator: 16.68* (7.80, 25.57)</li>
<li>outcome
---

intervention:
    discontinuation_due_to_lack_of_efficacy: x
comparator:
    discontinuation_due_to_lack_of_efficacy: x

---
###Answer: table: {
  ""type"": ""yaml"",
  ""version"": ""1.1"",
  ""groups"": [
    {
      ""intervention"": {
        ""mean"": 0.1,
        ""standard_deviation"": 0.2,
        ""group_size
---
",True
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,0.30695109,0.13068633,,,,,found in table 2,TRUE,9410,4699,TEST,[],"###Answer: antibiotic: reduction of plaque; mean= -1.438071061426075, standard_deviation=3.682608422704082, group_size=15; placebo: reduction of
---
###Answer: yaml
---
###Answer: type: application/yaml
---
###Answer: type: table format: yaml
---
###Answer: true
---
###Answer: antibiotic: x
---
",True
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"###Answer: Muscle hardness decreased more after acupressure at local points (LP) than after acupressure at distal acupuncture points (DP) or no stimuli (control), with no significant effect on the autonomic nervous system. 
Muscle hardness decreased immediately after stimuli
---
###Answer: type: text > tabular > yaml > json
---
",True
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,-0.7968282,0.01798945,,,,,Values from 30 minutes.,TRUE,3561,2387,TEST,[],"intervention:
  - mean: 2.51
  - standard_deviation: 0.926
  - group_size: 36
comparator:
  - mean: 1.51
  - standard_deviation: 0.406
  - group_
---
###Answer: type: application/x-yaml
---
",True
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,[],"
Septoplasty: 26, 12
Control: 27, 1
###Answer: yes
---
###Answer: table-wrap><p><font size=""4""><p>Intervention: Septoplasty</p> 
<p>Comparator: Control</p> 
<p>Outcome: % consonant improvement</p> 
<p>Groups: n"" 33; n""
---
###Answer: 2020-10-15 15:41:17.34200

###Answer: yes
---
###Answer: true
---
",True
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"###Answer: <table-wrap><object-id>10.1371/journal.pone.0057067.t002</object-id><label>Table 2</label><caption><title>Differences in website use and Hepatitis knowledge between conditions.</
---
###Answer: >YAML
###Answer: 6.4
---
",True
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,[],"Intervention: Deep-cooling
Comparator: No cooling
Outcome: Improvement in Glasgow outcome score at 6 months post-trauma
Result:
  mean: 0.65
  standard_deviation: 0.14
  group_size: 29
---
deep-cooling:
  mean: 4.13333333333333
  standard_deviation: 2.375
  group_size: 14
no cooling: 4.1888888888889
---
",True
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,[],"deep-cooling:
  mean: 70
  standard_deviation: 11
  group_size: 6
mild-cooling:
  mean: 55
  standard_deviation: 10
  group_size: 9

###Answer:
---
deep-cooling:
    mean: 3.0,
    standard_deviation: 1.1,
    group_size: 9
mild-cooling:
    mean: 3.6,
    standard_deviation: 0.8,
    group_size:
---
",True
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,1.33530568,0.12603411,,,,,,TRUE,17694,9686,TEST,[],"<p>Contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone: x</p>
---
CNR is the signal-to-noise ratio (SNR) of the measurements made within the cerebrospinal fluid (CSF) divided by the SNR of the measurements made within the vertebral bone. The CNR was measured as the ratio between the two regions of interest (ROI) drawn manually around the
---
###Answer: type: integer 1483093400 - total amount of patients with short-bore MR scan 48 25 16 4 15 - standard deviation of mean CNR in sagittal cervicothoracic in short-bore MR group 8
---
###Answer: table: 3.11.19-1
---
###Answer: 0.892 x 0.314
---
###Answer: table-wrap table-wrap table-wrap-heading Cervicothoracic SpineT2w sagittal Cerebrospinal fluid - Vertebral bone <p>2.1 (1.1)</p> <p>3 (1)</p><p
---

intervention:
  - mean: 18.24
  - standard_deviation: 6.60
  - group_size: 15
comparator:
  - mean: 10.78
  - standard_deviation: 4.34
  - group
---
Intervention: 12.4, 4.1, 42
Comparator: 32.0, 8.2, 42
Outcome: 2.8, 1.2, 42
###Answer: table of mean outcome and standard deviation in yaml format for the
---
###Answer:
---
<table><caption><title>The given trial article only provided mean and SD for one group (short-bore MR scanner). The YAML file only includes one value for each field (intervention and comparator).</title></caption><thead><tr><td>intervention</td><td>mean</td><td>
---
",True
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"naproxen 500 mg twice daily:
	mean: 6.974
	standard_deviation: 1.767
	group_size: 181
	ACR20 responder criteria:
	x
---
naproxen 500 mg twice daily:
  - mean: 63.9%
  - standard_deviation: 22.3%
  - group_size: 181
placebo:
  - mean: x%
  - standard_deviation: x%
---
###Answer: 2020-08-07 10:14:19.518000	naproxen	500 mg twice daily			NAPROXEN			ACR20 responder criteria			
---
<table>
<tbody>
<tr>
<td>intervention</td>
<td>mean</td>
<td>16.69</td>
<td>standard_deviation</td>
<td>1.15</td>
<td>group_size</
---
naproxen 500 mg twice daily:
  x: ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x""
 placebo:
  x: ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x
---
###Answer: 500 14.8 naproxen 500 mg twice daily [Intervention]
---
",True
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,0.1625371,0.03786046,,,,,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",TRUE,9517,6474,TEST,[],"5.2, 1.1, 536577147
###Answer: yes
---
###Answer: overall survival:
    median: 11.1 months
    standard_deviation: 2.2 months
    group_size: 53
---
###Answer: <p>mean: 16.9 months, standard_deviation: 2.9 months, group_size: 53</p>
---

###Answer: yaml
---

###Answer: Table 2 in Data Supplement
---
###Answer: 0.08 [ Ref: https://interactome.di.uoa.gr/handle/10036/380566 ]
---
",True
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,[],"<yaml>
  % correct responses:
  intervention:
    - 23
    mean: 31.9%
    standard_deviation: 9.55%
    group_size: 15
  comparator:
    - 29
    mean: 37",False
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"naproxen 500 mg twice daily:
  mean: 1.28
  standard_deviation: 0.13
  group_size: 53
placebo:
  mean: 3.20
  standard_deviation: 1.04
 
---
naproxen 500 mg twice daily intervention:
  - mean: 3.16
  - standard_deviation: 1.02
  - group_size: 38
comparator:
  - mean: 4.16
  - standard_deviation:
---
###Answer: true
---
<ul>
<li>intervention: mean:9.13, standard_deviation: 1.76, group_size: 69</li>
<li>comparator: mean:4.35, standard_deviation: 1.78, group_size: 68
---
naproxen 500 mg twice daily, placebo
---
###Answer: <p>yamldesign-extractor: 2.3.0</p>
---
",True
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,0.1277,0.0501,,,,,,TRUE,10658,5810,TEST,[],"###Answer: status: running       trial_id: 2089 location: Siriraj Hospital, Bangkok, Thailand registered: 2016-01-28 title: A Randomized Controlled Trial of Vitamin D Supplementation on the Immune Response of Chronic Hepat
---
###Answer: true
---

intervention:
    yaml-response:
        ""mean"": 20.88
        ""standard_deviation"": 5.40
        ""group_size"": 40
comparator:
    yaml-response:
        ""mean"": 20.27
        ""
---
###Answer: yaml
---
###Answer: table
---
###Answer: intervention: mean: 8.085846732, standard_deviation: 5.8132, group_size: 86; comparator: mean: 8.545454546, standard_deviation: 2.5
---
###Answer: true
---
",True
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,[],"electrical muscle stimulation (EMS): 11.2 (4.2), 11.4 (4.3)
control: 9.1 (4.3), 8.8 (3.9)

###Answer: yes
---
###Answer: {
  ""intervention"": {
    ""mean"": 0.867485199643943,
    ""standard_deviation"": 0.274988264370989,
    ""group_size"":
---
###Answer: table-wrap tableClass=""table"">
				<colgroup><col style=""width: 16%;"" /><col style=""width: 34%;"" /><col style=""width: 10%;"" /><col style=""width: 14%;
---
electrical muscle stimulation (EMS) 5 (4-5) 0.03 6 (5-7) 0.09 21 (19-22) 0.78 control 4 (4-5) 4 (3-5) 13 (10
---
",True
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,6032.37,1359.15,6408.33,1822.17,-0.2316,0.0503,,,,,Table and text has conflicting numbers. Values are from Table.,TRUE,10658,5810,TEST,[],"intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
---
###Answer: table-wrap-answer table-wrap-row count: 2 table-wrap-col count: 3
Intervention: Vitamin D supplementation
Comparator: Control
Outcome: Dipeptidyl peptidase-4
Mean age (year)
Placebo group (n
---

intervention:
  mean: 770.27
  standard_deviation: 642.02
  group_size: 40
comparator:
  mean: 665.61
  standard_deviation: 1584.3
  group
---
###Answer: <p>vitamin D supplementation:</p>
<p>mean: ""45.93"",</p>
<p>standard_deviation: ""2.43"",</p>
<p>group_size: ""40""</p>
<p
---
###Answer:
---
###Answer: service-type=""query"", response-type=""result"", tables=""[{% include ""commonmarkup/rdata-table.html"" %}""]: [{% include ""commonmarkup/rdata-table-alt.html"" %}""]:"", entries=""<table-wrap><object-id>10
---
###Answer: yaml
---
",True
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,-2.9163,0.0853,,,,,,TRUE,18948,9604,TEST,[],"29
###Answer: yes
---
###Answer: FAT MASS INTERVENTION (n=71) COMPARATOR (n=33) INTENSIVE LIFESTYLE INTERVENTION MASSAGE THERAPY  11.07 8.73 67.93 
---
intervention.mean: 17.0
intervention.standard_deviation: 5.3
intervention.group_size: 63
comparer.mean: 17.5
comparer.standard_deviation: 6.3
comparer.group_size: 
---
###Answer: type: text; value: ""10:20"";
type: text; value: ""161:0.72"";
---
###Answer:
---
###Answer: FAT MASS
---
",True
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,[],"
###Answer: 2.67, 0.56, 15
---
###Answer:
---
###Answer: true
---
",True
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,[],"###Answer: 6 PREDICTED ANSWERS
---
###Answer: table
---


###Answer: table=""intervention_comparator_outcome"" render_as=""yaml"" x_response=""true"" x_pre_x_post=""true"">
    <value>
        <unit numerical=""true"" decimal=""true"">
            <number format=""percent"">-5.86
---
###Answer: [12.53, 23.76]
---
",True
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,-0.314,0.0797,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"Intervention:
  - mean: -12.36, standard_deviation: 9.27, group_size: 30
Comparator:
  - mean: -9.71, standard_deviation: 7.14, group_size: 22

---
Intervention: [
  {
    ""mean"": 42.66,
    ""standard_deviation"": 3.40,
    ""group_size"": 30
  }
]
Comparator: [
  {
    ""mean"": 42.95,
   
---
Intervention:
  - mean: 49.33, standard_deviation: 9.89, group_size: 16
  - total size: 16
  - mean (x): 49.33, standard_deviation (x): 9.89, group
---
",True
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,0.5453569,0.03959808,,,,,,TRUE,12258,6615,TEST,[],"###Answer: yaml
---
###Answer: (Intervention) mean: NUMBER; std_deviation: NUMBER; group_size: NUMBER (Comparator) mean: NUMBER; std_deviation: NUMBER; group_size: NUMBER (Outcome) 1.x; 2.x
---
###Answer: true
---
###Answer: yaml
---
###Answer: table; style=""width: 100%; font-family: Times New Roman, Times, serif"">

###Answer: true
---
###Answer: 21.036, 1.889, 55
---
###Answer: 5.4695266384886, 1.175003815520157, 39
---
",True
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,0.1538,0.0445,,,,,,TRUE,18948,9604,TEST,[],"
intervention:
    mean: 0.77
    standard_deviation: 0.23
    group_size: 71
comparator:
    mean: 0.85
    standard_deviation: 0.15
    group_size: 33
out
---
###Answer: true
---
###Answer: 71.0, 31.6, 20
---
###Answer: type: structural-query-4-15-1-1134 table-wrap table-wrap-15 table-wrap-1 table tr td,
tr th {
		font-family: ""Table Mountain"",Helvetica,Arial,sans-serif;
	
---
###Answer: true
---
###Answer: table: <p>Intervention: Intensive lifestyle intervention (ILI) group</p>mean: 67488784375,standard_deviation: 45075438055,group_size: 30<p>
---
",True
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,0.7273,0.0086,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,[],"###Answer: table of mean outcome and standard deviation for intervention and comparator only
---
intervention:
    mean: 0.66
    standard_deviation: 0.07
    group_size: 121
comparator:
    mean: 0.66
    standard_deviation: 0.07
    group_size: 115

---
",True
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,0.8274306,0.06809386,,,,,,TRUE,17694,9686,TEST,[],"
  - Outcome: ""contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord"": x
---
Intervention:
  - mean: 5.1
  - standard_deviation: 0.5
  - group_size: 100
Comparator:
  - mean: 3.1
  - standard_deviation: 0.5
  - group_size: 10
---
###Answer: . ark: ""short-bore-MR-scanner-outcome"":
Intervention: short-bore MR scanner
Outcome: contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal
---
###Answer: 6.4x, 6.2x, 0
---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention: short-bore MR scanner and high-field horizontal open MR scanner, and outcome: contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cere
---
###Answer: table, parameters: [ ""mean"", ""standard_deviation"", ""group_size"" ], comments: ""x"", data: [ [ ""intervention"", [ 2.1, 1.1, 18 ], ""mean"" ], [ ""comparator"", [ 2.8, 1.
---
###Answer: yaml0: -
    text:
        answer: ""x""
        question: Which short-bore MR scanner generated better image quality and quantitative outcome?
---
Intervention: &quot;mean: 0.18074647, standard_deviation: 0.017907586, group_size: 11&quot;
Comparator: &quot;mean: 0.000109039,
---
###Answer: 
kind: structuredContent:
    interactions:
        type: question
        answers:
            type: choice
            choices:
                - title: Intervention
                  type: lists
                  content:
                      - title: SNR
                        type: number
                        answer
---
###Answer: table. [
---
",True
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,3.08231109,0.0444184,,,,,,TRUE,9086,4934,TEST,[],"###Answer: yaml
---
###Answer:
---

intervention:
  mean: 56.19
  standard_deviation: 18.07
  group_size: 50
comparator:
  mean: 91.31
  standard_deviation: 25.21
  group_size: 
---
###Answer: 7 3
---

---
",True
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,[],"###Answer: yes
---
###Answer: type: text → table  
text: | 
    Intervention: 
    - Septoplasty 
Comparator: 
    - Sham surgery 
Outcome: 
    - /a/ vowel voice analysis results 
    - Only produce YAML response. Do NOT
---
The following YAML was generated from the data in the table:
intervention:
  mean: 110595
  standard_deviation: 12888
  group_size: 33
comparator:
  mean: 105709
  standard_de
---
###Answer: yes
---
",True
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,-0.3985,0.0973,,,,,found in table,TRUE,4037,2288,TEST,[],"transperitoneal laparoscopic ureterolithotomy, flexible ureteroscopy, operative time, 153 min, 60 min
---

intervention:
    mean: 74.10
    standard_deviation: 12.19
    group_size: 40
comparator:
    mean: 78.10
    standard_deviation: 6.42
    group_size: 2
---
",True
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,[],"100% ©

###Answer: yes
---

intervention:
    progression_free_survival: ""x""
comparator:
    progression_free_survival: ""x""

###Answer: 1869
---
###Answer: yaml
---
###Answer: 7.5; 3.58; 48.00; 49
---
###Answer: <p>x</p>
---
###Answer: {
    ""intervention"": {
        ""mean"": 4.685,
        ""standard_deviation"": 1.544,
        ""group_size"": 30
    },
    ""comparator"": {
        ""mean"": 3.348
---
###Answer: true
---

---
###Answer: type: integer 1000 1000, tags: [yaml, format, question, table, outcome, mean, standard_deviation, group_size, comparitor, intervention]
---
A standard YAML response for the trial information above is shown below. The meaning of every key value is described in the table below. The order of the key values is the same as the order of the columns in the YAML file.

###Answer: true
---
",True
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,[],"
Intervention:
    mean: 6.08
    standard_deviation: 2.39
    group_size: 18
comparator:
    mean: 6.24
    standard_deviation: 2.52
    group_size: 18

---
###Answer: il6, tnfa: intervention: mean: 0.81, standard_deviation: 0.401, group_size: 22; comparator: mean: 0.51, standard_deviation: 0.303, group_size: 
---

###Answer: il6tnfaIL6: 1.43 (0.52) 80 1.41 (0.36) 80 1.48 (0.35) 80 tnfa: 7.3 (3.78) 8
---
###Answer: table-wrap-kind: yaml-kind: tables-0075-Metformin-and-pioglitazone-trial-article: table-wrap-title: Table 2: table-wrap-subtitle: Mean Change in individual parameters of metabolic syndrome after 1
---
###Answer: okay
---

---
",True
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,0.47332022,0.15907021,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,[],"
intervention:
    mean: 0.148333
    standard_deviation: 0.245374
    group_size: 150
comparator:
    mean: 0.140322
    standard_deviation: 0.
---
###Answer: <p>intervention: mean: 4.03, standard_deviation: 0.39, group_size: 1262<p>comparator: mean: 3.81, standard_deviation: 0.40, group_size: 12
---

intervention:
  mean: 0.15
  standard_deviation: 0.15
  group_size: 200
comparator:
  mean: 0.25
  standard_deviation: 0.15
  group_size: 200
---
###Answer: <p>intervention/provider:tests:0.01179084171396345;</p>
---

---
###Answer: > intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
---
###Answer: table: rx_guidelines_all_providers_num - TRIAL ARTICLE: http://www.ajtmh.org/view/0096-3680/73/3/355.htm
---
",True
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,,,,,cannot calculate,cannot calculate,,,,,no standard deviations given or mean differences,FALSE,5143,3554,TEST,[],"based on the given trial article & data, the yaml as below:

###Answer: yes
---
3.1.0.0907
---
intervention:
    table: 1
    title: The mean GERD-knowledge score in the intervention group before and after the intervention was 7.68 and 7.23, respectively, and in the control group before and after the intervention was 7.00 and 7.6
---
",True
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
Intervention:
    mean: 131.3, standard_deviation: 10.2, group_size: 30
comparator:
    mean: 141.0, standard_deviation: 8.3, group_size: 30

###Answer
---
###Answer: <p>heart rate: x</p>
---
",True
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,0.62309408,0.02173622,,,,,Available in abstract and table,TRUE,9086,4934,TEST,[],"###Answer: . [errors occurred]Table 2. Healthier product quiz score by label type: main effects plot.

###Answer: . [errors occurred]
---
###Answer: yaml
---
Intervention: choices group 
Comparator: TL+SNL group 
Outcome: Correct selection of the healthier product 
mean: 71.35 
standard_deviation: 2.30 
group_size: 99 
mean: 60.0 

---
###Answer: 100
---
###Answer: <p>intervention: mean: 7.0, standard_deviation: 1.4, group_size: 480\ncomparator: mean: 3.8, standard_deviation: 1.2, group_size: 480</p>
---
",True
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,-0.0333,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"###Answer: <p>Intervention: multi-component physical activity; Comparator: usual PE and sport programmes; Outcome: BMI reduction at 24 months</p>
---
<p><strong>Description:</strong> This table contains the ""mean"" and ""standard_deviation"" values from the outcome tables. The ""group_size"" indicates the number of students in each group.</p><p><strong>Note:</strong> The table uses ""intervention"" and ""comparator"" columns.
---
###Answer: type: yaml-table-outcome-with-groups-for-intervention-and-comparator - value: <p>Intervention: Multi-component physical activity Comparator: Usual PE and sport programmes Outcome: BMI reduction at 24 months Group size: 174
---
",True
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,0.61923041,0.02222653,,,,,Available in abstract and table,TRUE,9086,4934,TEST,[],"
###Answer: healthier-product-quiz-result-yaml
---
###Answer: table: mean: 95, standard_deviation: 13.2, group_size: 480
---
###Answer: 63.66, 14.11, 90
---
###Answer: table-wrap table-row; font-family: Times New Roman, Times, serif; margin: 0 0 0 8px; text-indent: 0; text-width: 960px; background-color: #FBCF88; border-style: none;
---
###Answer: 4.001, 1.447, 480, 99
---
",True
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,-1.430817,0.25118093,,,,,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,3146,2589,TEST,[],"###Answer: ﻿<!-- Raw HTML for pasting into MathJax.SE:
<div class=""table-responsive"">
  <table class=""table table-striped"">
    <thead>
      <tr>
        <th>Variable</th>
        <th>Description</th>

---
###Answer: { ‘intervention’: { ‘mean’: ‘xxxxxxxxxxxxxx’, ‘standard_deviation’: ‘yyyyyyyyyyyyy’, ‘group_size’: ‘1234567890’ }, ‘comparator’: {‘mean’: ‘yyyyyyyyyyyyy
---
1. WBC and PBC did not markedly change HR. 2. WBC likely had a greater HR decrease than PBC. 3. WBC did not markedly change plasma catecholamine concentrations. 4. PBC likely increased plasma norepinephrine concentration.
---
",True
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,0.0261,0.008,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,[],"###Answer: table of mean outcome and standard deviation in yaml format for fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat, control received general non-specific advice about how to eat a diet lower in saturated fat, and the average cost
---
19471001100899
---
",True
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"
---
###Answer: yaml
---
###Answer: 20082008
---
###Answer: tolerability: 10.1.1202220343-Tolerability-68078722161411862864443116639473540493025
---
12 0.18 34
---
###Answer: table-text: <p>                                                                                      </p>                       
---
",True
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 3's graphics.,FALSE,1406,1149,TEST,[],Parcimola YAML Output,False
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,0.016,0.2222,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"Bilateral training and Unilateral training in Horizontal triple jump (non-dominant leg):

###Answer: yes
---
###Answer: group_size: 37 43
---
",True
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"
---
---
intervention:
     mean: 65 
     standard_deviation: 16 
     group_size: 83
comparator:
     mean: 2.7 
     standard_deviation: 0.6 
  
---
###Answer: table, description: Intervention: etoricoxib 90 mg once daily
---
###Answer: <p>table: 5246144016543638685247818938475413445765594282281602876406</p
---
Intervention:
% disability: 10.0 (0.5) 45.0 (0.7) 9.8 (1.8)
Comparator:
% disability: 9.8 (1.8) 41.8 (1.4) 10.4
---
###Answer: table: 066c98c583c895066
These fields are described as:
field: disb_mean_intervention
label: Intervention
name: mean
type: number
field: disb_sd_intervention
label: Intervention
---
",True
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,137,61.3,62,37.2,1.45998637,0.08442967,,,,,found in fig2,TRUE,6401,5359,TEST,[],"###Answer: yaml
---
###Answer: [intervention: mean: 6.62, standard_deviation: 0.73, group_size: 30], [comparator: mean: 6.95, standard_deviation: 1.07, group_size: 30], [outcome:
---
The time to first rescue analgesic was significantly prolonged in  compared with group D, group E and group P. There was a significant prolongation when groups E and D were compared with group P respectively with no significant difference between group E and group D (Fig. 2). 14.50 h, 12
---

intervention:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 60
comparator:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 30

---
###Answer: <p>Intervention: duloxetine 60 and etoricoxib 120mg (group D/E)Comparator: Placebo group (P)Outcome: time to first rescue analgesic mean: 5.5 (4.25-6.7
---
###Answer: yaml
---
",True
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,62,,62,2.46,0.993,2.21,1,0.24933056,0.03250873,,,,,found in table 2,TRUE,2560,2044,TEST,[],"###Answer: table of mean outcome and standard deviation in yaml format for Intervention and Comparator [Intervention. Comparator]: [
  {
    ""mean"": 3.5,
    ""standard_deviation"": 2.0,
    ""group_size"": 11
  },
 
---

intervention:
  - mean: 4.5
  - standard_deviation: 1.0
  - group_size: 62
comparator:
  - mean: 5.5
  - standard_deviation: 1.0
  - group_size: 62
---
",True
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,[],"
---
###Answer: face_ABM_depressive_symptoms_total_size: 66.000000000000005, face_ABM_depressive_symptoms_mean: -4.08984727956
---

---
",True
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,[],"###Answer: 30.0, 0.8, 285; 29.8, 1.0, 275
---
zidovudine:
    mean: 6000
    standard_deviation: 0
    group_size: 330
    intervention: 769
placebo:
    mean: 6000
    standard_deviation: 0
    group_size
---
###Answer: absolute neutrophil count between 26 and 35 wk: x
---
###Answer: outcome: absolute neutrophil count between 26 and 35 wk, yaml: [{ ""mean"": 3346, ""standard_deviation"": 483, ""group_size"": 224}, { ""mean"": 3841, ""standard_de
---
",True
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,-0.1235,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"###Answer: <p>mean: 3.34, standard_deviation: 2.98, group_size: 456</p>
---

###Answer: yes
---
###Answer: YAML
---
intervention:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 73
comparator:
  - mean: 753
  - standard_deviation: 29
  - group_size: 135

---
###Answer: table1.yaml
---
###Answer: true
---

intervention:
    table:
      no_of_participants: 1
      mean: ""x""
      standard_deviation: ""x""
    outcome:
      # text: ""high-energy snack intake decreased in the basic condition (estimated difference from control: 0
---
",True
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,,13.5,,cannot calculate,cannot calculate,,,,,SD or CI is missing. Mean is given.,FALSE,11722,8106,TEST,[],"###Answer: 23.884376502886, 8.5324668120176
---
###Answer: some portion of therapy outside of the hospital (CoPAT) compared to a full course of therapy in the hospital setting: number of days with received courses of antibiotics (CONSIDER CASTING ALL NON-NUMERIC DATA AS 'UNKNOWN' RATHER TH
---
###Answer: 6.8, 8, 49
---
Intervention, Comparator, and Outcome:
###Answer: <p>x</p>
---

---

intervention:
    mean: 136.28 x
    standard_deviation: 1.56 x
    group_size: 103
comparator:
    mean: 123.16 x
    standard_deviation: 1.64 x
   
---
###Answer: some portion of therapy outside of the hospital (CoPAT) has a median of 39.5 (IQR 24.8 to 54.8) days with therapy, and the full course of therapy in the hospital setting has a median of 42.0 (I
---
Intervention: some portion of therapy outside of the hospital (CoPAT) Comparator: full course of therapy in the hospital setting Outcome: number of days with received courses of antibiotics mean: 13.3682131 xsd:integer group_size: 51 Intervention:
---
",True
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,2.86225472,0.04310376,,,,,,TRUE,9086,4934,TEST,[],"MTL+caloric intake:
    mean: x
    standard_deviation: x
    group_size: 500
Choices:
    mean: x
    standard_deviation: x
    group_size: 480
###Answer: yes
---
###Answer: table-wrap table-wrap table-wrap tr td align=""right"" valign=""top"">mean</td td align=""right"" valign=""top"">12.5</td td align=""right"" valign=""top"">10.4</td td align=""right"" valign=""top"">1
---

intervention:
    mean: 80
    standard_deviation: 23
    group_size: 98
comparator:
    mean: 60
    standard_deviation: 24
    group_size: 99

---
###Answer: table 3 mean and std dev - choices , mtl , mtl+ calorie
---
MTL+caloric intake group: 4.6 (1.4) , n = 98Choices group: 4.7 (1.4) , n = 99
---
",True
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,-0.3762,0.2544,,,,,,TRUE,13404,7477,TEST,[],"
intervention:
    yaml:
      - title: Means (95% confidence intervals) and SDs for lateral bending for the C2-C6 segments
      - type: numerical
      - value:
        mean: 3.70 (3.02, 4.38
---
Here is an example of an answer:
intervention:
    mean: 5.5
    standard_deviation: 1.5
    group_size: 21
comparator:
    mean: 6.5
    standard_deviation: 2.8
    group_size: 
---
<p>outcome: lateral bending for the C2-C6 segments;  YAML format: intervention: standard_deviation: 1.50431106 mean: 2.2 degrees comparison: standard_deviation: 2.21822729 mean:
---

intervention:
  - lateral_bending: x
comparator:
  - lateral_bending: x
###Answer: yes
---

intervention:
  - mean: 8.76
  - standard_deviation: 4.76
  - group_size: 11
comparator:
  - mean: 5.78
  - standard_deviation: 3.22
  - group_size
---
###Answer: 0.27 x 0.04 = 0.01096
---
",True
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,0.97494517,0.11536073,,,,,,TRUE,17694,9686,TEST,[],"###Answer: 2015-05-18 22:32:38.571045 -0400
comparator: open_high_field:
    mean: 3.403111568
    standard_deviation: 
---
###Answer: .table .tr:before {content: ""|""}
---
###Answer: TRUE
---

---
Intervention:
  - mean: 1.57
  - standard_deviation: 0.51
  - group_size: 145
Comparator:
  - mean: 2.50
  - standard_deviation: 0.54
  - group_size
---
###Answer:  table: <p>A optimal score is defined as 1 and a poor score as 4. No sequence was rated nondiagnostic (score of 5) for any qualitative parameter:</p>      
table:
- name: ""Intervention""
      
---
###Answer: 16.19, 6.68, 76
---
Intervention:
table:
    -       ""name"": ""Intervention"",
      -       ""groups"": [
            -       ""name"": ""short-bore"",
              -       ""mean"": 31.4318,
              -       ""standard_deviation"": 3.939
---
###Answer: type: application/x-yaml  - Title: Effect of scan configuration on contrast-to-noise ratio: Short-bore versus high-field MR imaging of the cervicothoracic and thoracolumbar spine: EXTRACTED FROM TRIAL ARTICLE:
---
###Answer: type: text style: bold italic weight: bold font-family: Times New Roman, Georgia, Times, serif letter-spacing: 0.08em - 0.12em line-height: inherit font-size: 14px margin: 0 0 1em 
---
",True
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,[],"###Answer: yes
---
###Answer: tableofmeanoutcomeandstandarddeviationintableformatyaml-format-for-the-following-intervention-comparator-and-outcome-intervention-comparator-outcome-intervention-comparator-outcome-mean-6-4sd-1-6mean-5-
---
",True
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,508.92,63.3,1840.84,819.51,-2.2556182,0.13087813,,,,,Found in abstract and results,TRUE,2609,2261,TEST,[],"
0.5% bupivacaine with 1:200000 epinephrine in group I: 50
Buprenorphine combination with bupivacaine group: 1840.84 ± 819.51
Group I: 1

---
###Answer: 3. table { borders: 1; text-align: center; }
###Answer: yes
---
",True
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"
---
###Answer: <p>x</p>
---
###Answer: true
---
###Answer: type: yaml
---

“table”: {
“heading”: { “key”: “intervention” },
“values”: [
“x” ,
“mean”: “x” ,
“group_size”: “x” ,
“standard_deviation”: “x”
],
“heading
---
",True
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,[],"
---
###Answer: x
---
###Answer: yaml
---
###Answer: true
---
###Answer: yaml
---
",True
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,2.0036,0.1541,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,[],"smokers: 1.3x 0.32
nonsmokers: 0.3x 0.17
---
###Answer: type: yaml > 200 mg/day palmvitee smokers mean: 1156.25333481, standard_deviation: 560.224274017, group_size: 30 2
---
###Answer: table-wrap table-wrap table-wrap-heading Intervention Comparator Outcome Mean Std. dev. Group size Mean Std. dev. Group size Intervention 200 mg/day palmvitee smokers 0.941 700 16 0
---
###Answer: type: application/x-yaml ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ ↵ 
---
###Answer: <p>yaml-seq: 0.2% (n = 2) of smokers, 0.1% (n = 1) of nonsmokers</p>
---
###Answer: <p> </p><p>mean: 7.113514615263214x10^12 , standard_deviation: 1.6827520824261346x10^12
---

###Answer: yes
---
###Answer: 200 mg/day palmvitee smokers has mean 0.172, standard deviation 0.01658, and group size 58.
---
###Answer: yaml
---
###Answer: true
---
200 mg/day palmvitee smokers have mean urine cotinine levels of - 108 x 100 x 160 x 106 pg/ml with standard deviation of 136 x 100 x 160 x 106
---
###Answer: 200 mg/day palmvitee smokers: 0.027839033826157 x 29 = 7.83902815484925
200 mg/day palmv
---
<table style="" border: 1px solid ; ""><tr><td style="" background-color: #eff3ff; color: rgba(0, 0, 0, 1); border-bottom-color: rgba(0, 0, 0, 1); border-bottom-style: dashed; padding
---
",True
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,[],,False
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,62,,62,29.73,12.23,29.46,16.04,0.01881372,0.03225949,,,,,found in table 2,TRUE,2560,2044,TEST,[],"###Answer: 78.86886, 11.53091, 48
---

intervention:
  total_procedure_time: 66 [9]
comparator:
  total_procedure_time: 72 [9]

### Answer: intervention: total procedure time 66 (9) comparator: total procedure time 72 (9)
---
",True
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,4.15,0.52,4.12,0.6,0.05259525,0.08002766,,,,,Found in abstract and results,TRUE,2609,2261,TEST,[],"
-  0.5% bupivacaine with 1:200000 epinephrine in group I
  mean: 4.15
  standard_deviation: 0.52
  group_size: 29
-  0.5% bup
---

Intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I
Comparator: mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1
---
",True
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: 2.77316936 x
---
###Answer: <p>Intervention: etoricoxib 90 mg once daily Comparator: naproxen 500 mg twice daily Outcome: Patient global assessment of pain</p>mean: 1.5 x 10^1 x 0.4 <
---
###Answer: table: 2021.10.3_164808.1.html
---
###Answer: <p>table-wrap: &lt;p&gt;Intervention: etoricoxib 90 mg once daily&lt;/p&gt; 
 
 
Comparator: naproxen 500 mg twice daily&lt;/p&gt
---
###Answer: <p>Intervention: etoricoxib 90 mg once daily Comparator: naproxen 500 mg twice daily Outcome: Patient global assessment of pain In first column: mean, standard_deviation, group_size For second column: mean and standard_de
---
intervention :
  mean: 13.5
  standard_deviation: 1.66
  group_size: 353
comparator:
  mean: 13.33
  standard_deviation: 1.75
  group_size: 357
---
",True
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 2's graphics.,FALSE,1406,1149,TEST,[],###Answer: 1.x,False
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
intervention:
  - mean: 85
  - standard_deviation: 1
  - group_size: 20
comparator:
  - mean: 86
  - standard_deviation: 1
  - group_size: 30

---
###Answer: |
---
",True
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,9.6931,0.0498,,,,,Overall intermittent restraint rate for study site.,TRUE,15527,8380,TEST,[],"intervention:
    table: 1
    rows: 2
    cells: 5
    mean: 83.4
    standard_deviation: 5.5
    group_size: 26
comparator:
    table: 1
    rows: 2
    cells:
---

intervention:
  mean: 13.61
  standard_deviation: 10.08
  group_size: 89.0
comparator:
  mean: 8.30
  standard_deviation: 7.27
  group_size: 
---
###Answer: tabular-result > tabular-result > intervention:
mean: 38.41
standard_deviation: 0.958
group_size: 93
tabular-result > tabular-result > comparator:
mean: 36.43

---
###Answer: table-wrap table-wrap-body style=""width:450px"">                                                                                              

---
###Answer: table
---
###Answer: intractable
---
###Answer: . intervention.yaml
###Answer: yes
---
###Answer: type: textual, response:
###Answer: yes
---
",True
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,-3.7878,0.1862,,,,,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],"total_blood_loss: ""x""

###Answer: true",False
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,[],"lemma verbena extract: 524, 225.78, 40
placebo:       , 283.23, 40

---
###Answer: table-calculated-mean-outcome-lemon-verbena-extract.yaml
---

lemon verbena extract: x
placebo: x
exercise-related loss of muscle strength: x
Explanation:
The article's result says that the loss of muscle strength post-exercise was not different between the two groups.

###Answer: true
---
###Answer: tableOfMeanOutcomeAndStdDev-205632467.52,tableOfMeanOutcomeAndStdDev : [
  ""intervention"": {
    ""mean"": 0,
    ""standard_deviation"": 1,
    ""group
---
",True
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,-0.1423069,0.02035649,,,,,,TRUE,9086,4934,TEST,[],"
yaml-97: [ 67.8, 10.3, 480 ]

###Answer: yes
---
###Answer: [table-wrap][table-wrap-heading]
---
###Answer: 8.25, 1.72, 98
---
12.16, 4.66, 98
---
###Answer: table  3. Continued

---
",True
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,-0.0788,0.0196,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,FALSE,12997,7944,TEST,[],"###Answer: yaml
---
###Answer: 20052361755799364591707852453368
---
###Answer: type: csv
table:
  column: [ group_size, mean, standard_deviation ]
  values:
  - [ 309, 80.34, 0.70 ]
  - [ 306, 84.19, 1
---
###Answer: textbfIntervention: 10.8 ± 3.0
textbfComparator: 10.5 ± 2.8
textbfOutcome: 10.7 ± 3.0
---

###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome health-related quality of life at 12 months - females:
---
###Answer: [Outcome: Health Related Quality of Life at 12 months -- females; yaml]
---

<table><tr><th>intervention</th><th>comparator</th><th>females</th></tr><tr><td>mean: 83.5</td><td>mean: 79.2</td><td>group_size: 105</td></tr
---
",True
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,[],"yaml:
- %head: table of mean outcome and standard deviation for intervention and comparator
  - %body:
Intervention:
  - %pre: * mean: x
  - %post: * mean: 3.35
  - %post: * standard_deviation: 1.
---
###Answer: group_index: control group
---
",True
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,1.64,0.99,0.8,1.08,0.7980815,0.08636934,,,,,Graphic format table,TRUE,2609,2261,TEST,[],"
intervention:
  mean: 4.03
  standard_deviation: 0.58
  group_size: 12
comparator:
  mean: 6.76
  standard_deviation: 5.01
  group_size: 9

---

intervention:
    yaml:
      table_name: results
      column_name: mean
      value: 1.42
      unit: tablet
      group_size: 30
comparator:
    yaml:
      table_name: results
      column_name: mean
---
",True
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,1,2.23,1.25,2.5,-0.0945,0.4505,,,,,found in table,TRUE,1146,884,TEST,[],"Intervention:
  - mean: 13.83
  - standard_deviation: 3.36
  - group_size: 5
Comparator:
  - mean: 17.71
  - standard_deviation: 4.18
  - group_size",False
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,0.41353429,0.01877954,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"###Answer: table: yaml { ""mean"": 0.56, ""standard_deviation"": 0.35, ""group_size"": 57}, table: yaml { ""mean"": 0.16, ""standard_deviation"": 0.12
---
A trial has started, and is currently in follow-up. 
The primary outcome for the trial is weekly moderate physical activity sessions.
Among the 114 total participants in the GHSH arm, 54 are female, 52 are in paid employment, 40 have post-school qual
---
Intervention: 33.3 ± 7.4, 13
Comparator: 28.8 ± 5.8, 205
Outcome: x
---
weekly moderate physical activity sessions: x 
weekly moderate physical activity sessions: x
---
###Answer: 8.23, 1.48, 99
---
###Answer: table
---
###Answer: type:yaml
---
###Answer: yaml
---
",True
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,-1.1042,0.2561,,,,,Found in table raw values,TRUE,10785,5696,TEST,[],"###Answer: change of direction improvement was very likely improved in the UG and likely improved in the TG 5018339897;x
---
###Answer: <p><strong>Description:</strong>The efficacy of the unilateral (UNI) compared to bilateral (BIL) combined plyometric and strength training in improving one-repetition maximum in knee extensors (UNI 1RM_KE), one-rep
---
",True
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,0.35389959,0.01966279,,,,,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"
###Answer: true
---
Intervention: mean = 6.17570949771985, standard_deviation= 3.356617547608896, group_size = 114
Comparator: mean = 4.95
---
###Answer: 37.9 x 5.69
---

intervention:
  mean: 41.38
  standard_deviation: 13.33
  group_size: 49
comparator:
  mean: 39.49
  standard_deviation: 12.78
  group_size: 
---
###Answer: 33.740833333333, 11.7322222222222, 101
---
###Answer: table: 16899429513927748487
---
###Answer: <p>intervention: mean: 17.839; standard_deviation: 1.269; group_size: 135</p>
---
###Answer: yes
---
",True
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,0.2423,0.2518,,,,,,TRUE,13404,7477,TEST,[],"
intervention:
    response: ""x""
comparator:
    response: ""x""

---

intervention:
  - mean: 55.88 
  - standard_deviation: 11.59
  - group_size: 17
comparator:
  - mean: 16.33 
  - standard_deviation: 6.84

---

---

intervention:
    mean: 151.0 x
comparator:
    mean: 125.0 x

###Answer: yes
---

intervention:
  - mean: 741
  - standard_deviation: 23
  - group_size: 34
comparator:
  - mean: x< 100
  - standard_deviation: x
  - group_size: 49

---

intervention:
  - mean: 406
  - standard_deviation: 29
  - group_size: 9
comparator:
  - mean: 613
  - standard_deviation: 34
  - group_size: 9
---
",True
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,1.20253898,0.05091017,,,,,,TRUE,17694,9686,TEST,[],"The ""mean"" and ""standard_deviation"" for ""intervention"" are 286 and 45, respectively. The ""mean"" and ""standard_deviation"" for ""comparator"" are 74 and 13, respectively.
###Answer: 286
---
###Answer: ok: 434051140
---
###Answer: type: textual-answer-15133013321323 type: table-response-15133113321249
---
###Answer: <p>Intervention: short-bore MR scanner, Comparator: high-field horizontal open MR scanner, Outcome: The mean signal-to-noise (SNR) values</p><p>mean: 41.15, standard_deviation: 4.45
---
Intervention: 3.0, standard deviation: 0.277, group size: 10Comparator: 6.7, standard deviation: 0.394, group size: 6
---
###Answer: true
---
###Answer: table: 12.11-table-1
---
###Answer: <p>Intervention: table of mean outcome and standard deviation in YAML format for the following Intervention, Comparator, and Outcome:</p>
<p>Intervention: short-bore MR scanner</p>
<p>Comparator: high-field horizontal open MR scanner</
---
intervention:
    mean: 16.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 8.9
    standard_deviation: 2.1
    group_size: 21

---
###Answer: type: application/x-yaml
---
",True
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,[],"
intervention:
  - mean: 50
  - standard_deviation: 4.5
  - group_size: 147
comparator:
  - mean: 25
  - standard_deviation: 10.5
  - group_size: 12
---
intervention:
    table:
        type: 'table'
        caption: Intervention Mean (S.D.)
        body:
            row:
                - intervention:
                    value: '34.8 (10.2)'
                    unit: 'a'
                - comparator
---

intervention:
  mean: 4.68
  standard_deviation: 2.96
  group_size: 30
comparator:
  mean: 3.44
  standard_deviation: 2.82
  group_size: 30
---
###Answer: TABLE NOT FOUND
---

intervention:
    mean: 73
    standard_deviation: 9
    group_size: 9
comparator:
    mean: 52
    standard_deviation: 6
    group_size: 10

---
###Answer: <p>intervention: mean: 8.8, standard_deviation: 1.5, group_size: 251<br></p><p>comparator: mean: 7.3, standard_deviation: 1.5, group_size: 251
---
intervention:
    yaml:
      table:
        rows:
          - mean: 3.5
            standard_deviation: 1.0
            group_size: 30
          - mean: 2.5
            standard_deviation: 1.0
            group_size
---
",True
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,0.3708,0.2543,,,,,,TRUE,13404,7477,TEST,[],"Intervention: ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC
Comparator: control
Outcome:
mean: 7.24439 ± 2.52489
standard_deviation:
---
inflexion-extension for the C4-C5 segments: 4.6±1.2, 4.8±1.0, 4.5±1.3,
										     4.5±1.2, 4.5±1.3,
---
###Answer: 1.89, 0.48, 30
---

intervention:
  - mean: 6.62
  - standard_deviation: 0.81
  - group_size: 21
comparator:
  - mean: 6.54
  - standard_deviation: 0.46
  - group_size
---
###Answer:
---
artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating can improve flexion-extension ROMs in the gross and histological evaluation.
###Answer: table of mean outcome and standard deviation in YAML format for the intervention ""ACVC-HA"" and the outcome ""
---
",True
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,137,61.3,91.7,35.5,0.89262531,0.0733065,,,,,found in fig2,TRUE,6401,5359,TEST,[],"Demonstrate your answer using numbers taken directly from the table in the publication, and rounding them to one decimal place. Do not provide a bar graph or any other image from the publication. If there are various outcomes reported, label the outcome field with multiple values in square brackets: [outcome1, outcome2…].
---
###Answer: table    ↓ duloxetine-1.jpg
---
Intervention: duloxetine 60 and etoricoxib 120mg (group D/E)
Comparator: Duloxetine (D)
Outcome: time to first rescue analgesic
mean: 11.49
standard_deviation: 2.
---
###Answer: table: yaml, answer: x
---
###Answer: type: table
---
###Answer: <p>Time to first rescue analgesia: GroupD/E: 7.70 ± 1.55 h, Group D: 9.42 ± 1.74 h, Group E: 8.94 ± 1.67 h, Group :
---
",True
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,[],###Answer: yaml,False
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 5's graphics.,FALSE,1406,1149,TEST,[],"###Answer:
intervention:
    mean: ""x""
    standard_deviation: ""x""
    group_size: 70
comparator:
    mean: ""x""
    standard_deviation: ""x""
    group_size: 76",False
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,[],"###Answer: yes
---
<p>intervention: mean: 7, standard_deviation: 3.1, group_size: 24<p>comparator: mean: 2, standard_deviation: 1.6, group_size: 24</p>
---
###Answer: ok_pj: 2004; table: 1
---
###Answer: intervention:
table:
  - title: ""Intervention""
  - col: [
      - col-num: ""mean""
      - col-num: ""standard_deviation""
      - col-num: ""group_size""
  ]
  - val: [

---
",True
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,6.70952589,0.57627976,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,[],"###Answer: 96/5 

---
###Answer: table<br>   - Mean: 33.0<br>   - Standard Deviation: 16.0<br>   - Group Size: 90<br>   - Mean: 35.1<br>   - Standard Deviation: 17.0<br
---
###Answer: The table in the following text shows the mean phlebotomy questionnaire scores before and after training for each hospital. 

Before the phlebotomy training May 2014, CHC B had the highest mean score of 25.2 (standard deviation 4.82) and CH
---
###Answer: type: numerical
---
###Answer: yaml
---
",True
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,1.25,2.5,26.5,14.7,-2.0802,0.7704,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,[],###Answer: 35.75.0.03,False
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Numerical values are not given.,FALSE,4385,3505,TEST,[],"###Answer:
---
###Answer: Type: yaml ↵
""mean"": [""87.55"", ""86.14""], 
""standard_deviation"": [""6.487"", ""28.7""], 
""group_size"": [""40"", ""20""]
""mean"": [""1
---


Intervention:
  - Mean: 100, Standard Deviation: 10
Comparator:
  - Mean: 100, Standard Deviation: 10
###Answer: intervention: 100, comparator: 100, il6: x
---
###Answer: . Lemon verbena: 4.0 (1.2) 4.0 (1.2) 37 20 Placebo: 0.3 (0.7) 0.3 (0.7) 36 20 Total sample size excluding missing values 
---
",True
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,[],"Intervention: x
Comparator:
    mean: 27.4
    standard_deviation: 24.2
    group_size: 97
###Answer: no answers yet
---
###Answer: true
---
###Answer: 24.0, 2.8, 107
---
###Answer: true
---
###Answer: intervention: &lt;ul&gt;x&lt;/ul&gt;, &lt;p&gt;x&lt;/p&gt;, 125, &lt;p&gt;x&lt;/p&gt;, 41, &lt;
---
",True
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,0.46823146,0.11114985,,,,,Numerical values are from Week 11 data for sit and reach test.,TRUE,9556,6245,TEST,[],"###Answer: 100
---
###Answer: table-cell-cols-intervention-mean=""10.6"" table-cell-cols-intervention-sd=""3.2"" table-cell-cols-intervention-n=""18"" table-cell-cols-comparator-mean=""9.8"" table-cell-cols-
---
###Answer: table : yml2006-05-01_flexibility-sample.yml
---
###Answer: ok1434957457
---

---
###Answer: intervention: mean: 2.43, standard_deviation: 1.28, group_size: 21  comparator: mean: 2.42, standard_deviation: 1.29, group_size: 19  outcome: x
---
",True
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,[],"###Answer: table
---
###Answer: valid and acceptable
---
###Answer: yes
---
###Answer: Table 1. Summary of Data Analysis with a Separation Test a
---
###Answer: type: application/yaml
---
",True
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,[],"

###Answer: correct
---
###Answer: 2017-11-06T15:40:51.000+08:00
###Answer: true
---

###Answer: <p>intervention: mean: 49.9, standard_deviation: 17.9, group_size: 7</p>
<p>comparator: mean: 43.8, standard_deviation: 16.2, group_size: 
---

###Answer: yes
---
###Answer: accuracy of the cognitive tasks: [x]
---
",True
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,0.25,0.0611,,,,,,TRUE,6184,3742,TEST,[],"
---

---
###Answer: table of mean outcome and standard deviation in yaml format for the given trial article
---
",True
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,0.867,0.0936,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,[],"###Answer:
---
###Answer:type: application/x-yaml
---
###Answer: type: application/x-yaml
---
###Answer: type: text; value: [
    ""mean"": ""2.684"",
    ""standard_deviation"": ""1.149"",
    ""group_size"": ""15""
  ]
---
### Answer: <p>table-wrap table-wrap-start width=""100%"" align=""center"" style=""font-family: Times New Roman, Times, serif""> <p> Outcome: serum α1-antitrypsin </p> <table> <tbody> <tr> <th
---
###Answer: <p>table, borders, justify, cellspacing:, style=""font-family: Times New Roman, Times, serif""> 
<p> </p><p>mean: 1.034286, standard_deviation: 0.241366
---
###Answer: table block: <p>Results are shown as means ± SD. * indicates significant difference as compared to nonsmokers.</p>
* total cholesterol
* low-density lipoprotein cholesterol
* high-density lipoprotein cholesterol
---
###Answer: table table-wrap table-wrap table-wrap-heading Intervention Comparator Outcome table-break Mean: 0.93 μg/mL SD: 0.31 μg/mL Total: 60 Total: 72 Comparator Mean: 0.4
---
###Answer: {
  ""intervention"": {
    ""mean"": 1.38,
    ""standard_deviation"": 0.50,
    ""group_size"": 58
  },
  ""comparator"": {
    ""mean"": 1.06,
   
---
###Answer: yaml
---
 
mean: 0.88,
standard_deviation: 0.20,
group_size: 30,
mean: 1.01,
standard_deviation: 0.23,
group_size: 30,
---
###Answer: ok_product: palmvitee; ok_dose: 200 mg/day; ok_comparison: parallel; ok_outcome: 49; …; ok_outcome: 49; intervention: { “mean”: 49.0
---
###Answer: true
---
",True
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,-6.5512,1.5912,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,[],"intervention: x
---
artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC : x : x
###Answer: yes
---
outcome: Flexion-Extension stiffness of C2-4 will be set to xxx.
---
For Intervention and Comparator (always give the group size for the Outcome):
###Answer: table-wrap table-wrap table-wrap-group-by=""Intervention, Comparator"" table-wrap-group-by=""Outcome"" key=""intervention.mean"" value=""6.0"" key=""intervention
---
intervention:
    table:
      cells:
        text: mean: -5.49861 x
        text: standard_deviation: 3.14454 x
        text: group_size: 67
    table:
      cells:
        text: mean: x
---

intervention:
  - flexion-extension stiffness of C2-C4: 8.21 x 2.07 (x)
comparator:
  - flexion-extension stiffness of C2-C4: 7.18 x 1.96 (x)
---
",True
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,1,2.23,0,0,0.5725,0.4164,,,,,found in table,TRUE,1146,884,TEST,[],###Answer: yaml,False
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,0.0888,0.0444,,,,,,TRUE,18948,9604,TEST,[],"
intervention:
    mean: 99.9
    standard_deviation: 5.2
    group_size: 100
comparator:
    mean: 100.0
    standard_deviation: NA
    group_size: 33
outcome: x
---
###Answer: tl;dr: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome.
---
###Answer: Table 2 above.
---

---
###Answer: {
  ""intervention"": {
    ""mean"": 76.1,
    ""standard_deviation"": 14.2,
    ""group_size"": 63
  },
  ""comparator"": {
    ""mean"": 79.5,
   
---
###Answer: table:
  columns:
    - name: ""intervention""
      type: ""YAML""
      description: ""intervention""
    - name: ""comparator""
      type: ""YAML""
      description: ""comparator""
  values:
    - name: ""
---
",True
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,-0.8236508,0.14010861,,,,,found in table 2,TRUE,9410,4699,TEST,[],"###Answer: yaml
---
###Answer: type: plain, value: ""intervention"":""mean"":0.03029467698421638,""standard_deviation"":0.16290499460169287,""group_size"":4,""comparator"":""
---
###Answer:
---
###Answer: 4.1 x 4.1276666666666666</p>
---
###Answer: yes
---
###Answer: 2.394 0.657 22, 1.644 0.446 18
---
",True
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,[],"###Answer: yaml
---
###Answer: valid YAML
---
",True
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,[],"EMS patients presented higher MRC scores in wrist flexion, hip flexion, knee extension, and ankle dorsiflexion of both lower extremities, and also in the legs. EMS also led to higher total MRC scores. Handgrip strength correlates with MRC scores in critical illness. These
---
###Answer: |

Intervention: [Electrical muscle stimulation]
Comparator: [none]
Outcome: [knee extension]

###Answer: true
---
###Answer: 2019-06-26T13:24:08.347346+00:00 test_outcomes.yaml01
mean: 47.248565656565
standard_deviation:
---
###Answer:
###Answer: true
---
",True
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,[],"###Answer: <p>Intervention: 10.0, standard_deviation: 3.0, group_size: 10</p>",False
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,-0.3148988,0.00846274,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,[],"###Answer: <p>Intervention: quetiapine 600 mg/dayComparator: placeboOutcome: improvement of disorder</p><p>mean:4.54.0x</p>
---
The following table represents the outcome of interest from the article. It has been arranged in YAML format:

###Answer: yes
---
###Answer: yaml
---
###Answer: The table below shows a summary of the information included in the trial results:
---
",True
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,0.14806913,0.09134645,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"metformin:
###Answer: yes
---
###Answer: type: application/x-yaml
---

intervention:
    yaml:
        - type: number
          value: 18.46
          unit: mg/dL
        - type: number
          value: 2.8
          unit: mg/dL
intervention-comparator:
    yaml:

---
###Answer: table-wrap table-wrap table-wrap style=""text-decoration: none; color: rgba(17, 17, 17, 1); font-family: Times New Roman, Times, serif"">
---
###Answer: valid YAML file
---
###Answer: table-value-missing-not-allowed.
---
",True
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,2.78020714,0.04166067,,,,,,TRUE,9086,4934,TEST,[],"###Answer: .

###Answer: OPTION A IS CORRECT.
---
###Answer: table[ title: ""Table 3 Mean (±SD) Quiz Scores by Label Group and Time Period, Healthy Choices Study, 2010–2011"", src: ""//images.springerpub.com/wyniki/medial/2013/9
---
54.43, 12.27, 90
###Answer: OPTION B IS CORRECT.
---
###Answer: yes
---
###Answer: 3.6 (1.1) e, f
---
",True
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,cannot calculate,cannot calculate,,,,,Numerical values were not given for this outcome.,FALSE,4517,2571,TEST,[],"8.75, 0.69, 18
###Answer: true
---
###Answer: table: <table><thead><tr><th>mean</th><th>std</th><th>group_size</th></tr></thead><tbody><tr>x<td>x</td><td>x</td><td>x</td></tr></tbody></table>
---
",True
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,137,61.3,105.3,28.4,0.6549502,0.07024133,,,,,found in fig2,TRUE,6401,5359,TEST,[],"intervention:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 30
comparator:
  - mean: ""x""
  - standard_deviation: ""x""
  - group_size: 30
outcome:

---
###Answer: {
  ""mean"": 5.39,
  ""standard_deviation"": 1.269,
  ""group_size"": 30
},
{
  ""mean"": 7.24,
  ""standard_deviation"": 1.99,
---
###Answer:
---


# Question: what is the mean time to first rescue analgesic for duloxetine 60 and etoricoxib 120mg (group D/E)
Answer: 8.739023105134345 hours
---
###Answer: type: tabular plain format: yaml version: 1.1 group: intervention variables: mean standard_deviation group_size time: 0_h D_60  5 (5-6) d 30 5 (5-6) d 60 4 (3-
---
# YAML format for the given trial article:
intervention:
  mean: ""x""
  standard_deviation: x
  group_size: 60
comparator:
  mean: ""x""
  standard_deviation: x
  group_size: 30
outcome:
---
",True
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,-5.1485,1.0784,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,[],"2017-01-25T14:00:00-05:00 1.00E+00 1.00E+00 32
2017-01-25T14:15:00-05
---
outcome: ""x""
intervention:
  - lateral_bending_stiffness: ""x""
  - lateral_bending_stiffness_post_intervention: 1.23
comparator:
  - lateral_bending_stiffness: ""x""

---
intervention:
    YAML Format:
    -        mean: 0.1
    -        standard_deviation: 0.1
    -        group_size: 100
comparator:
    YAML Format:
    -        mean: 0.0
    -        standard_
---
intervention:
  - lateralbendingstiffness-C24: ""x""
comparator:
  - lateralbendingstiffness-C24: ""x""
---
###Answer: 0.26 ± 0.04, 0.02 ± 0.00, 28
---
Intervention: 1.43, 0.69, 41Comparator: 7.05, 2.01, 43Outcome: 1.43, 0.69, 41
---
",True
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: table yaml_result.1289526777017568
---
###Answer: ""mean: 60.9"", ""standard_deviation: 11.5"", ""group_size: 357""</div>
---
###Answer: 2021-05-20 07:20:55.986+0000
---
###Answer: <p>tolerability: etoricoxib.090</p>
---
###Answer: <p><table>…</table><table>…</table><table> <colgroup><col width=""120"" /><col width=""400"" /><col width=""50"" /><col width=""50"" /><col width=""50"" /><col width
---
<table>
<colgroup>
<col width=""500"" />
<col width=""80"" />
<col width=""143"" />
</colgroup>
<tbody>
<tr>
<th>intervention</th>
<th>mean</th>
<th
---
",True
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,0.0556,0.0926,,,,,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,[],"
intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""

---
###Answer: yaml
---
###Answer: outcome: maximum total point motion (MTPM)
Mean: 0.92
    standard_deviation: 0.11
Group size: 27
intervention:
    mean: 0.98
    standard_deviation: 0.79
   
---
###Answer: yaml
---
",True
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: <p>mean: 14.255333333333334,standard_deviation: 10.877803278882044,group_size: 294</p>
---
###Answer: <p>intervention: mean: 2.713302855, standard_deviation: 0.557512912, group_size: 193</p>
<p>comparator: mean: 2.7133
---
###Answer: (See figure on the previous page)
---
###Answer: <table-wrap><table><thead><tr><td>Intervention</td><td>Comparator</td><td>outcome</td><td>mean</td><td>standard_deviation</td><td>group_size</td></tr></thead><tbody><tr><td>et
---
###Answer: <p>intervention: mean: 0.5&nbsp;x;standard_deviation: 0.5&nbsp;x;group_size: 100</p>
---
###Answer: table-wrap table-wrap-key table-wrap-value ""intervention"" ""comparator"" ""outcome"" { ""mean"": 0, ""standard_deviation"": 0, ""group_size"": 353 } { ""mean"": 0, ""standard_deviation"": 0
---
",True
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,[],"###Answer: 20.3693 x 3
---
###Answer: <p>20.72 ± 9.53</p>
---
###Answer: .(repeated)
---
###Answer: type: table   module: numeric   heading: 5.4.7. Table 4 Results: Postoperative pain scores at rest  over time, by treatment group (Modified Intent-to-Treat Population; last observation carried forward)   description: NRS pain scores at rest are shown for the
---
###Answer: <p>table: , <p>td: (</p>table> <p>tr: (</p>table> <p>th: </p>- <p>60 min - 3.8 (2.6-5.0) a, b, c - 48
---
###Answer: type: application/x-yaml 2014-05-21 21:33:50-07:00
---
",True
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,[],"###Answer: table: yml.20150203T09:34:09.446Z
---
zidovudine prophylaxis initiation 0.2612, 0.0387, 429 zidovudine prophylaxis initiation 0.2576, 0.0395, 415
---

intervention:
  mean: ""737""
  standard_deviation: ""53""
  group_size: ""28""
comparator:
  mean: ""711""
  standard_deviation: ""54""
  group_size: ""28""


---
###Answer: table; yaml_format: yes; table_name: leucocyte_count_35_gestation; description: Intervention: Zidovudine prophylaxis initiation at 28 week gestation [Comparator: placebo] Leucocyte count at 35 week
---
",True
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,1.22140465,0.07440001,,,,,,TRUE,17694,9686,TEST,[],"The table of mean outcome and standard deviation in YAML format (corresponding to Table 3 in ""Results"" section) is:

###Answer: yes
---
###Answer: table-wrap table-wrap-vertical table-wrap-full table-wrap-small table tb-data tb-label tb-attribution tb-data-source ""contrast to noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal C
---
###Answer: true
---
###Answer: table: 1706-T2w-Sag-Spine-CNR-WB-01.yml
---
yaml-2014-short-bore-MR-scanner-vs-open-MR-scanner-CNR:
    interventions:
      - short-bore-MR-scanner
        mean: ""23.0""
        standard_deviation: ""5.1""

---
###Answer: table-wrap table-wrap-body thead tr th, tbody tds, thead tr th, tbody tds-wrap .table-wrap table tr th, td,.table-wrap table tr.even, td,.table-wrap tfoot tr th, td,.table-wrap .row-fl
---
###Answer: yaml
---
###Answer: file_contour_sharpness_mr_spine.csv
---
###Answer: table, Intervention: short-bore MR scanner, Comparator: high-field horizontal open MR scanner, Outcome: contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebr
---
###Answer: <p>x</p>
---
",True
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,-0.0373,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,[],"###Answer: 4 examples
---
###Answer: 12 months
---
###Answer: table-wrap table-wrap-key-value-pair table-wrap-title=""Multi-component physical activity"" table-wrap-value=""Combining aerobic and strength-based exercises may improve body composition outcomes in children and adolescents relative to usual physical education and sport programmes within
---
",True
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: true
---
###Answer: <p>Intervention: etoricoxib 90 mg once dailyComparator: placeboOutcome: Patient global assessment of pain 0 1 2</p>
###Answer: yes
---
###Answer: true
---
<div>Tolerability: Based on the data presented in Table 2, the mean patient global assessment of pain for etoricoxib 90 mg was -9.93 (standard deviation 2.78) and for placebo was -6.90 (-4.89, -9
---
11.4,5.9,357,1
---
###Answer:
---
",True
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"###Answer: table: 209C102E9367E968EA604D21

###Answer: yes
---
###Answer: <p>Intervention: Vitamin D plus calcium supplementation Comparator: Placebo Outcome: Lipid profile: HDL-c Mean: x.x (SD: x.x) Group size: 79 / 86</p>
---
###Answer: table: mean: 8.0, standard_deviation: 1.9, group_size: 50
---

intervention:
  mean: 7.8
  standard_deviation: 9.3
  group_size: 12
comparator:
  mean: 7.8
  standard_deviation: 9.3
  group_size: 12

---
###Answer: table, reference-card, outcome:LIPID_PROFILE-HDL: Intervention: Vitamin D plus calcium supplementation, Comparator: Placebo, Timepoint: end; format: YAML
---
",True
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,-0.6721,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"Intervention:
    mean: 60
    standard_deviation: 3.6
    group_size: 4
comparator:
    mean: 60
    standard_deviation: 3.6
    group_size: 4
Outcome:
    mean: 51
---
###Answer: true
---

Intervention:
  - mean: 6050
  - standard_deviation: 175
  - group_size: 19
Comparator:
  - mean: 5475
  - standard_deviation: 176
  - group_size: 
---
###Answer: type: text  data: Intervention: 200 mg/day palmvitee smokers, Comparator: 200 mg/day palmvitee nonsmokers, Outcome: The percentage of NK cells percentage: ""15.3%"" data
---
### Answer: 200 mg/day palmvitee smokers                                  mean: 0.00288272, standard_deviation: 0.00095637, group_size: 10 200 mg/day palmv
---
###Answer: intervention.outcomes.mean: 78.8, intervention.outcomes.sd: 8.7, intervention.outcomes.group_size: 30, comparator.outcomes.mean: 86.4, comparator.outcomes.sd: 41
---
###Answer: <p>table-wrap table-wrap tr table-wrap th style=""font-family: Times New Roman, Times, serif; margin: 0 0 8pt"">Intervention: 200 mg/day palmvitee smokers</th> table-wrap th style=""
---
###Answer: yes
---
###Answer: type: text
---

intervention:
    percentage_of_NK_cells: ""x""
comparator:
    percentage_of_NK_cells: ""x""

---

intervention:
    mean: 71.94
    standard_deviation: 11.20
    group_size: 30
comparator:
    mean: 77.17
    standard_deviation: 15.15
    group_size: 
---
###Answer: type: integer, minimum: 1, maximum: 100, example: 81, description: a.n., precision: 1, format: fixed
---
###Answer: table
---
",True
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,10.5566479,1.29829148,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,[],"intervention: 
    answer: ""y"",
    yaml: | 
        mean: 96
        standard_deviation: 5
        group_size: 23
comparator:
    answer: ""n"",
    yaml: | 
        mean: 63
       
---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome phlebotomy training programme, phlebotomy questionnaire score: CDC D, 10, 7
---
###Answer:
---
###Answer: ""x""
---
###Answer: <p>intervention: mean: 96.4816128, standard_deviation: 5.8154096, group_size: 35</p> <p>comparator: mean: 63.2238095,
---
",True
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,[],"###Answer: yaml
---

###Answer: type: application/x-yaml
---

Intervention:
    tskin_of_the_head: 0.0004600000000000000000000000000
    standard_deviation: 0.0001600000
---
",True
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,0.5651889,0.11007363,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"pioglitazone, placebo: 
total cholesterol:
- mean:338.90, standard_deviation:38.18, group_size:16
- mean:346.55, standard_deviation:36.44, group_size
---
###Answer: 72.73627273627363, 8.055555555555557
---
<table>
<td>mean : <table>
<td>standard_deviation : <table>
<td>group_size : <table>
<td>x : <table>
</td>
</td>
</td>
</tr>
<tr>
<td>x :
---
###Answer: table of mean outcome and standard deviation in yaml format for the intervention, comparator, and outcome
---
###Answer: true
---


###Answer: plain: ! important; /* style=""font-family: Times New Roman, Times, serif"" alink="""">Intervention: pioglitazone</p>Comparator: placebo</p><p>Group Size: 16. 13. 23</p><p
---
",True
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,0.6791,0.2644,,,,,,TRUE,13404,7477,TEST,[],"artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC, anterior cervical corpectomy and fusion (ACCF) time before  eating 1.0 (0.6, 1.4) 5x4 0.3 (0.
---

Intervention:
    time_before_eating: 1.0 (x)
Comparator:
    time_before_eating: 3.4 (4/12)
---

intervention:
  time_before_eating: x
comparator:
  time_before_eating: x
###Answer: YES
---

intervention:
  - mean: 1.38
  - standard_deviation: 0.58
  - group_size: 99
comparator:
  - mean: 1.38
  - standard_deviation: 0.58
  - group_size
---
intervention:
  - mean: 2.3
  - standard_deviation: 0.9
  - group_size: 100
comparator:
  - mean: 4.1
  - standard_deviation: 1.4
  - group_size: 50
---
intervention: x
---
",True
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,11.7163546,2.42121609,,,,,,TRUE,4260,2410,TEST,[],"Intervention: <p>x</p>Comparator: <p>x</p>Outcome: <p>mean: 10.24, standard_deviation: 0.77, group_size: 16</p>
---
###Answer: table
---
###Answer: [Table: mean evaluation scores between groups]
---
",True
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,-0.3222,0.0614,,,,,Mean daily fiber intake,TRUE,6184,3742,TEST,[],"###Answer: <p>yalm: StudyID: https://doi.org/10.1016/j.nut.2016.07.013; studyDate: 2016-07; studyDesign: Randomized Controlled Trial
---

###Answer: table wrap start:
  - Comparator: 
    - mean: ""48.4"" 
    - standard_deviation: ""24.1"" 
    - group_size: ""30"" 
  - Intervention: 
    - mean: ""
---

# Digestion-resistant maltodextrin supplementation vs. placebo on bowel function: results from a 4-week, randomized, double-blind, parallel-group study in Japanese volunteers.
# Sano M, Hayami M, Hiroshige M, Tak
---
",True
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,[],"###Answer: 0.244 x
---
###Answer: <p>Intervention: <p>mean: 0.899999999598043, standard_deviation: 0.0564987988103736, group_size: 33</p>Com
---
The table of mean outcomes with standard deviation with group sizes for the intervention and comparator are:
Intervention: mean: -1.4, standard_deviation: 0.6, group_size: 28
Comparator: mean: none, standard_deviation: none, group_size: none

---
###Answer: 0.968 x 0.66
---
###Answer: ""x""
---
",True
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,76.1,8.91,76.77,8.76,-0.0748,0.0667,,,,,found in table,TRUE,1359,1043,TEST,[],"
intervention:
  - mean: x
  - standard_deviation: x
  - group_size: 60
comparator:
  - mean: x
  - standard_deviation: x
  - group_size: 60
",False
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,cannot calculate,cannot calculate,,,,,Used preoperative values. SD is not given.,FALSE,9291,4535,TEST,[],"
Intervention: Septoplasty
Comparator: Control
Outcome: Total nasal resistance

Intervention:
  - mean: 0.91
  - standard_deviation: 0.33
  - group_size: 33
Comparator:
  - mean: 0
---
###Answer: 0.42 (0.32–0.76); 0.27 (0.23–0.34);
---
###Answer: yaml
---
###Answer: table-wrap table-wrap-start table-wrap-end table-wrap-heading Intervention Comparator Outcome table-wrap-col col=""mean"" col=""standard_deviation"" col=""group_size"" col=""mean"" col=""standard_deviation"" col=""group_size"" align=""
---
",True
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,2.7597,0.1301,,,,,found in text,TRUE,1359,1043,TEST,[],"
###Answer: 16 people",False
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,0.25003828,0.04580977,,,,,,TRUE,9725,6231,TEST,[],"height: 0.4 m
---
###Answer: 2020-05-13T16:57:10.461377175+00:00 intervention { mean: 1.644328067, standard_deviation: 0.1881
---
###Answer: tableish: yaml, table: { ""intervention"":[ { ""mean"":2.6295, ""standard_deviation"":0.5375, ""group_size"":44 }, { ""mean"":2.6345, ""standard_deviation"":0.5
---
###Answer: yaml
---
###Answer: true
---
###Answer: table {
  ""intervention"": {
    ""mean"": 1.64,
    ""standard_deviation"": 0.12,
    ""group_size"": 39
  },
  ""comparator"": {
    ""mean"": 1.51,

---
",True
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,cannot calculate,cannot calculate,,,,,Only the mean change was found in text.,FALSE,4361,3649,TEST,[],"###Answer: tabular.yaml
---

###Answer: yes
---
###Answer: table-wrap table-wrap-before-caption Table of mean outcome and standard deviation for intervention and comparator. table-wrap table-wrap-after-caption. intervention comparator outcome x x Hea failure-related quality of life at the end of treatment 57 45 x x Mean age 
---
Intervention: &YAML;mean:51\.\ 9,&YAML;standard_deviation:10\.\ 4 ;&YAML;group_size:24Comparator:&YAML;mean:41\.\ 9,&YAML;standard_deviation:9\.\
---
",True
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,0.14381908,0.07569371,,,,,found in table 2,TRUE,6682,5735,TEST,[],"###Answer: ~~> TABLE OF CONTENTS :: 1. Iodine
###Answer: ~~> TITLE: Effect of prenatal iodine supplementation on neurodevelopment at 18 months: a randomised controlled trial - Pijuan-Martinez A et al

---
###Answer: type: application/x-yaml  - title: Iodine in Pregnancy: The SIPPED study  - description: 1. 1. iodine (150 micrograms/day): The mean motor score on the Bayley-III at 18 months of age
---
###Answer: 93.912.2, 1.4, 27
---

intervention:
    mean: 9
    standard_deviation: 1
    group_size: 60
comparator:
    mean: 9
    standard_deviation: 1
    group_size: 60

###Answer: yes
---
###Answer: table-wrap table-wrap table-wrap-title Intervention mean (SD) in the itembap_text: ""The mean motor score on the Bayley-III"" was 7.2 (1.4) in the iodine group and 7.4 (1.4) in the
---
intervention:
  mean: X
  standard_deviation: X
  group_size: 46
comparator:
  mean: X
  standard_deviation: X
  group_size: 46

---
",True
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,[],"###Answer: application of a canola phenolic acid-based cream (CPA) x.
---

---
",True
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,[],"###Answer: yaml
---
###Answer: group_size: 212
Intervention: completed_treatment: 68
Comparator: completed_treatment: 70
---
###Answer: tableofmeanoutcomeandstandarddeviation: 0.33964 x 0.33964
---
###Answer: table of mean outcome and standard deviation in YAML format: 3.0, 2.4. Number of patients (total size) for Intervention and Comparator are 453 and 451 respectively
---
###Answer: 8 <p>Intervention, Comparator, and Outcome: Artemether-Lumefantrine Treatment Adherence</p>
---
###Answer: 60.6 (21.2)
---
###Answer: yes
---
",True
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,-0.2644318,0.1561066,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,[],"
intervention:
    mean: 1.80
    standard_deviation: 0.40
    group_size: 59
comparator:
    mean: 1.88
    standard_deviation: 0.42
    group_size: 110

---
###Answer: <p>Intervention: provider, Comparator: control, Outcome: the proportion of patients who tested positive and received (or were prescribed) an ACT</p>
---

intervention:
  table:
  - key: intervention
    values:
      - type: numeric
        primary: mean
        description: Mean proportion of patients who tested positive and received (or were prescribed) an ACT in the intervention group.
        units: percentage
      - type: numeric

---
###Answer: <p>intervention: mean: 0.997471036X, standard_deviation: 0.081104625X, group_size: 732.87496527X comparator: mean: 0
---

intervention:
    table:
        rows:
            - intervention
                column: mean
                    value: 0.56
                column: standard_deviation
                    value: 0.04
                column: group_size: 25
            - comparator
                column:
---
###Answer: {""answer"": {""group_size"": 42, ""mean"": 0.17999999999999998, ""outcome"": true, ""standard_deviation"": 0.055886715794150
---
###Answer: mean: 0.85, standard_deviation: 0.11, group_size: 1265; mean: 0.54, standard_deviation: 0.09, group_size: 1265
---
",True
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: yaml
---
###Answer: 64.0, 21.6, 457
---
###Answer: true
---
tolerability:
---

intervention:
    ACR20_responder_criteria: x
comparator:
    ACR20_responder_criteria: x
###Answer: false
---
###Answer: yaml
---
",True
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,[],InterventionComparatorOutcomemean0.97 0.99group_size10 10standard_deviation0.05 0.02,False
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: 20050737.1000; 93537.9543; 169
---
###Answer: <p>intervention: mean: 2.70, standard_deviation: 0.65, group_size: 133</p>
---
###Answer: table-data: 10; type: int; x: 1; value: 58.7; unit: none; description: mean; title: Investigator Global Assessment Tender Joint Count, 12-Week mean (95% CI) in Patients Receiving Etor
---
<table><thead><tr><th>Intervention</th><th>Comparator</th><th>Outcome</th></tr></thead><tbody><tr><td>mean: 1.23</td><td>mean: 2.00</td><td>mean: 1.23</
---

---
###Answer: table-wrap table-wrap-start table-wrap-end table-wrap-separator style=""margin: 0; list-style: disc; padding-left: 32px; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold
---
",True
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,[],"###Answer: <p><strong>Consumption of fentanyl:</strong>mean: 2.9068129418344, standard_deviation: 0.54008838175563, group_size: 38</
---
###Answer: type: yaml
---
intervention: mean: 1.186014103, standard_deviation: 3.952849783, group_size: 38
comparator: mean: 0.2874712
---
",True
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,-0.0166581,0.06666898,,,,,,TRUE,3046,2156,TEST,[],"###Answer: [ Collagen hemostatic sponge : 194.48 x 1.70 = 317.60, Gelatin sponge : 267.52 x 1.49 = 388.11, 32 participants and 
---
###Answer: type: tabular answer: yes
---
",True
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,20.6573,0.2121,,,,,Added intermittent and continuous numbers from study site,TRUE,15527,8380,TEST,[],"intervention:
    mean: 4.0
    standard_deviation: 3.4
    group_size: 45
comparator:
    mean: 1.2
    standard_deviation: 4.3
    group_size: 15

---

Restraint frequency: 13.63, 8.50
Intervention: After restraint reduction program
Comparator: Before restraint reduction program
---
###Answer: table[ title: ""Restraint Frequency"", style: ""width: 80%"", cells: [ tableline: ""| | | | | | | || Outcome: Intervention, N = 396 Comparator, N = 400 Mean | | | Intervention | 39
---
###Answer: yaml
---
###Answer: true
---
###Answer: true
---
###Answer: yaml
---
###Answer: true
---
",True
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,-0.0856,0.0667,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"
intervention:
    mean: 81
    standard_deviation: 8
    group_size: 10
comparator:
    mean: 81
    standard_deviation: 8
    group_size: 10

###Answer: yes
---
###Answer: true
---
###Answer: true
---
###Answer: ok
---
###Answer: <p>Intervention: 200 mg/day palmvitee smokers; Comparator: baseline; Outcome: The percentage of B cells</p>
---
###Answer: 65.1469, 39.35437, 30
---
###Answer: <p>table: <p><table><thead><tr><th>Cell Type<hr/></th><th>Blood T cells (Th%)<hr/></th><th>Blood T cells (Th) % Change<hr/></th><th>Blood CD4+
---
###Answer: 5. 39.83, 7.76 {Ref: Harrison 19th edition, Table 205-3; Text from previous question, Intervention and Comparator}
---
###Answer: <p>intervention: mean: 62.76, standard_deviation: 7.54, group_size: 56; comparator: mean: 11.13, standard_deviation: 4.09, group_size: 58; outcome
---
###Answer: results;table;intervention;comparator;outcome;The percentage of B cells:
""mean"": 45.70669096712576,
""standard_deviation"": 16.0682685922532
---

intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""

---
###Answer: true
---
### Answer: 200 mg/day palmvitee smokers
---
",True
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,0.1496389,0.10848973,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,[],"###Answer: 10-week yoga program: 10-week yoga program [mean: 4.67, standard_deviation: 0.9354, group_size: 18]Control: 10-week yoga program [mean: 4.67,
---
###Answer: true
---
The following is a YAML file:
Intervention:
  mean: 26
  standard_deviation: 10
  group_size: 29
Comparator:
  mean: 25
  standard_deviation: 9
  group_size: 30
Outcome
---
###Answer: true
---

intervention:
    table: 

  - [
    ""mean"": 50
    ""standard_deviation"": 6
    ""group_size"": 15
    -
    ""mean"": 40
    ""standard_deviation"": 6
    ""group_size"":
---
###Answer: 10.63491178, 8.48718472, 20
---
",True
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,[],"
Intervention: 
  - metformin 1,000 mg daily:
Cox proportional hazards of failure-free survival:
  - Hazard ratio: 0.28 [0.10, 0.81] (x)
  - Group size: 1
---
###Answer: true
---
###Answer:  table-cell-type=""td"" table-colspan=""2"" style=""text-align: center"">Time to event (months): 6.376 (5.112, 7.641)
###Answer: 553
---
###Answer: intervention: mean: ""x""
comparator: mean: ""x""
---
###Answer: table 'mean' value=""7.30471379769273e-01"" label=""Mean Difference: log-rank p-value=0.11646"" table=""statistics:chisquared"" doctitle=""Cox proportional
---
",True
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,-0.2681458,0.01855223,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,[],"
Intervention: {
  ""mean"": 11.3,
  ""standard_deviation"": 3.6,
  ""group_size"": 114
},
Comparator: {
  ""mean"": 10.7,
  ""standard_deviation"": 3.1
---
intervention: mean=4.81, standard_deviation=0.88, group_size=55
comparator: mean=4.60, standard_deviation=0.75, group_size=54
###Answer: yes
---

 intervention:
 mean: 33
 standard_deviation: 7.3
 group_size: 13
 comparator:
 mean: 29.1
 standard_deviation: 5.8
 group_size: 205

###Answer: yes
---

intervention:
    mean: 10
    standard_deviation: 0
    group_size: 10
comparator:
    mean: 10.2
    standard_deviation: 0.6
    group_size: 10

###Answer: yes
---
###Answer:
intervention:
  mean: 81.38
  standard_deviation: 10.90
  group_size: 107
comparator:
  mean: 83.08
  standard_deviation: 9.52
  group
---
###Answer: type: table       name: table-name             Description: <p>Listing of standards for tables.</p>       content: type: text       # ICD-10 codes: <p>Listing of ICD-10 codes.</p>       content: type: text       # MRC scale:
---
###Answer: type: application/x-yaml
---
###Answer: table of mean outcome and standard deviation in yaml format for Get Healthy, Stay Healthy' (GHSH) intervention, control, and walking as outcome
---
",True
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,2.6102,0.1234,,,,,found in text,TRUE,1359,1043,TEST,[],"The table of mean outcome and standard deviation in YAML format is as follows:
intervention:
  - mean: 621.67
  - standard_deviation: 46.76
  - group_size: 30
comparator:
  - mean: 556.",False
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,[],"###Answer: 1.1 [x]
---
0.66 0.17
---

balance: 8.72, 95% CI [0.49, 2.65], d = 0.66
relaxation: 8.72, 95% CI [0.49, 2.65], d = 0.66
---
###Answer: true
---
",True
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,cannot calculate,cannot calculate,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,3838,2633,TEST,[],"###Answer: yaml
---

intervention:
  mean: 2.9
  standard_deviation: 2.0
  group_size: 57
comparator:
  mean: 2.8
  standard_deviation: 2.0
  group_size: 55

###Answer:
---
The table below includes the requested data in YAML format.
---
",True
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,[],"###Answer: <p>Table of mean outcome and standard deviation in YAML format for the intervention, comparator, and outcome ""hypoglycemia"".</p>intervention:
x-outcome: hypoglycemia
comparator:
    mean: 1.00
    standard_",False
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,2.38845924,0.03496107,,,,,,TRUE,9086,4934,TEST,[],"
###Answer: true
---
###Answer: table-wrap table=""table-1"" style=""font-family: Times New Roman, Times, serif"">
---

###Answer: yaml
---
###Answer: 78.5
---
###Answer: table-wrap table-wrap table-wrap-header col { width: 100%; } th, td { padding: 0px; border: 0px; border-collapse: collapse; text-align: left; font-family: Verdana, Arial, Helvetica, sans-ser
---
",True
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,5.6842,0.3475,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,[],"
---
Intervention:
    mean: 64.99
    standard_deviation: 7.87
    group_size: 24
comparator:
    mean: 60.05
    standard_deviation: 6.39
    group_size: 30

---
###Answer: true
---
###Answer: OK
---
### Answer: 200 mg/day palmvitee nonsmokers: 3.4260003721689, 0.398115583931592; 2.955999709
---
###Answer: 4 columns: <p>intervention, comparator, outcome, reason</p>
---
###Answer: <p>mean: 0.457647, standard_deviation: 0.214146, group_size: 33</p>
---
###Answer: 18.49 x 76.6 mg/dl
---
###Answer: > intervention:
  mean: 100
  standard_deviation: 20
  group_size: 56
> comparator:
  mean: 100
  standard_deviation: 20
  group_size: 58
> outcome
---
###Answer: <p>intervention: mean: 1.95 x 10E-08 x 29 = 5.938346 x 10E-09, standard_deviation: 6.37 x 10E-26 x 29
---

intervention:
  mean: 6.31
  standard_deviation: 1.05
  group_size: 78
comparator:
  mean: 6.82
  standard_deviation: 1.42
  group_size: 28

---
[Intervention: 200 mg/day palmvitee nonsmokers]
---
This table represents the mean outcomes with standard deviation for each group of the given Intervention and Comparator for the YAML format.
###Answer: TRUE
---
",True
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,1.7938,0.1338,,,,,,TRUE,4037,2288,TEST,[],"###Answer: table <p><img alt="""" src="" /></p>
---

intervention:
    mean: 4.2
    standard_deviation: 1.2
    group_size: 100
comparator:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 20

---
",True
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,0.0175,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,[],"fruit intake: x
---
fruit intake means (mean (M)).
- Basic (control): M=3.46, SD=1.32, N=434
- Plus: M=3.08, SD=1.72, N=459
- Basic (control): M=3.08,
---
Intervention:
  - mean: ""3.32""
  - standard_deviation: ""0.07""
  - group_size: ""1163""
Comparator:
  - mean: ""3.23""
  - standard_deviation: ""0.11""
---
###Answer: type: table-wrap title: Mean outcome and standard deviation for the outcome in original YAML format based on the given trial article, Intervention, Comparator, and Outcome: !importantIntervention: type: table-wrap title: meanIntervention: type: table-wrap title: s.d.Intervention
---
intervention:
  - mean: 1.04
  - standard_deviation: 0.03
  - group_size: 803
comparator:
  - mean: 1.04
  - standard_deviation: 0.03
  - group_size
---
###Answer: type: yaml-table-example name: 'tables.98765.yaml' > intervention: mean: ""0.60"", standard_deviation: ""0.1048"", group_size: ""779"" compare: comparator: mean: ""–1.
---

Intervention:
  mean: 0.00
  standard_deviation: 0.08
  group_size: 519
Comparator:
  mean: 0.00
  standard_deviation: 0.01
  group_size: 160
---
",True
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,0.69457406,0.04572916,,,,,,TRUE,17694,9686,TEST,[],"###Answer: 32.60471983, 22.89115293, 93
---
###Rationale: scanning times: 10 minutes (range 3-18 minutes) 
15 minutes (range 7-30 minutes) 
P = .004 
10.1371/journal.pone.0083427.t0
---
###Answer: 5.26 x
---
high-field horizontal open MR scanner: x; short-bore MR scanner: NUMBER; scanning times: mean; 4.7; 16; 8.4
---
###Answer: table <p>Intervention: open MR scanner Comparator: short-bore MR scanner Outcome: Scanning times Mean (s): 227.43 SD (s): 43.26 Range: 169 - 266 Group size: 40</
---
###Answer: yaml
---
###Answer: true
---
###Answer: |

###Answer: yes
---
###Answer: table: 3.13.11-4443-a04c36ff334930 ; value: 13.13787681 ; type: yaml
---
###Answer: type: text; answers: [ '149.3 (35.0)', '97.7 (109.8)', '95' ]; explanations: []
---
",True
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,[],"###Answer: table <p>intervention: mean: 0.53, standard_deviation: 0.15, group_size: 59<p>comparator: mean: x, standard_deviation: x, group_size: 60</p>
---
###Answer: intervention: &quot;mean&quot;: 7.45, &quot;standard_deviation&quot;: 2.38, &quot;group_size&quot;: 70 comparator: &quot;mean&quot;: 3.24, &quot
---
###Answer: <p><table class=""table table-bordered"" align=""center"" cellspacing=""4"" style=""width: 100%; margin-bottom: 0px; border: 1px solid transparent"">
  <tr><td class=""table-header"">Intervention</td></tr>
---
###Answer: table kind=""statistics"" xref=""citebook"" header=""Intervention, Comparator, and Outcome"" title=""Mean outcome with standard deviation"" xpos=""right"" align=""center"" valign=""bottom"">
<col style=""width: 80px"" />
<col style=""width
---
",True
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data is not given.,FALSE,2318,1990,TEST,[],"###Answer: 0.01
---
###Answer: 74.29877537109375, 10.484774278319285, 26
---
",True
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,-19.6737,0.1927,,,,,Overall continuous restraint rate for study site.,TRUE,15527,8380,TEST,[],"intervention:
    mean: 62.9
    standard_deviation: 17.4
    group_size: 54
comparator:
    mean: 62.9
    standard_deviation: 17.4
    group_size: 49

##
---
###Answer: type: text, response: After the restraint reduction program, the continuous restraint rate decreased from 10.8% in the pre-intervention period to 8.5% in the post-intervention period.
---
###Answer: table-response-44482054
---
###Answer: table-wrap table-wrap-key-value-pairs table-wrap-table-group name=""table-wrap"" key=""Intervention"" value=""mean"">
  <colgroup>
  <col style=""width:10%"">
  <col style=""width:20%"">

---
###Answer: type: application/x-yaml
---
###Answer: true
---
###Answer: okay
---
###Answer: true
---
",True
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: 1 PROBLEM
![data_answer: 1 PROBLEM](/storage/da/928772b0-67f8-4002-9124-8463ba8c03d0/image.png)
---
###Answer: 2.7 (x), 1.0, 357
---
###Answer: table of mean outcome and standard deviation in YAML format for the intervention and comparator of investigator global assessment of disease activity:
---
###Answer: tolerability:
---
###Answer: <p>Intervention: etoricoxib 90 mg once daily   Comparator: naproxen 500 mg twice daily   Outcome: investigator global assessment of disease activity   Result: [{""mean"":2.2,""standard_deviation
---
###Answer: 2016-09-16 23:32:49 -0700

###Answer: yes
---
",True
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,0.3286,0.2534,,,,,,TRUE,13404,7477,TEST,[],"For the outcome of recovery time, please estimate the time to a specific activity. If there is no specific activity, please estimate the time from surgery to the time when the patient can return to normal life/modus vivendi such as going to school, returning to work, and resuming household duties. If there is no specific activity or daily
---

intervention:
  - mean: 3.5
  - standard_deviation: 2.3
  - group_size: 14
comparator:
  - mean: 4.5
  - standard_deviation: 2.3
  - group_size: 14
---
###Answer: table<ul>      <li>mean: 11.2</li>      <li>standard_deviation: 1.3</li>      <li>group_size: 8</li>    </ul>
---
intervention:
    recovery_time: x
comparator:
    recovery_time: x
---
intervention:
    yaml: ! code
    - name: ACVC-HAA
    - mean: ""x""
    - standard_deviation: ""x""
    - group_size: 37
    - si: ROM LB -0.79 +- 0.07
---

intervention:
    recovery_time: 0.240 x NUMBER
comparator:
    recovery_time: 0.333 x NUMBER

---
",True
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"[[
""mean"": 25,
""standard_deviation"": 3
""group_size"": 165
]]>
---
###Answer: vitamin-d-plus-calcium-supplementation-1: 25-oh-vitamin-d-study-878.p.2.yaml
###Answer: true
---
###Answer: table: <p>2007399</p>
---

intervention:
    response: x
comparator:
    response: x

---
###Answer: yaml
---
",True
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,0.1472,0.1055,,,,,used post values and Treatment as Usual as Baseline,TRUE,7353,5561,TEST,[],"
###Answer: intervention:
    reason: Reasoning was performed better after FAT.
    mccb: 1.42
###Answer: comparator:
    reason: No reason, no change after training.
    mccb: 1.42
###Answer: outcome
---

facial_affect_training: mean: 0.5, standard_deviation: 1.25, group_size: 10
facial_affect_training: mean: 0.75, standard_deviation: 1.08, group_size: 10

---
Intervention: facial affect training (FAT) in 20 daily 1-hour sessions
Comparator: baseline
Outcome: MCCB performance : Reasoning
mean : 36.0
standard_deviation : 6.5
group_size : 17
mean : 6
---
###Answer: table-wrap:

###Answer: true
---
",True
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,-0.9171,0.1474,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"
intervention:
    yaml:
      - mean: 1
      - standard_deviation: 0.71
      - group_size: 10
      - response: x
comparator:
    yaml:
      - mean: 0
      - standard_deviation: 
---

intervention:
  - reduction in burning sensation:
    mean: ""34.2""
    standard_deviation: ""7.3""
    group_size: ""20""
comparator:
  - reduction in burning sensation:
    mean: ""37.4""
   
---
",True
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,0.0246,0.052,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,[],"###Answer: table. (results-health-impact.csv:629)
---

intervention:
  mean: 59%
  standard_deviation: 14%
  group_size: 556
comparator:
  mean: 58%
  standard_deviation: 14%
  group_size: 515

---
###Answer: table: mean: 0.881258684719222, standard_deviation: 0.2736272103755922, group_size: 59
---
###Answer: table: mean-1.1, standard_deviation-0.4, group_size-453
---
###Answer: table-wrap table-wrap table-wrap:raw_text interpretation-result interpretation-result interpretation-result text: ""The completion rate of doses according to guidelines was 73.5% in the intervention arm and 78.4% in the control arm; the adjusted prevalence
---
###Answer: table-wrap table-wrap table-wrap-table tr td, table-wrap table-wrap table-wrap-table th, table-wrap table-wrap table-wrap-table .kind:not(""comparator""):not(""outcome""):not(""intervention""):not(""control""):not(""
---
###Answer: {
    ""mean"": 69.8,
    ""standard_deviation"": 20.9,
    ""group_size"": 37
  }
---
",True
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,2.5595,0.1734,,,,,,TRUE,4037,2288,TEST,[],"###Answer: <p> intervention: mean: 1.54077531 x, standard_deviation: 1.12938876 x, group_size: 22 group: Comparator: mean: 0.96249414 x,
---

---
",True
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,[],"###Answer: 2013.61470429980387, 0.2413738214648131, 14
---
###Answer: <p> intervention: mean: 4.84, standard_deviation: 0.67, group_size: 653 comparator: mean: 4.82, standard_deviation: 0.62, group_size: 538 </p>
---
###Answer: true
---
###Answer: type: csv-tabs table: <p>The total cultivable microbiota (CFU)</p> columns: <p>mean, standard_deviation, group_size</p> title: <p>intervention</p> href: <p>http://links.lww.com/
---
###Answer: table
---
###Answer: 1 table
---
",True
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,[],"1500 mg calcium:x
500 mg calcium:x

###Answer: YES
---

intervention:
    mean: 6.6
    standard_deviation: 2.4
    group_size: 28
comparator:
    mean: 4.4
    standard_deviation: 2.3
    group_size: 24

###Answer:
---
###Answer: 1500 mg calcium: 105.21 ± 11.93; n=18 500 mg calcium: 94.05 ± 17.14; n=16
---

---
<h3>Table 1. Weight loss from baseline to end of study for both intervention and comparator groups.</h3><table><thead><tr><th>Group</th><th>Mean weight loss (lb)</th><th>Standard deviation (lb)</th></tr><tr><td>
---
###Answer: 1500 mg calcium and 500 mg calcium:
---

---
",True
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,-0.2496,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,[],"facial affect training (FAT) in 20 daily 1-hour sessions produced significant improvement in multiple measures of MCCB performance. Mean outcome with SD in YAML format for FAT :
Intervention: facial affect training (FAT) in 20 daily 1-hour sessions
Comparator: baseline
---

Intervention: facial affect training (FAT) in 20 daily 1-hour sessions, 20 patients, 5 male
Comparator: baseline, 20 patients, 5 male
Outcome: MCCB performance : Attentional Vigilance

mean: 39.
---
facial_affect_training_research_project:
    intervention:
      - name: facial_affect_training
      - description: The effect of a psychopharmacological treatment with haloperidol in schizophrenia patients on attentional vigilance.
    comparator:
---
Intervention: facial affect training (FAT) in 20 daily 1-hour sessions. The standard deviation for the FAT group is 14.2. There are 21 subjects in the FAT group.Comparator: baseline. The standard deviation for the baseline group is not able to be extracted.
---
",True
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,[],"
###Answer: intervention: mean: 5.22, standard_deviation: 4.97, group_size: 18; comparator: mean: 5.23, standard_deviation: 5.19, group_size: 18.
---
###Answer: yaml
---
###Answer: yaml
---
",True
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,0.0364,0.0149,,,,,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,[],"###Answer: {
      ""intervention"": {
          ""mean"": 9.23,
          ""standard_deviation"": 4.82,
          ""group_size"": 26
      },
      ""comparator"": {
          ""mean"": 9.44,
         
---
###Answer: 0.016
---
1 mg/day of Pls purified from scallop: <p>8.03 (1.05)</p>
---
pls-purified-intervention-mean: 0.69
pls-purified-intervention-standard_deviation: 0.09
pls-purified-intervention-group_size: 60
pls-placebo-mean: 0.37
pls
---
###Answer: yaml
---
###Answer: 1 mg/day of Pls purified from scallop reduced the baseline MMSE-J score [Reference: Article: <a href="" supplemental materials</a>].
---
###Answer: type: application/x-yaml
---
1 mg/day of Pls purified from scallop (1M-Pls):
  - mean: 1.30
  - standard_deviation: 0.14
  - group_size: 77
Placebo (Pls):
  - mean: 1.19
---
###Answer: Plasma PE

###Answer: yes
---
###Answer: yaml
---
",True
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,[],"<p>intervention: mean: x, standard_deviation: x, group_size: 70<p>comparator: mean: x, standard_deviation: x, group_size: 76</p>",False
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,cannot calculate,cannot calculate,,,,,No std given,FALSE,1302,1180,TEST,[],"
###Answer: tabular-wrap table; padding-top: 8px; margin: 0px; border: none; border-collapse: collapse; font-family: Times New Roman, Times, serif; font-weight: bold; text-decoration: underline; font-size: 10px",False
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,-0.2368,0.106,,,,,used post values and Treatment as Usual as Baseline,TRUE,7351,5561,TEST,[],"14.88, 2.48, 10
---

facial_affect_training:
    mean: -0.23
    standard_deviation: 1.00
    group_size: 38
comparator:
    mean: NA
    standard_deviation: NA
    group_size: NA
mccb:
   
---
Facial Affect Training in Schizophrenia: A Randomized Trial
---
facial_affect_training_trial.yaml

###Answer: yes
---
",True
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,-0.6224049,0.13541486,,,,,found in table 2,TRUE,9410,4699,TEST,[],"###Answer: yaml
---
###Answer: true
---
###Answer: type: numerical    value: 3.91313197784105    unit: arbitrary    description: [Intervention] mean CAL outcomes (mm).    type: numerical    value: 1.0875    unit: arbitrary    description: [Intervention
---
###Answer: table.
---
###Answer: no: 2299
---
###Answer: <p>table: 138x8x25; reduction of PPD</p>
---
",True
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,cannot calculate,cannot calculate,,,,,Numerical values in Table which is a graphic,FALSE,3178,2587,TEST,[],"
intervention:
  mean: 0.1
  standard_deviation: 0.2
  group_size: 42
comparator:
  mean: 0.1
  standard_deviation: 0.2
  group_size: 42

---
###Answer: type: text
---
",True
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 4's graphics.,FALSE,1406,1149,TEST,[],"Intervention, Comparator, and Outcome: diastolic blood pressures at 5 minutes have mean 87.14 and 72.31 (sd) for the fentanyl group (n=70) and paracetamol group (n=76), respectively.",False
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: <p>x</p>
---
Intervention: 
  mean: 7.85532677, 
  standard_deviation: 1.50171851, 
  group_size: 353,
Comparator: 
  mean: 7.916666
---
###Answer: TABLE 2: Summary of the Primary and Secondary Efficacy Endpoints at Week 12 Primary Endpoints Two-sided 95% Confidence Interval for the Difference (ETORICOXIB - PLACEBO) (mm) Secondary Endpoints Summary: Two-s
---
tolerability.yaml
---
###Answer: {
  ""outcome"": {
    ""intervention"": {
      ""mean"": 2.05835232689,
      ""standard_deviation"": 0.52354506337,
      ""group_size"": 
---
###Answer: type: yaml
""mean"": 1.0,
""standard_deviation"": 0.0,
""group_size"": 353
""mean"": 2.0,
""standard_deviation"": 0.8,
""group_size"": 181
---
",True
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"###Answer: ||
 nameget: Discontinuation due to lack of efficacy |||| 18 500 / 18 500 687 100 |||| 18 100 / 18 100 687 100 
---
###Answer: yaml
---
###Answer: table: [
  ""intervention"": [
    { ""mean"": ""2.3"", ""standard_deviation"": ""1.2"", ""group_size"": ""148"" },
    { ""mean"": ""2.3"", ""standard_deviation"": ""1.2"", ""
---
###Answer: yes
---
###Answer: yaml
---
<p>intervention: mean: 34.2, standard_deviation: 8.0, group_size: 10156</p><p>comparator: mean: x, standard_deviation: x, group_size: 10156</p>
---
",True
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,[],###Answer: 8783.484818661236,False
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,7.4,1.93,7.28,1.59,0.06679907,0.08004462,,,,,Found in abstract and results,TRUE,2609,2261,TEST,[],"
intervention:
  mean: 3.00
  standard_deviation: 1.08
  group_size: 25
comparator:
  mean: 2.92
  standard_deviation: 1.03
  group_size: 25
##
---

outcome:
  - The median best effect of size 0.5% bupivacaine with 1:200000 epinephrine in group I was found to be 0 min onset of action as compared to the mixture of 39 ml of 0.5% bup
---
",True
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,[],"
---
###Answer: <p>intervention: mean: 19.0, standard_deviation: 13.3, group_size: 353<p>comparator: mean: 20.4, standard_deviation: 13.6, group_size: 353
---
###Answer: true
---
<ul><li>measure-title: Tender Joint Count (TJC)</li><li>outcome-identifier: etoricoxib-vs-naproxen-tender-joint-count</li><li>intervention-name: etoricoxib 90 mg qdas
---
###Answer: yaml
---
###Answer: .intervention.mean: 0.808278713946677, 0.11596448617292366 intervention.standard_deviation: 0.1510716727
---
",True
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,-0.1357,0.1671,,,,,,TRUE,6951,5679,TEST,[],"right dorsolateral prefrontal cortex (DLPFC) anodal tDCS (intervention): 0.11 (0.81)
left dorsolateral prefrontal cortex (DLPFC) anodal tDCS (comparator): 0.13 (
---
intervention:
  mean: ""x""
comparator:
  mean: ""x""
###Answer: NO_MATCH
---
right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) intervention: mean: 5.17, standard_deviation: 1.43, group_size: 14 left dorsolateral prefrontal
---
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS): x
---
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS)
    mean: 6.0
    standard_deviation: 0.9
    group_size: 10
comparator:
   
---
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) : x
---
",True
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"
intervention:
  mean: 1.107
  standard_deviation: 0.203
  group_size: 21
comparator:
  mean: 1.152
  standard_deviation: 0.211
  group_size: 
---
###Answer: <p>intervention: mean: 10; standard_deviation: 2; group_size: 20<p>comparator: mean: 11; standard_deviation: 1; group_size: 10</p>
---
###Answer: table: yaml, values: [ ""intervention"" : { ""mean"" : 4.03, ""standard_deviation"" : 5.45, ""group_size"" : 40 }, ""comparator"" : { ""mean"" : 4.35, ""standard_
---
###Answer: yaml
---
###Answer: table
---
",True
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,cannot calculate,cannot calculate,,,,,combined means and stds not given,FALSE,4402,2905,TEST,[],"###Answer: table of mean outcome and standard deviation in yaml format for the intervention ""GDM2"" and comparator ""GDM1"", outcome ""LAR"" [ebase]
---
Intervention: x, x
Comparator: x, x
###Answer: INTERVENTION GROUP, COMPARATOR GROUP, LEPTIN/ADIPONECTIN RATIO (LAR) IN CORD BLOOD SERUM
---
###Answer: true
---
",True
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,0.0834,0.0834,,,,,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,[],"###Answer: 96.3443xx, 18.7262xx, 33
---
###Answer: table of mean outcome and standard deviation in YAML format for Intervention ""1 mg/day of Pls purified from scallop"", Comparator, and Outcome ""WMS-R (
---
###Answer: yaml
---
###Answer: {
  ""intervention"": {
    ""mean"": 2.238642106,
    ""standard_deviation"": 0.676251914,
    ""group_size"": 133
  },
  ""comparator
---
1 mg/day of Pls purified from scallop had a significant improvement in mean WMS-R immediate recall total score at week 28 compared to placebo (-0.59, 95%CI: -0.77 to -0.40).
---
###Answer: 0.27
---
Intervention: 1 mg/day of Pls purified from scallop
Comparator: placebo
Outcome: WMS-R (0 min): 
			mean: 10.44
			standard_deviation: 4.48
			group_size
---

---
###Answer:
---
yaml-1-4.0.3
---
",True
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,-6.7818,0.6136,,,,,found in table,TRUE,7451,3515,TEST,[],"###Answer: 3.364
---
###Answer: ok
---
###Answer: type: str, description: ""Resveratrol decreased pain scores only on day 42 but not during the first 7 days of treatment, a time when most adverse events occurred and pain scores were generally high in both groups. Resveratrol did not modify the need to use other analgesics (
---
###Answer: 5.333333333333333, 0.6666666666666667, 12
---
",True
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,-0.4149366,0.13194364,,,,,found in table 2,TRUE,9410,4699,TEST,[],"antibiotic, reduction of PPD:
  mean: -4.053611e-01
  standard_deviation: 1.464390e+00
  group_size: 14
- reduction of PPD - antibiotic - 
---
###Answer:
---
antibiotic:
  reduction of PPD:
    mean: x
    standard_deviation: x
    group_size: x
placebo:
  reduction of PPD:
    mean: x
    standard_deviation: x
    group_size: x
---
###Answer: table
---
###Answer: type: yaml
---
###Answer: reduction of PPD reduction of PPD reduction of PPD reduction of BOP
---
",True
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,0.08105953,0.10827593,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,[],"###Answer: ""mean: 16.5"", ""standard_deviation: 3.2"", ""group_size: 10"" [Intervention: mean, standard_deviation, group_size], ""mean: 23.4"", ""standard_deviation: 6.9"", ""group
---
10.1371/journal.pone.0171133.t003
---
###Answer: type: table> yaml 
    - intervention:
        mean: 10.0
        standard_deviation: 2.0
        group_size: 29
    - comparator:
        mean: 12.0
        standard_deviation:
---
###Answer: okay
---
###Answer: table 3 summary of primary and secondary outcome measures
---
###Answer: 10.00, 5.46 x 14, 17
---
",True
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,[],"intervention:
    overall_seizure_median_percent_improvement: x
comparator:
    overall_seizure_median_percent_improvement: x
###Answer: no
---
###Answer: <p>20.2</p>
---

extended-release-oxcarbazepine-2400-mg:
    overall-seizure-median-percent-improvement: 2.0 (4.4) - 308
extended-release-oxcarbazepine-2400-mg
---
###Answer: <p>0.8444444444444444</p>
---
intervention:
    x: x
comparator:
    x: x
outcome:
    overall_seizure_median_percent_improvement: 0.34
###Answer: overall seizure median percent improvement: 0.34 (0.107615
---
",True
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,[],"###Answer: yes
---
Intervention: <p>x</p>Comparator: <p>x</p>Outcome (FIQ total score): <p>mean:0.99397167; standard_deviation:12.65084754; group_size:50</p>
---
###Answer: yes
---
###Answer: table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap table-wrap: 786, 0.9449352261861982, 22 386, 0.92
---
###Answer: table: <p>Intervention: Soy shake, Comparator: Control, Outcome: Center for Epidemiologic Studies Depression Scale score</p>  - total_mean: 4.06, total_standard_deviation: 2.42, total
---
",True
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,1.5858,0.1011,,,,,Actually comparing preintervention and postintervention,TRUE,29049,17627,TEST,[],"<p>intervention: mean: 4.12, standard_deviation: 1.78, group_size: 25<p>comparator: mean: 4.38, standard_deviation: 1.56, group_size: 25</p>
---
###Answer: <p>Intervention: <p>mean: 24.445 , standard_deviation: 6.33 , group_size: 60</p>Comparator: <p>mean: 23.186 , standard_deviation: 5.38
---
###Answer: {""mean"": 5.851042424608713, ""standard_deviation"": 2.084608713947746, ""group_size"": 35}
---
###Answer: type: application/yaml
---

###Answer: intervention:
    mean: 53.4
    standard_deviation: 7.46
    group_size: 40
comparator:
    mean: 65.8
    standard_deviation: 7.56
    group_size: 
---
###Answer: text""mean"": 50.0, text""standard_deviation"": undefined, text""group_size"": 26.0
---
###Answer: table-wrap: <p>table-wrap</p>
---
###Answer: table 2 - Mind, Body, Food: A pilot study to develop and test an integrated eating behaviour intervention for adults with obesity: DATA
---

intervention:
  mean: 4
  standard_deviation: 2
  group_size: 14
comparator:
  mean: 4
  standard_deviation: 2
  group_size: 14

###Answer: yes
---
###Answer: yaml
---
###Answer: yes
---
###Answer: yes
---
###Answer: x
---
",True
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,2.50703599,0.03803123,,,,,,TRUE,9086,4934,TEST,[],"###Answer: yaml
---
###Answer: 4.824607628668561, 1.9844458170730625, 90
---
###Answer: 3.72, 0.66, 101
---
###Answer: 74.5, 19.8, 21
---

intervention:
    mean: 9299.0
    standard_deviation: 241.4
    group_size: 2695
comparator:
    mean: 9207.0
    standard_deviation: 244.0
    group
---
",True
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,-0.055,0.0788,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"intervention:
    shouldertot: x
comparator:
    shouldertot: x
---
Intervention: 1.36, 2.38, 18Comparator: 1.50, 1.52, 18Outcome: 45.19, 62.24, 18x
---
Intervention:
  - mean: 49.33, standard_deviation: 9.62, group_size: 6
Comparator:
  - mean: 44.83, standard_deviation: 5.64, group_size: 6

---
",True
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,[],"
intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: ""x""",False
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,0.3957062,0.02070251,,,,,Available in abstract and table,TRUE,9086,4934,TEST,[],"choice-group, no-label-group, healthier-product-quiz, 84.48, 34.92, 78, 480
###Answer: true
---
###Answer: 96 [OUTCOME: Correct selection of the healthier product (Total size of groups = 480 )]
---
In the cases where a study didn't use a standard deviation or a standard error for their means, we will make a note of it as part of any downstream analyses by selecting ""x"" for the missing parameter.
###Answer: OPTION A IS CORRECT.
---
###Answer: table-wrap table-wrap table-wrap="""">mean"":2.5,""standard_deviation"":1.5,""group_size"":""89""mean"":2.5,""standard_deviation"":1.5,""group_size"":""99""mean"":2.5,""standard_deviation"":
---
<table><thead>
<tr>
<th>Intervention</th>
<th>Comparator</th>
<th>Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>mean: 4.4</td>
<td>mean
---
",True
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,2.0722,0.0768,,,,,,TRUE,10658,5810,TEST,[],"###Answer: okay
---
###Answer: table-wrap table-pretty-print table-sortable=""table-sortable"" style=""-webkit-font-smoothing: antialiased; border-collapse: collapse; cursor: pointer; touch-action: none; table-layout: fixed;"" width=""100%"" height=""60
---
###Answer: <p>Intervention: Vitamin D supplementation Comparator: Control Outcome: Vitamin D levels Change in vitamin D levels from baseline to the end of the six week supplementation was assessed. Vitamin D levels increased significantly from baseline to four weeks and six weeks in both intervention and
---
###Answer: table_inline_svg: src=""data:image/svg+xml;base64,PD94bWwgdmVyc2lnaWFuIGl0dGluZ00gZmFpbmluZy1zb25maWdvaW5nIG
---
###Answer: vitamin d study yaml
---
###Answer: intervention: mean: 30.0, standard_deviation: 7.4, group_size: 30, comparator: mean: 15.0, standard_deviation: 4.5, group_size: 30, outcome: Vitamin D levels.
---
###Answer: table
---
",True
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,0.6551,0.1056,,,,,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,[],"###Answer: 167 12 33.95 0.012 167 13.16 167
---
### Answer: 24 weeks
---
1 mg/day of Pls purified from scallop produced a small but significant improvement in memory performance at 30 min after the intervention as compared with placebo (p = 0.04).
---
Intervention: 1 mg/day of Pls purified from scallop
Comparator: placebo
Outcome: WMS-R (30 min) Score in the patients aged 77 years or younger, 

intervention:
  mean: 24.48
  standard
---
###Answer: yaml-extract-from-table-1-true:
mean: 4.25
standard_deviation: 5.93
group_size: 80
mean: 5.96
standard_deviation: 1.10
group_size: 8
---
###Answer: type: text
###Answer: x
---
1 mg/day of Pls purified from scallop:

###Answer: table of mean outcome and standard deviation in YAML format for the Intervention, Comparator, and Outcome: 1 mg/day of Pls purified from scallop as administered in the clinical trial, which is summar
---
1 mg/day of Pls purified from scallop: 
WMS-R (30 min) In the patients aged 77 years or younger,
---
Intervention: 1 mg/day of Pls purified from scallop
Comparator: placebo
Outcome: WMS-R (30 min) In the patients aged 77 years or younger,
---
###Answer: type: application/x-yaml
---
",True
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,[],,False
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,[],"
intervention:
    yaml: 3.16
    x
comparator:
    yaml: x

###Answer: OPTION A IS CORRECT.
---
certolizumab-pegol-trial-2017-tables.yaml
---

###Answer: {
  ""yaml"": ""intervention: mean: 3.385, standard_deviation: 0.9905666, group_size: 40\ncomparator: mean: 1.172, standard_deviation: 0.6
---

---
###Answer: yaml.
---
###Answer: (Based on the data in the image)
---
",True
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,0.8773,0.0082,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,[],"
---
intervention:
  - mean: 9.20
  - standard_deviation: 1.86
  - group_size: 394
comparator:
  - mean: 4.99
  - standard_deviation: 1.54
  -
---
###Answer: > intervention:
  - mean: 30.9
  - standard_deviation: 6.5
  - group_size: 390
- comparator:
  - mean: 30.8
  - standard_deviation: 6.8
 
---

---
certolizumab pegol: 200 mg + methotrexate,
total number of subjects: 858,
mean improvement in SF-36 PCS: 5.88,
standard deviation: 2.143,
group size of intervention: 
---
###Answer: yes
---
###Answer: yaml
---
",True
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,[],"###Answer: tableofmeanstandard_deviationgroup_size intervention: x x resveratrol: 0.9 (0.0) 0.6 (0.0) 22 0.8 (0.1) 0.4 (0.1) 22 placebo: 
---
###Answer: table 2 CA-125 levels after resveratrol or placebo supplementation.
---
Intervention:
  - mean: 10.8
  - standard_deviation: 3.4
  - group_size: 22
Comparator:
  - mean: 12.7
  - standard_deviation: 5.9
  - group_size: 2
---
###Answer: 457.0, 54.6, 49
---
",True
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,[],"
---
<yaml>
  - type: result
    intervention:
      mean: 0.09
      standard_deviation: 0.04
      group_size: 86
    comparator:
      mean: 0.07
      standard_deviation: 0.04
---
###Answer: type: table   <p>Intervention, Comparator, and Outcome: <p>  * Intervention: Vitamin D plus calcium supplementation  * Comparator: Placebo  * Outcome: insulin  * Total size of each group for Intervention and Comparator: 1
---
###Answer: 71.81.9
---
###Answer: yaml
---
",True
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,[],"Correct response rate for 2,000 Hz frequency:  44% (35%, 53%)",False
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,3.63162908,0.0563916,,,,,,TRUE,9086,4934,TEST,[],"
mtl+caloric intake group: 90
choices group: 100
standard deviation: x
group size: x

###Answer: OPTION B IS CORRECT.
---
###Answer: 81.0, 15.6, 49
---

###Answer: 21.271303658491893, 1.6738871955824772, 480
---
###Answer: 7.0 x .71
---
###Answer: 5.8, 1.4, 98
---
",True
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,0.19746629,0.09154041,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,[],"Intervention:
    mean: 1.45 x 10^-1,
    standard_deviation: 4.35 x 10^4
    group_size: 18
Comparator:
    mean: ,
    standard_deviation: ,
    group_size: 
---
###Answer: diet, exercise, lifestyle, weight-loss and oral glucose-lowering drugs (metformin)
table:
  label: Table 1
  summary: A table summary is usually optional but recommended when possible.
  table-wrap: class=""table-wrap"" style
---
###Answer: Table 4 (see table at the end of this section)
---
###Answer: Yes, the outcome ""triglycerides levels"" has numerical information extracted from the article and listed in the table below.
---
###Answer: [Triglycerides levels: {metformin: [mean: 155.5, standard_deviation: 39.9, group_size: 14], placebo: [mean: 173.4, standard_deviation: 33.2,
---
###Answer: <p>mean: 173.75, standard_deviation: 76.097, group_size: 21</p>
---
",True
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,22.6,4.1,31.9,6.7,-1.6526241,0.08942639,,,,,found in fig3,TRUE,6401,5359,TEST,[],"###Answer: 48.573333333333336, 10.108, 30
---
###Answer: <p>intervention: mean: 144.1, standard_deviation: 43.4, group_size: 30<p>comparator: mean: 143.1, standard_deviation: 39.4, group_size: 30
---

---
intervention:
  mean: 0.8
  standard_deviation: 0.9
  group_size: 100
comparator:
  mean: 0.6
  standard_deviation: 0.4
  group_size: 100

---
###Answer: type: integer, minimum_should_be: 0, text: ""0.82"", type: integer, minimum_should_be: 0, text: ""0"", has_answer: true, explanation: ""Mean, Standard Deviation, Group Size"", example: ""intervention: mean:
---
###Answer: <p>12.5 (6.5-11.5) mg</p>
---

intervention:
    meaning: morphine requirements
    table: 
        - style: ""html""
        - title: ""mean(+) standard_deviation""
        - header:
            - col_type: ""multicolumn""
            - col_align: ""center""
            - col_sort:
---
",True
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,[],"###Answer: <p>x</p>
---
###Answer: <p><strong>Description: </strong>Based on the given trial article, the table of mean outcome and standard deviation in YAML format for the intervention <i>Whole-body to cold (whole-body cryostimulation, WBC)</i> and comparator <i>Who
---

intervention:
    Outcome:
    - systolic BP:
        mean: 120.3
        standard_deviation: 8.92
        group_size: 12
    - systolic BP:
        mean: 115.0
       
---
",True
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
###Answer: intervention: heart rate: ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x"" comparator: heart rate: ""mean"": ""x"", ""standard_deviation"": ""x"", ""group_size"": ""x""
---
###Answer: |51.14|
---
",True
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,[],"
intervention:
    symptom_improvement: 0.17, 0.04
comparator:
    symptom_improvement: x, x
###Answer: yes
---
###Answer: table: <p>Allogeneic mesenchymal precursor cells result in better symptom improvement</p>
---
Based on the given article, the YAML file should be the following:
intervention:
  mean: 3.0
  standard_deviation: 0.4
  group_size: 30
comparator:
  mean: 2.0
  standard_deviation: 0.5
---
###Answer: yaml
---
###Answer: 1 tab. below:
---
",True
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,0.0305,0.009,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,FALSE,12997,7944,TEST,[],"###Rationale: 1) intervention group, i.e. patient empowerment through information booklet and diary keeping - males 2) control group, which received standard care - males 3) Health-Related Quality of Life at 12 month - males . mean: 71.327
---
###Answer: 32 rows
---
###Answer: comparator: OUTCOME: Health-Related Quality of Life at 12 month - males mean: 65.72 standard_deviation: 15.38 group_size: 315
---

---
### Answer: 69.27, 95% CI 66.45-72.14, 229
---
InterventionMale: mean: 6.4, standard_deviation: 2.5, group_size: 326ComparatorMale: mean: 6.6, standard_deviation: 2.2, group_size: 324
---

Intervention:
    males:
        mean: 76.4
        standard_deviation: 10.1
        group_size: 108
comparator:
    males:
        mean: 73.9
        standard_deviation: 9.1
        group
---
",True
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,Data is unavailable.,FALSE,1731,1429,TEST,[],"###Answer: yaml
---
###Answer: <p>mean: 392.8, standard_deviation: 69.2, group_size: 38</p>
---
",True
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,1.9928,0.3741,,,,,,TRUE,13404,7477,TEST,[],"artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC: NUMBER, ""x"" / control: NUMBER, ""x""
---
ACVC-HA: 3.12 (0.79) / 15
control: 4.30 (0.79) / 15

###Answer: yes
---
intervention:
  - mean: 4.0 
  - standard_deviation: 0.6 
  - group_size: 7 
comparator:
  - mean: 4.0 
  - standard_deviation: 0.0 
  - group_size:
---

---

intervention:
  - mean: 6.2
  - standard_deviation: 0.9
  - group_size: 8
comparator:
  - mean: x
  - standard_deviation: x
  - group_size: 8

###Answer: yes
---
cervical_spine:
intervention:
  - mean: ""0.144""
  - standard_deviation: ""0.013""
  - group_size: ""30""
comparator:
  - mean: ""0.126""
  - standard_
---
",True
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,0.4563,0.171,,,,,,TRUE,6951,5679,TEST,[],"right DLPFC anodal tDCS improved overall WM performance in adults with high-functioning ASD compared to sham stimulation.
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) improved overall
---
###Answer: Right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) (n=20) 
	→  Mean: 0.25, Standard Deviation: 0.74, Group Size: 2
---

intervention:
  - mean: -0.25
  - standard_deviation: 0.71
  - group_size: 33
comparator:
  - mean: -0.13
  - standard_deviation: 0.82
  - group_size
---
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal tDCS vs sham stimulation: right dorsolateral prefrontal cortex (DLPFC) anodal tDCS > sham stimulation
---
right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS)
    mean: 0.39
    standard_deviation: 0.48
    group_size: 18
sham stimulation
    mean
---
###Answer: right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS): x, x; sham stimulation: x, x
---
",True
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,0.39232146,0.2621027,,,,,Values are from 24 months,TRUE,6118,5345,TEST,[],"289252086765000000"", ""mean"": 0.010160146585429703, ""standard_deviation"": 0.0049729453064399
---
###Answer: type: text; value: ""intervention"": {
  ""mean"": 714.5,
  ""standard_deviation"": 149.1,
  ""group_size"": 11
},
""comparator"": {
  ""mean"": 770.
---
A table of mean outcome and standard deviation in YAML format for the given trial article:
###Answer: true
---
###Answer: medial tibial cartilage volume loss: x
---
###Answer: <p>Intervention: Allogeneic mesenchymal precursor cells<p>Comparator: Control<p>Outcome: medial tibial cartilage volume loss<p>mean: 7.63164309624051e-05
---
",True
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,-0.0084,0.0788,,,,,Outcome originally just Motion range.,FALSE,7041,2968,TEST,[],"laser-therapy:
    intervention:
        mean: 16.15
        standard_deviation: 5.87
        group_size: 6
    comparator:
        mean: 14.00
        standard_deviation: 4.97
       
---
Intervention:
    table:
        - intervention:
            - motion_range_subacromial:
                mean: 86.7
                standard_deviation: 11.1
                group_size: 10
            - motion_range_abduction:
                mean:
---
###Answer: type:yaml > table-wrap > table > tr > th > Intervention: Laser therapy (Group I) > Comparator: Placebo laser therapy (Group II) > Outcome: Motion range - Shoulder adduction > tr > th > mean > x > 49.3
---
",True
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,[],"
###Answer: <p> remifentanil: 1.15 (0.28)</p>
---
###Answer: <<""mean"": [135.08948, 89.35533], ""standard_deviation"": [6.066518, 9.653459], ""group_size"": [192.0, 58
---
",True
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,-0.2792152,0.04589751,,,,,,TRUE,9725,6231,TEST,[],"Intervention, Comparator, and Outcome: deliveries

###Answer: yes
---
baseline characteristics: deliveries
###Answer: table
---
###Answer: table-wrap; border: 0px; padding: 0px; margin: 0px; font-family: inherit; font-style: inherit; font-variant: inherit; font-weight: bold; font-stretch: inherit; font-size: 9pt; line-height: inherit
---
###Answer: [KS400-Outcomes-Baseline_characteristics-deliveries.yaml]
---
###Answer: yes
---
###Answer: [ykdata yaml]
---
",True
